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Part I. Five approaches, including two successful routes, toward the synthesis 
of the 1,7-dioxaspiro[5.5]undecanyl segment 7 of the macrolide antibiotic rutamycin B 
are described. The first plan for synthesis of 53 envisioned an aldol condensation of 
aldehyde 55 with ketone 57. Aldehyde 55 was prepared from (S)-(-)-4-benzy1-2­
oxazolidinone (67) in eight steps. Ketone 57 was obtained from methyl (R )-(+3­
hydroxy-2-methylpropionate (65) in fifteen steps. 
The second approach to 53 was based on addition of a higher order cuprate 
derived from iodide 60 to epoxide 59.  Iodide 60 was produced from (S)­
hydroxymethylpropionate 66 in eleven steps. Epoxide 59 was obtained from aldehyde 
55 via a three step route. 
A third advance toward 53 utilized the dianion of sulfone 61 and the epoxide 
59. Sulfone 61 was prepared from iodide 60 through straightforward displacement. 
The failure to obtain 53 by any of these three routes is rationalized. 
The first successful pathway to 53 involved coupling of hydrazone 58 with 
amide 56. Hydrazone 58 was formed in situ from the ketone 57, while preparation of 
amide 56 required two steps from aldehyde 55. Treatment of the coupled product 111 
with acid gave dihydroxy spiroketal 112. 
Redacted for PrivacyThe second successful route employed a Julia coupling of sulfone 63, obtained 
from iodide 60, with aldehyde 62. Under mild acidic conditions, the ketone 124, 
obtained from the Julia adduct 122 in two steps, underwent cyclization to trihydroxy 
spiroketal 1. The structures of both 1 and 112 were confirmed by comparison with 
authentical samples. 
Part IL Continuation of the sequence from 112 toward the total synthesis of 
rutamycin B is described. Wadsworth-Emmons reaction of phosphonate 7, prepared 
from hydroxy ketone 125 in four steps, with keto aldehyde 10 afforded 158. Aldehyde 
10 was prepared in seven steps from 133,  obtained from (R)-3-hydroxy-2­
methylpropionate (65). Aldehyde 9 was also obtained from 133 through a twelve-step 
sequence. The hydroxy ketone 159, obtained from titanium tetrachloride-mediated 
aldol condensation of aldehyde 9 with 158, was protected as its hexasilyl ether 160. 
Strategies for the final conversion of 160 to rutamycin B are discussed. ®Copyright by Shan Wang
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 Synthetic Studies on the Macro lide Antibiotic Rutamycin B 
Chapter I: General Introduction 
Brockmann and Henkel isolated the first macrocyclic antibiotic, which  they 
named pikromycin because of its bitter taste, from a strain of Streptomyces in  1950.1 
The structural characteristics of pikromycin and of other related antibiotics isolated 
subsequently showed a common feature - a macrocyclic lactone. Woodward proposed 
the term "macrolide" to describe this class of compounds.2 
e2 
R1 = OH, R2 = CH3, R3 = H: Erythromycin A 
R1 = H,  R2 = CH3, R3 = H:  Erythromycin B R = OH: Pikromycin 
R1 = OH, R2 = H,  R3 = H:  Erythromycin C R = H:  Narbomycin 
R1 = H,  R2 =H,  R3 = H: Erythromycin D 
R1 = OH, R2 = CH3, R3 =OH: Erythromycin F 
Macrolides are ubiquitous in nature, occurring in a very wide variety of 
organisms including marine species. Microorganisms of the Streptomyces family are 
an especially prolific source of macrolides.  Many macrolides possess antibiotic 
activity, and a few, such as the erythromycins,3 are highly valued for their medicinal 
properties. As a structural class, macrolides surpass even the steroids in their spectrum 
of biological activities. Not surprisingly, there has been a great deal of interest in the 
synthesis of macrolide antibiotics, with the result that many innovative strategies have 
been developed for assembling the complex architecture of these substances. 2 
Two issues of paramount importance must be faced when considering the 
synthesis of a complex macrolide. First, there is the systematic creation of multiple 
chiral centers, some of which may be subject to stereomutation en route to the target. 
The second challenge is the closure of a seco acid to a highly functionalized, often 
labile lactone at or near the final stage of the synthesis. Our investigation of synthetic 
routes to the antibiotic rutamycin B have addressed these  dual problems with 
interesting, and sometimes unexpected results. These studies have served not only as a 
test-bed for new methodology, but also as a stimulus for the  invention of fresh 
synthetic strategies. 
Thompson and co-workers4 isolated rutamycin A in 1961 from cultures of 
Streptomyces griseus. Its structure and relative stereochemistry were elucidated by X-
ray diffraction.5 The discovery of this natural product was followed by the isolation of 
a close structural analogue, rutamycin B, from cultures of Streptomyces aureofaciens 
by Keller-Schierlein,6 who assigned its relative stereostructure by NMR spectroscopy. 
The assignment of absolute configuration to the rutamycins is due to Evans and co­
workers, who completed an asymmetric synthesis of the spiroketal segment 1.7 
17 
R = OH: Rutamycin A  1 
R = H:  Rutamycin B 3
 
Like other members of the oligomycin8 family of macrolide  antibiotics,9 
rutamycin B possesses a 1,7- dioxaspiro[5.5]undecanyl ring system which is integrated 
into a 26-membered macrolactone ring biosynthesized largely from propionate units. 
Macrolide  R1  R2  R3  X 
Oligomycin A  Me H  OH CH2 
Oligomycin B  Me H  OH CO 
Oligomycin C  Me H  H CH2 
Oligomycin E  Me OH OH CO 
Rutamycin A  H  H OH CH2 
Rutamycin B  H  H  H  CH2 
Phthoramycin 
Within this group, the structure of rutamycin B represents variations in the degree of 
oxidation at C28 and the substitution pattern at C26. This family of macrolides also 4
 
shares important structural similarities with  cytovaricin10 and the closely related 
macrolide phthoramycin.11 
Like cytovaricin, the rutamycins are cytotoxic and have potent antifungal 
activity.  Rutamycin B has been shown to prevent oxidative phosphorylation in 
mitochondria by inhibiting H+-ATPase.12,13 In almost every biological system ATP 
is used either directly or indirectly as an energy source. As most cell types are 
impermeable to ATP, it must be recycled in each cell. Consequently, every cell type 
throughout the biological world catalyzes an ATP synthesis-hydrolysis cycle of the 
ATP 
Energy Input 
Coupling 
Deenergized 
Processes 
{Oxidation 
Phosphorylation 
Glycolysis 
by 
"ATPases" 
Energized 
Processes 
ADP  Maintenance of 
Pi  Normal Cell Function 
Fig. 1.  ATP Synthesis-hydrolysis cycle catalyzed by most living cells 
general type depicted in Figure 1.12 This cycle is of critical importance to  individual 
cell function and, therefore, to the function of intact prokaryotic or eukaryotic 
organisms. As a case in point, a 70 kg adult human while at rest may turn over as 
much as 50% of his/her body weight in ATP per day, a value that may increase under 
working conditions to almost 800kg, or roughly one ton.  Consequently, the ATP 
synthesis-hydrolysis cycle of each cell type must be able to respond on demand to 
energy needs and to operate in a tightly coupled manner.  This remarkable feat is 
accomplished by a diverse variety of 'ATPase' enzymes, of which at least three classes 
are 'ion motive' ATPases. The mode of action of rutamycin B is believed to involve 5
 
termination of the H+ transferring process in mitochondria in order to prevent oxidative 
phosphorylation. This results in termination of the cycle and death of the cell, as 
illustrated in Figure 2.12 
H+ 
SLAVES 
MASTER 
(F0F1) 
Fig. 2. Coupling relationship between the master 'ion motive' ATPase (F0F1) and the slave ATPase 
The many important roles that macrolides perform in living systems,  from 
regulatory functions to defense against predators, have led organic chemists to study 
these complex, naturally occurring structures in great detail. Most recently,  these 
investigations have taken the form of synthetic exercises that have led to some notable 
achievements in the field, such as the total synthesis of bryostatin by Masamune,13 the 6
 
total synthesis of halichondrin B by Kishi,14 and the total synthesis of avermectin B la 
by Hannessian, Ley and White.15 
Me02 
0 
0 
AcOs'*.  ''''  OH 
CO2Me 
Bryostatin 7  Avermectin Bia 
OH 
Forty years ago, one of the most distinguished organic chemists of this century 
made an often-quoted remark about the synthesis of erythromycin. The late Professor 
Woodward16 stated: "Erythromycin, with all our advantages, looks at present quite 
hopelessly complex, particularly in view of its plethora of asymmetric centers...." A 
comparison of the nine stereocenters of erythromycin with the seventeen stereogenic 
carbons in rutamycin B puts Woodward's pessimism in a historical context that nicely 
illustrates the enormous progress made in stereoselective synthesis since his time. As a 7
 
footnote, it should be added that Woodward achieved a brilliant synthesis of the 
"hopelessly complex" erythromycin shortly before his death in 1981 (Scheme 1).17 
r 
OMe 
1) mesitaldehyde dimethyl 
acetal, TFA 
2) EtSLi, HMPA 
3) CICOS-2-pyr, Et3N 
4) toluene, reflux 
0 H
1--N,, 
0, 
H 
0  0 
Erythromycin A  Erythronolide A 
derivative 
Scheme 1 
The first synthesis of a polyoxomacrolide 18 antibiotic, methymycin, was 
accomplished in 1975 by Masamune and co-workers.19 This was a significant event, 
as it catalyzed a vigorous level of subsequent activity in the area of macrolide 
synthesis. Extensive efforts in this arena have brought about new concepts, strategies, 
and methods for the construction of these structurally unique macrocyclic systems. 
Above all, the synthesis of methymycin demonstrated that medium- and large-ring 
lactones could be obtained from their corresponding seco acids, e.g. 2 (Scheme 2). 8
 
This was contrary to the then prevailing view, based mainly on Stoll's classic work,20 
which held that such intramolecular cyclization was inherently disfavored. 
(CF3CO)20 
> 
'OTBS
Ho HO 
2 Methymycin 
Scheme 2 
The methymycin synthesis,19 however,  disclosed a fundamental problem 
associated with macrolide synthesis. Creation of the many chiral centers arrayed along 
the open-chain (acyclic) seco acid demanded a level of stereocontral that was 
unavailable at the time. Synthetic strategies designed to overcome this problem have 
developed primarily along three lines:21 
1. The Ring Approach. This traditional but still effective method makes use of 
the clearly defined cis and trans relationships of substituents on a cyclic system, often a 
five- or six-membered ring, that is amenable to stereocontrol. Ring cleavage transfers 
this stereochemistry to the resulting acyclic system. 
2.  The Carbohydrate Approach.  The inherent stereochemistry of 
monosaccharides, such as glucose, is transferred to segments of macrolides through 
appropriate chemical operations. Thus, the many readily available monosaccharides 
conveniently serve as a "chiral pool". 
3. The Acyclic Approach. Chiral, open-chain segments of macrolides are 
stereoselectively constructed from acyclic precursors. This approach, which can be 
iterative, is a relatively new development in synthesis but has shown great promise. 9 
The advantage of this last approach is obvious.  Repetition of a synthetic 
operation, if executed with high diastereoselection (and enantioselection) at each step, 
would greatly simplify the synthetic design and minimize the number of steps leading 
to a seco acid. The challenge associated with acyclic stereoselection is formidable,  but 
this technique has been investigated intensively in recent years and many new methods 
for the elaboration of chiral centers have been invented using this principle. This thesis 
will describe a convergent, acyclic approach toward the macrolide rutamycin B that 
will illustrate some of these methods. 
1. Carboxyl Activation: 
= 
Mukaiyama  Corey 
0 
0  CI 
Yamaguchi 
2. Hydroxyl Activation: 
02H 
X =  Ph3P®  Mitsunobu 
Scheme 3 10
 
Retrosynthetic analysis of rutamycin B suggests several  plausible 
disconnections of the macrocycle. Two of these are at the bond between C17-C18 and 
at the lactone C-OR bond. This analysis permits two possible modes of ring closure 
involving either macrolactonization or connection of two (E)-alkene units to form the 
trans, trans-conjugated diene system.  Conventionally, macrolide syntheses are 
completed by closing the ring from a seco hydroxy acid in the final step, as in the 
Evans' synthesis of rutamycin B.19 The alternative approach to synthesis of rutamycin 
0 0 
-O. + 
..,...  H'' e 
OBz 
CO2H 
4-t-butyl-N-isopropyl­
2-imidazoly1 disulfide, 
PPh3 
0 
Erythromycin A  Erythronolide A 
derivative 
Scheme 4 11 
B, in which macrocyclization is envisioned by means of a diene construction, offers a 
novel but largely untested stratagem.  Fortunately, many reagents based on 
organopalladium, organocopper and organotin species, to name a few, have become 
available to facilitate synthesis of 1,3-dienes. This approach to rutamycin B would 
provide a rigorous test of this methodology in an exceedingly complex venue. 
CHO
 
-.­
TES
"MOTES 
t-BuS  0  t-BuS  0 
1) NaBH4 
2) (Cl2CHCO)20 
3) AcOH 
4) CuOTf; i-Pr2NEt 
.1­
.1­
."'OH 
I 
0  '40H 
6-Deoxyerythronolide B  R = COCHCl2 
Scheme 5 
As stated above, Masamune's19 synthesis of methymycin first established the 
viability of the "seco acid" approach to macrolides.  In the intervening years, 
macrolactonization methods9 have greatly increased in scope and efficiency. Of the 
two most frequently employed techniques for macrolactone synthesis from (o-hydroxy­12
 
carboxylic acids (Scheme 3), that invoking carboxyl activation is by far the most 
common. 18c,23,24,25  The Corey (Scheme 4),26 Masamune (Scheme 5)27 and 
Woodward (Scheme 1)17 syntheses of erythronolide, Grieco's synthesis of tylonolide 
(Scheme 6),28 and Evans' synthesis of cytovaricin (Scheme 7)29 all exemplify this 
method.  Hydroxyl activation, as in lactone synthesis based on the Mitsunobu 
reaction,30 is the other more limited alternative. Few general techniques have been 
reported in the past three decades that have been able to increase the efficiency of 
macrolactone synthesis by this latter approach. 
OH 
CHO 
1) 2,21-dipyridyl disufide, 
PPh3 
2) toluene, reflux 
Tylonolide 
Scheme 6 13 
OTES 
OTES  Me0 
Me0,, 
0 
0  TES  t-Bu t-Bu 
TES,  t-Bu  ,t-Bu  Si 
O  %Si  5 
07ts ,OTES 
/711:0TES  9
O 0  TES 
... 
H TES  HO2C
1  OPMB PhSO2  H02C"  OH 
+ 0 
ODEIPS 
OPMB  OTBS 
OCH 20CH2C C13 
OHC 
OTBS 
DMAP-HCI, DMAP, DCC, 
CHCI3 
OTES 
MeO,,, 
0 
TES%  t-Bum  t-Bu 
O  Si O 
7;0 0.0H 
DTES ,OH 
0 0 
"0  ODEIPS "0  OH  OTBS 
Cytovaricin 
Scheme 7 14 
By contrast, many new methods for constructing conjugated diene systems have 
been devised that are both high yielding and broadly applicable. One of them was 
illustrated in Nicolaou's total synthesis of 0 -mycinosyltylonolide,31 where an 
intramolecular Wadsworth-Emmons reaction32 was used to produce a trans,trans­
diene and close the ring (Scheme 8). Recently, much attention has been devoted to the 
(MeO 
K2CO3, 18-crown-6 
> H  OH 
R 
1 
0-Mycinosyltylonolide 
Scheme 8 
synthesis of conjugated dienes using the palladium(0)-catalyzed coupling of vinyl 
iodides with either vinylstannanes (Stille)33 or vinyl boronates (Suzuki),34 and it has 
been demonstrated that these processes can succeed with highly functionalized 
coupling partners (Scheme 9). 
R'  R"\__= \_-_­ BR°12 R._______, SnBu3
R R  +  Pd(0) 
R" ".-----..-**--%..
R' 
Stine  Suzuki 
Scheme 9 
Evans' strategy for the synthesis of rutamycin B22 involved initial construction 
of the diene unit through a palladium(0)-catalyzed reaction of the vinyl iodide 4 with 
the vinyl boronate 3 (Suzuki coupling). The macrocycle was completed by connecting 15
 
the secondary alcohol at C25 with the carboxyl moiety using the macrolactonization 
technique of Yonemitsu.35  The latter is a modification of the Yamaguchi25 
macrolactonization method (Scheme 10). 
3 
31 
Rutamycin B 
4 
Scheme 10 
As pointed out above, our goal was not only to complete a total synthesis of 
rutamycin B, but also to use the route for the exploration of new synthetic strategies 
and as a test-bed for new methodology. Bypassing the more conventional approach in 
which lactonization is the ring forming step in macrolide synthesis, we chose to 
connect the diene unit of rutamycin B as the means for effecting closure of the 
macrolide. Our initial synthetic plan shown in Scheme 11 divides the synthesis of 
rutamycin B into construction of two segments, the polypropionate fragment 5 and the 
spiroketal 7. This retrosynthetic analysis arises through disconnection of the C15-C16, 
C17-C18 and C2-C3 bonds. It was originally intended that the C16-C17 unit 6 would 16
 
be inserted at the final step via a Stille33 coupling. However, as events unfolded, we 
found that a plan incorporating the bis(stannyl)ethylene moiety in this manner was 
impractical. Furthermore, the presence of many functional groups in our synthesized 
precursors frustrated attempts to introduce the vinylstannane moiety early in the 
synthesis. These obstacles, ultimately led to a new synthetic strategy based on the 
conjugated diene construction mentioned above. 
RO  0  OR 0 
0
5 
Bu3Sn 
18  _\.=\ 
0  SnBu3 
25  6 0  26 
28  21/O  OH
 
29
 
30  31 
Rutamycin B 
7 
Scheme 11 
The formation of a C-C bond by coupling sp2 carbons owes its early 
development to studies carried out on the synthesis of biaryl systems. The most 
extensively exploited methodology for the elaboration of symmetrical biaryls is the 
classical Ullmann reaction,36 usually defined as the copper-mediated self-coupling of 
an aryl halide (Equation 1). A major advance in this area was made in the early 17 
1970s, when Semmelhack and co-workers discovered that a nickel(0) reagent could be 
used in place of elemental copper (Equation 2).37 Later, they used the same nickel(0) 
species in the presence of triphenylphosphine to form a trans,trans -diene through direct 
dimerization of an alkenyl halide (Equation 3)38 (Scheme 12). 
"Cu"
ArX  ArAr  eq. 1 
Ullmann 
Ni(COD)2, DMF, 50°C 
eq. 2 
Semmelhack 
R 
eq.3 
Scheme 12 
Many improvements have been made since these original reports, including the 
introduction  of more convenient reagents  such  as  tripheny1-39 and 
trialkylphosphinenickel(0) species40 as well as a nickel(0) reagent prepared by 
reduction of nickel(11) chloride using zinc in the presence of potassium iodide and 
thiourea.41 However, this nickel(0)-mediated trans,trans-1,3-diene construction has 
never been attempted in the context of a macrolide synthesis. 
The synthetic plan in final form is illustrated in Scheme 13. It hinges on the 
initial connection of the spiroketal 7 with aldehyde 10 through a Wadsworth-Emmons 
olefmation,32 then on aldol coupling of the resulting ethyl ketone via its titanium 
enolate42 with the aldehyde 9. A Takai reaction43 would be used to install the vinyl 
iodide at C16, and an ensuing ring closure with a nickel(0) reagent44 would give 
rutamycin B. 18
 
00H 
Takai 
4_.16 OH 0  OH 0
17 r<  I  0I 2 I 
>  0 
OH  0  OH 
Rutamycin B  8 
18 
1 
2
,i:)(0E1)2 
9 H  .OR  0  0 
16 
RO  OR OR' 0  O 
13 
O 
9  10 
Scheme 13 
Both Evans' synthesis of rutamycin B (Scheme 10) and our own retrosynthetic 
plan (Scheme 13), make use of a 1,7-dioxaspiro[5.5]undecane moiety as a key building 
block. Our putative spiroketal 7 harbors eight of the seventeen stereogenic centers of 
the natural product, and therefore careful attention must be paid to the stereocontrolled 
construction of this complex intermediate. Prior to the discussion of its preparation, it 
is  appropriate  to  first  review  the  chemical  properties  of  the  1,7­
dioxaspiro[5.5]undecane ring system and how they can be used advantageously. 
Spiroketals45 enjoy widespread occurrence as substructures of natural 
substances from many sources, including insects, microbes, plants, fungi, and marine I 
19
 
organisms. The increasing pharmacological importance of compounds containing 
spiroketal assemblies has triggered intense interest in their synthesis.  1,7­
Dioxaspiro[5.5]undecanes have been particularly well studied and are the most easily 
analyzed spiroketals for their preferred conformations. Where there is symmetrical 
substitution, there are four possible all-chair conformers of this system corresponding to 
II 
%_._.  B 
R' 
1 anomeric 
effect 
Iv 
R' 
no anomeric 
2 anomeric  1 anomeric  effect 
effects  effect 
A  /wen
B ring 
III 
B R' 
Fig. 3. All-chair conformations of 1,7-dioxaspiro[5.5]undecanes 
independent inversion of each six-membered ring, as shown in Figure 3.46  In the fully 
unsubstituted case, it has been shown that I is the most stable conformer of the 
dioxaspiro[5.5]undecane ring system. This has been ascribed to maximization of a 
thermodynamic anomeric effect,47 resulting from the preference for a carbon-oxygen 
bond at the 2-position of a tetrahydropyran ring to reside in an axial orientation. The 
anomeric effect is known to have a profound influence on the conformation of 20
 
spiroketals. In the case of spiro[5.5] systems, the bisaxial arrangement of spiro C-0 
bonds is commonly observed in both saturated and unsaturated rings, a structural 
feature supported by the many synthetic compounds containing this ring system that 
have been characterized spectroscopically or crystallographically.45,46,47 
Early work on the synthesis of spiroketals embedded in naturally occurring 
structures proceeded on the assumption that the configuration of the Spiro carbon 
corresponded to the thermodynamically most stable form.46,47  It was therefore 
presumed that acid-promoted spirocyclization of a dihydroxy ketone precursor should 
result in the desired configuration at the spiro center if the substitution pattern closely 
mimicked that of the natural product. This was indeed found to be a valid assumption. 
In fact, nowhere is the preference for axial C-0 bonds in spirocyclic ketals more 
apparent than in the acid-catalyzed closure of a dihydroxy ketone to form a 
dioxaspiro[5.5]undecane. Our synthetic strategy as well as that of Evans takes 
advantage of this inherent thermodynamic bias in the formation of the 1,7­
dioxaspiro[5.5]undecanyl segment of rutamycin B. 
11 
1 
TESQ  0 
V 
N,NMe2  0  0 
PMBO 
Et 
12 
- NOMe 
Me 
13 
Scheme 14 21 
Evans' synthesis of the 1,7-dioxaspiro[5.5]undecanyl segment 17 of rutamycin 
B (Scheme 14) employed, as one of the key steps, acylation of the metalated hydrazone 
13 with the N-methoxy-N-methyl amide 12.  All of the absolute stereochemical 
relationships in 12 and 13 were established through alkylation and aldol bond 
constructions using N-acyloxazolidinone chiral auxiliaries. The equatorial alcohol of 
the spiroketal 1 was obtained through a samarium-catalyzed Meerwein-Ponndorf-
Verley reduction.48 Subsequent acid-catalyzed spirocyclization proceeded smoothly 
along with deprotection. 
1) LiOOH, THE -H20
NaNTMS2, I  2) LiAIH4 
PMB 0 N  3) PMB-Br, NaH
\(Bn  Et  Et 
74%  16
84% 
14  15 
89%	  1) 9-BBN, NaOOH 
2) Swern oxidation 
0 0  OH	  0 0 
n-Bu2BOTf, Et3N  A  PMBey.,,.,CHO 0 N  OPMB '  0 +
 
100%
 \--/  6  --/.
Bn 
Me  Et
 
Bn
 
17 19  18 
1) AIMe3, MeONHMeHCI
81%  2) TESCI, imidazole 
TESO  0
PMBOIsir
OMe 
Et  Me Me
 
12
 
Scheme 15 
Evans' synthesis of amide 12 began with the acyloxazolidinone 14, which had 
been prepared previously.49 Alkylation of the sodium enolate derived from 14 with 22 
ally! iodide afforded 15, which was subjected to saponification and reduction. 
Protection of the resulting alcohol as the p-methoxybenzyl ether 16, followed by 
hydroboration and Swern oxidation provided aldehyde 17, which was subsequently 
employed in a boron-mediated aldol reaction with the N-propionyloxazolidinone 18 to 
afford the /3-hydroxy imide 19. Transamination of 19 and silylation of the resulting 13­
hydroxy imide gave the desired amide 12 in good yield (Scheme 15). 
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Synthesis of the hydrazone 13 began with an asymmetric aldol addition of the 
boron enolate derived from N-propionyloxazolidinone 18 to crotonaldehyde. This 
provided imide 20 with excellent stereoselectivity.  Subsequent saponification, 
reduction, and monotosylation afforded allylic alcohol 21.  Chamberlin's 
iodohydroxylation procedure,50 followed by reductive removal of the iodide, yielded 
anti 1,3-diol 22, which after ketalization gave acetonide 23 as a single diastereomer. 
The synthesis of 13 was completed by conversion of tosylate 23 to the corresponding 
iodide, which was treated with the lithio derivative of acetone dimethylhydrazone to 
furnish the desired hydrazone (Scheme 16). 
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Scheme 17 
The two subunits 12 and 13 were linked through an acylation process. The 
metalated hydrazone was added to amide 12 to yield the vinylogous amide 24. Evans 
found that the correct choice of solvent and base was critical to the success of this 
reaction. The use of lithium diisopropylamide obtained from n-butyllithium in hexane 24
 
resulted in incomplete deprotonation of 13, whereas lithium diisopropylamide prepared 
by addition of methyllithium in ether to a solution of diisopropylamine in 
tetrahydrofuran gave satisfactory results (Scheme 17). 
Complete deprotection of 24 and spiroketalization was carried out under mild 
acidic conditions.  The resulting secondary alcohol 25 was protected as its tert­
butyldimethylsilyl ether 26, and the ketone was reduced to the equatorial alcohol 27 
with samarium diiodide in isopropanol (Scheme 18). 
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Scheme 18 
The spiroketal 3 was obtained from hydroxy ketal 27 through a four-step 
sequence initiated by silylation of the equatorial alcohol to give the protected ketal 28. 
Subsequent removal of the p-methoxybenzyl group and Swern oxidation of the derived 25 
primary alcohol afforded aldehyde 29, which was homologated to the vinylboronic acid 
3 using Matteson's procedure51 (Scheme 19). 
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Analysis of the polypropionate segment 4 of rutamycin B, particularly the 
presence of carbonyl groups at C7 and C11, and hydroxyl functions at C5, C9, and C13 
in 4, suggested that this linear subunit could be considered the product of four aldol 
bond connections. Each of these projected reactions is a syn aldol construction, and 
each reaction is double-stereodifferentiating in nature. Precedence for the aldol linkage 
of C8 with C9 in syn fashion had been established with achiral aldehydes for titanium 
ketone enolates by Evans52 and for boron enolates by Paterson.53 Thus, 4 could be 
formed in principle by condensation of the aldehyde 30 and the enolate from ketone 31. 26 
The I3-ketoimide 3354 in this scenario is the source of seven of the ten stereogenic 
centers in 4, all of which are set in place by either aldol or acylative bond constructions 
(Scheme 20). 
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Synthesis of aldehyde 30 began with Swern oxidation of alcohol 35, which had 
been prepared previously.55 Aldehyde 32 was treated with the (E)-boron enolate56 
derived from /3- ketoimide 33 to provide the anti aldol adduct 36. Directed reduction of 27
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fl-hydroxyketone 36 using sodium triacetoxyborohydride afforded the anti diol 37.57 
Reduction of 37 to the corresponding triol 38 using Penning's procedure58 and 
regioselective protection with p-anisaldehyde dimethyl acetal yielded the p­
methoxybenzylidene acetal 39.  Silylation of the remaining alcohol, followed by 
reductive cleavage of the acetal with diisobutylaluminum hydride,59 gave 40. The 
cinnamyl moiety was truncated by oxidation of the olefm60 followed by diol cleavage. 
The resultant aldehyde was homologated to a vinyl iodide employing a modification of 
Takai's procedure.43 Finally, Swern oxidation of the primary alcohol at the opposite 
terminus afforded the target aldehyde 30 (Scheme 21). 
The next phase of Evans' approach to rutamycin B involved synthesis of ethyl 
ketone 31, which was initiated by acylation of the titanium enolate of 13-ketoimide 33 
with the propionate-derived ortho ester 3461 to give ketal 41.  Chelate-controlled 
reduction of ketone 41 with zinc borohydride62 afforded alcohol 42, which was 
protected as its silyl ether 43. Direct reduction of the terminal imide moiety gave a low 
yield of aldehyde 45, but this problem was conveniently solved by transesterification63 
of the imide to provide thioester 44 which was reduced to 45 using Fukuyama's 
conditions.64 The synthesis of 31 was completed by Horner-Emmons olefmation65 of 
45 followed by deketalization66 of the resultant a,/3- unsaturated ester 46 (Scheme 22). 
Reaction of aldehyde 30 with the titanium enolate52 derived from ketone 31 
provided the syn adduct 47. Silylation of 47 gave 48, from which the p-methoxybenzyl 
group was removed by oxidation. The resulting alcohol was oxidized under Dess-
Martin conditions67 to give the completed polypropionate fragment 4 (Scheme 23). 30 
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With both the spiroketal 3 and polypropionate segment 4 in hand, Kishi's 
modification68 of the Suzuki coupling34 was used to connect these subunits to give the 
diene 49. The tert-butyl ester was converted to a carboxylic acid and the triethylsilyl 
protecting group was removed selectively to give the seco acid 50. Yonemitsu 
macrolactonization conditions35 were used to prepare the lactone 51, and final 
deprotection with the hydrofluoric acid-acetonitrile complex afforded rutamycin B. 
This remarkable effort by a single student in the Evans laboratory completed the first 
and so far the only total synthesis of this macrolide (Scheme 24, 25). 
Our own synthetic investigations on rutamycin B were begun well before the 
Evans' synthesis appeared in print. From the outset, our planned approach to both the 
polypropionate moiety and the spiroketal unit of rutamycin B was quite different from 
that of Evans. After Evans reported completion of his synthesis, we were able to take 
advantage of several strategic elements in his plan to advance our route. In fact, one of 
our two successful pathways to the spiroketal of 1 closely parallels that of Evans. 
However, a second and ultimately more practical route to this spiroketal was developed 
that is completely original. In particular, construction of the polypropionate backbone 
(C3-C17) follows a strategy that eschews the aldol methodology of Evans in favor of 
an iterative approach that employs asymmetric crotylation.  Also, the sequence in 
which subunits are assembled again diverges from that used in Evans' rutamycin 
synthesis. 
The first  part of this  thesis recounts the synthesis of the  1,7­
dioxaspiro[5.5]undecanyl segment 7 of rutamycin B, while the second part describes 
our continuing studies toward completion of the total synthesis of this macrolide. 32 
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Chapter II: Total Synthesis of the 1,7-Dioxaspiro[5.5]undecanyl Segment of
 
Rutamycin B
 
An important element in our synthetic plan for the spiroketal portion of 
rutymacin B is that it takes advantage of an inherent thermodynamic bias in the 
formation of the 1,7-dioxaspiro[5.5]undecane from an acyclic precursor. Uncoiling of 
the spiroketal 52 leads to a linear structure represented as the pentahydroxy ketone 53 
(Scheme 26). Our expectation that this polyhydroxy ketone will close under mild acid 
catalysis to generate the spiroketal moiety of rutamycin B in the desired configuration 
is supported by Evans' construction of a similar ketal in his synthesis of cytovaricin.29 
A rationale for this outcome is based on the fact that the spiro center (C27) possessing 
the natural configuration of 1 places the larger alkyl groups in an equatorial orientation 
while conferring maximum anomeric stabilization.46,47 
OR 
QH 
52 7 
v 
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28 23  25 
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OH OH 0  OH OH 
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Scheme 26 35
 
Three plausible retrosynthetic analyses of the linear structure 54 are outlined 
below. Pathway A postulates that 54 can arise from aldol condensation69 of aldehyde 
55 with the enolate of ketone 57 or alternatively, condensation of amide 56 with the 
enolate of hydrazone 58.70 Pathway B envisions 54 as the product of a reaction 
between epoxide 59 and either an organometallic nucleophile derived from iodide 6071 
or the anion of sulfone 61.72 Finally in pathway C, Julia coupling73 of aldehyde 62 
B 
v 
Scheme 27 36
 
with the sulfone 63, a homolog of 61, could also provide a route to the pentahydroxy 
ketone 54 (Scheme 27). 
Aldehyde 55, a key substance for preparing amide 56, epoxide 59 and aldehyde 
62, can be derived, in principle, from crotylation74 of aldehyde 64, which in turn can 
be acquired from the N-butyryloxazolidinone 14 (Scheme 28).49 Synthesis of ketone 
57 and its hydrazone 58 was envisioned by a route which starts from methyl (R)-(+3­
hydroxy-2-methylpropionate (65).75 On the other hand, sulfones 61 and 63 would be 
available from iodide 60, which could originate from methyl (S)-(+)-3-hydroxy-2­
methylpropionate (66).76  The advantage in choosing 65 and 66 as our starting 
materials was that both could provide the stereocenter at C30 of rutamycin B (Scheme 
29). 
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Pathway A: The Aldol Approach 
Synthesis of Aldehyde 55 (C19-C25 Segment) 
Synthesis of 55 began with ( S)-(-)- 3- butyryl- 4- benzyloxazolidin -2 -one (14),49 
a known compound obtained from acylation of (S)- (- )- 4- benzyl -2- oxazolidinone (67) 
with butyryl chloride. An asymmetric Michael reaction of the titanium enolate of 14 
si-face alkylation 
Fig. 4. Michael addition to oxazolidinone 14 38 
with acrylonitrile under Evans' conditions52 furnished 68 as a single stereoisomer in 
high yield. Assignment of (R) configuration at the new stereogenic center of 68 is 
based on alkylation by acrylonitrile at the si face of the enolate of 14 as shown in 
Figure 4.  The chiral auxiliary was cleaved from 68 by reduction with lithium 
borohydride, and the resulting hydroxy nitrile 69 was transformed to aldehyde 64 by 
protection of the alcohol as its tert-butyldimethylsilyl (TBS) ether 70 using tert­
butyldimethylsilyl trifluoromethanesulfonate (TBSOTO followed by reduction of the 
TiCI4, Ti(Oi -Pr)4, 0
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Scheme 30 
nitrile with diisobutylaluminum hydride (DIBAL-H) (Scheme 30) 27 
Coupling of aldehyde 64 with the (Z)-crotylboronate 71, prepared from (S,S)­
diisopropyl tartrate (DIPT) according to Roush's procedure,74 gave homoallylic 
alcohol 72 as a 5:1 mixture of two diastereomers. The mixture of alcohols was 
protected as their bis tert-butyldimethylsilyl ethers 73 and was subjected to ozonolysis 39
 
to yield 55 (Scheme 31).78 The formation of the two new stereogenic centers at C23 
and C24 can be explained by the cyclic transition state shown in Figure 5. The (S,S) 
chiral auxiliary in boronate 71 ensures that the crotyl group is directed to the re face of 
0 *,,CO2i-Pr 
TBS  /----\Bbl
CO2i-Pr 
71 
4 A MS, toluene, -78°
 
64
  72 85% 
97%  TBSOTf, Et3N, 
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Scheme 31 
the aldehyde carbonyl while Z configuration of the double bond dictates a syn 
relationship of C23 and C24. 
Synthesis of Ketone 57 (C26-C34 Segment) 
The  route  to  5 7  departed  from  (R )-(-)-2- methyl -1- [(tert­
butyldimethylsilyl )oxy]propan -3 -ol (74),79 derived from methyl (R)-(-)-3-hydroxy-2­
methylpropionate (65) through standard silylation and reduction with diisobutyl 
aluminum hydride. Alcohol 74, which provides the stereocenter at C30 of rutamycin 40
 
1. TBSCI, imidazole, 
DMF, rt (100%)
Me02E1  2. DIBAL-H, Et20, 
65  -65°C to -25°C (99%)  74 
1. TsCI, pyr, rt 
81%  2. Nal, acetone, A 
3. PhS02Na, DMF, 35°C 
propylene oxide, 
n-BuLi, HMPA, 
TBS  THF, -78°C  ROTBS 
OH  SO2Ph  91% 
78  75, R = OTs 
76, R = I 
77, R = SO2Ph 
92%  2.5% Na-Hg, EtOH, rt 
OH 
79 
Scheme 32 
B, was converted to sulfone 77 through tosylation to give tosylate 75, followed by 
displacement with iodide and then a second displacement of 76 with sodium 
phenylsulfmate.75  The anion of 77, generated by treating the sulfone with n­
butyllithium (n-BuLi) and hexamethylphosphoramide (HMPA) in tetrahydrofuran, was 
reacted with racemic propylene oxide to give hydroxy sulfone 78 as a mixture of 
stereoisomers.80 Reductive removal of the sulfone group with sodium amalgam81 
yielded 79 as a 1:1 mixture of isomers at the center bearing the hydroxyl function 
(Scheme 32). 41 
CO2i-Pr 
CO2 -Pr 
Z-crotyl, re-face addition 
Fig. 5. Transition state for (Z)-crotylboronation of aldehyde 64 with (S,S)-Boronate 71 
Oxidation of 79 with pyridinium chlorochromate (PCC)82 gave ketone 80 
which was protected as its ketal 81 with ethylene glycol. Removal of the silyl group 
from 81 using tetra-n-butylammonium fluoride (TBAF), followed by Swern 
oxidation83 of the alcohol 82, afforded aldehyde 83 (Scheme 33). 
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Several methods appeared to be suitable for producing the syn relationship seen 
at C30 and C31 of rutamycin B,69,84,85 and with aldehyde 83 in hand, it was decided 
to examine these options in the context of a route to the hydroxy ketone 89. Treatment 
of 83 with the allylboronate 84 prepared from (R,R)-diisopropyl tartrate under Roush's 
conditions (Scheme 34),84 or with the allylborane 86 generated from (+)-2-carene 
0402i-Pr 
°  (84)
"/  BO  'CO2i-Pr 
toluene, -78°C 
78% 
83 
Scheme 34 
under Brown's conditions (Scheme 35),85 provided 85 as a 4:1 (Roush's) and 8.6:1 
(Brown's) mixture of two diastereomers.  In both cases, the configuration of the 
secondary alcohol was the outcome of si face (Felkin)86 attack of the ally! group. This 
resulted from stereocontrol by the (R,R) chiral auxiliary in boronate 84, as shown in 
Me 
si-face (Fe lkin) addition 
Fig. 6. Transition state for allylboronation of aldehyde 83 with (R,R)-Boronate 84 43
 
Figure 6, and by the chiral diisocaranyl ligands in borane 86, as shown in Figure 7. 
Protection of 85 furnished the silyl ether 87 which was subjected to a Wacker 
oxidation,87 using palladium(11) chloride and copper(I) chloride as catalysts, to yield 
4_).r% (86) 
Et20, -78°C 
48% 
85 
83 
Scheme 35 
the methyl ketone 88. The latter was desilylated with the hydrogen fluoride-pyridine 
complex to give hydroxy ketone 89 in good yield. On the other hand, when 85 was 
Me 
si-face (Felkin) addition 
Fig. 7. Transition state for allylborination of aldehyde 83 with (-)-diisocaranylallylborane 86 
treated under the same Wacker oxidation conditions, only a minor quantity of 89 was 
obtained, confirming that the free hydroxyl group interferes with this process (Scheme 
36). 44
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The hydroxy ketone 89 could also be obtained in one step, in this case as a 10:1 
mixture of stereoisomers by treating aldehyde 83 with the chiral enolate69 prepared 
from acetone and (+)-diisopinocampheylborane trifluoromethanesulfonate (Ipc2BOTf) 
(Scheme 37).  Here, the ( +)- isopinocampheyl ligands serve to furnish syn 
stereochemistry by promoting addition of the ketone enolate to the si face of 83. The 
steric bias imparted by the isopinocampheyl substituents on boron is due principally to 
(+)-Ipc2BOTf, acetone, 
i-Pr2NEt, CH2Cl2, -78°C 
63% 
83 
Scheme 37 
a protruding secondary methyl substituent of one of the isopinocampheyl groups, the 
second isopinocampheyl ligand providing a buttressing effect as shown in Figure 8. 45
 
si-face addition, no induction from a-chiral center 
Fig. 8. Transition state for the asymmetric aldol reaction of 83 with acetone 
The anti-1,3-diol moiety present in ketal 90 was set in place with excellent 
stereoselectivity by a directed reduction of the /3-hydroxy ketone 89 with 
tetramethylammonium triacetoxyborohydride.57 In this reduction, borohydride is first 
coordinated to the alcohol, and the alkoxyborohydride then transfers hydride in an 
intramolecular process to the re face of the ketone as shown in Figure 9. The resulting 
IAc 
0 /
BO 
H 
M 
Internally directed re-face addition of 89 
to give anti-1,3-diol 90 
Fig. 9. Transition state for directed anti reduction of ketone89 46
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diol 90 was protected as its silylene derivative 91,88 and the ketal was selectively 
hydrolyzed in the presence of pyridinium p-toluenesulfonate (PPTS) to give ketone 57 
(Scheme 38). 
With 55 and 57 in hand, attention was turned towards linkage of these materials 
using aldol methodology.  Unfortunately, all efforts along these lines were 
unproductive.  Neither the conventional lithio enolate of 57 nor a chiral boron 
enolate69 resulted in its successful coupling with 55. In fact, only starting materials 
were recovered in all cases (Scheme 39). 
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Failure to effect the aldol condensation of 55 with 57 forced us to consider an 
alternative plan that would connect C28 with C29 instead of forming the C25-C26 
bond. Two approaches based on this strategy were explored. These were coupling of 
epoxide 59 with iodide 60 using cuprate chemistry,44 and reaction of 59 with the lithio 
derivative of sulfone 61.45 
Pathway B: Epoxide Approaches 
Synthesis of Epoxide 59 (C19-C28 Segment) 
Homoallylic alcohol 92 was prepared as a 4:1 mixture of two diastereomers by 
reaction of aldehyde 55 with Brown's89 chiral borane derived from (-)­
diisopinylcampheylmethoxyborane and allylmagnesium bromide.  The (-)­
diisopinocampheylligands on the boron atom served to furnish anti stereochemistry by 
Ipc 
H 
re-face (Felkin) addition 
Fig. 10. Transition state for asymmetric allylborination of aldehyde 55 with 
(-)-diisopinylcampheylallylborane 
addition to the re face of 55 as shown in Figure 10. Protection90 of the alcohol of 92 
as its p-methoxybenzyl (PMB) ether was carried out using p-methoxybenzyl 48 
trichloroacetimidate (93) in the presence of a catalytic quantity of triflic acid and 
yielded 94. Epoxidation of the terminal olefin of 94 with m-chloroperoxybenzoic acid 
(MCPBA) occurred with no stereoselection and furnished 59 as a 1:1 mixture of 
stereoisomers at the epoxide (Scheme 40). 
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Synthesis of Iodide 60 (C29-C34 Segment) 
The synthesis of iodide 60 started from (2S, 3S)-1-benzyloxy-2-methylhex-5­
en-3-ol (97),89 prepared from methyl (S)-(+)-3-hydroxy-2-methylpropionate (66) using 
literature methods. Protection of the primary alcohol with benzyl trichloroacetimidate, 
followed by reduction of the methyl ester with lithium aluminum hydride gave alcohol 
95.76 A quantitative Swern oxidation of the primary alcohol afforded 96. This 
aldehyde underwent asymmetric allylation using Brown's allylborane, again prepared 49
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from (-)-diisopinylcampheylmethoxyborane, to give homoallylic alcohol 97 containing 
the expected syn relationship between C30 and C31 of rutamycin B (Scheme 41). 
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Protection of 97 as its tert-butyldimethylsilyl ether 98 was followed by a 
Wacker oxidation, which provided ketone 99, and subsequent removal of the silyl 
protecting group91 furnished /3-hydroxy ketone 100. When Wacker oxidation was 
attempted directly on 97, the hydroxy ketone 100 was obtained in very low yield, thus 
confirming our previous observation that a free alcohol interferes with this process 
(Scheme 42). 
Me4NHB(OAc)3, 
CH3CN, AcOH, -30°C 
OH 0  82%  (5H OH 
101 100 
1. t-Bu2Si(OT02, 
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T 
1  12, Ph3P, imidazole, PhH, A 
O_O  0,c_O 
t-Bu' `t-Bu  96% 
102, R = OBn 60 
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Scheme 43 
As with 89, the anti -1,3 -diol moiety of 101 was set in place by a directed 
reduction of 100 with tetramethylammonium triacetoxyborohydride. The diol of 101 
was protected as its silylene derivative 102, and the benzyl ether was cleaved by 
hydrogenolysis92 to give the corresponding alcohol 103. The latter was converted to 
60 through iodination with triphenylphosphine diiodide in the presence of imidazole 
(Scheme 43).93 51 
Several attempts were made to react epoxide 59 with both the higher order 
cuprate71 derived from iodide 60 and directly with the organolithium derivative of 60, 
all of which resulted in failure. Only the reduction product 104, alcohol 103, and 
recovered 59 were obtained from this reaction (Scheme 44). 
TBS 
+ 
59 
eSCu(CN)Li 
t-BuLi, Et20, -78°C i  ,t-BuLi, Et20 
-78°C 
+ 59 +  103  0_ .,0
SI, t-Bir t-Bu 
104 
Scheme 44 
In light of our earlier success in the reaction of propylene oxide with the a­
lithio anion from sulfone 77 (Scheme 32), it was decided to examine a model reaction 
of the a-lithio anion of sulfone 61, prepared directly from iodide 60 with sodium 
phenylsulfinate, with propylene oxide.  We were encouraged to find that 
hydroxysulfone 105 was, in fact, obtained in good yield (Scheme 45). Based on this 
positive result, a variation of this approach using 59 as the epoxide component was 
next explored as a route to 54. However, in contrast to the favorable outcome of the 
model reaction with 61, its lithio derivative did not react with 59 (Scheme 46). 
Although there is good literature precedent72 for predicting success from this reaction, 52
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the process has been known to fail in circumstances94 where large steric demand is 
present in the reacting components, or where the reactivity of the lithiosulfone may be 
reduced due to complexation of the metal. Either of these factors could provide a 
possible explanation for the lack of reactivity in our case. 
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THF, -78°C - rt 
PhS02.,....,--.......r.--..T.  Recovered 59, 61 
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A Return to Pathway A: The Hydrazone Route 
Evans' synthesis of the spiroketal segment 1 (Scheme 14) of rutamycin B7 
employed the lithium enolate of hydrazone 13 in a condensation with the Weinreb 
amide 12.70 A model study carried out in anticipation of a coupling analogous to that 
106  107 
I 
Me Li (halide free), 
i-Pr2NH, THF, -78°C  0 ii 
NMe2 
NH 
25% 
MeONHMe.HCI 
DCC, DMAP, 
CH2Cl2, 0°C 
40% 
9 >C, PMe 
N, 
Me 
110 
109 
Scheme 47 
of Evans demonstrated that the lithium enolate of hydrazone 107, prepared from 6­
methyl-5-heptene-2-one (106), reacted with the Weinreb amide 109, prepared from 
butyric acid (108), to give the vinylogous amide 110. As noted by Evans,7 we found 
that halide-free methyllithium was necessary for generating the lithium 
diisopropylamide used to obtain the enolate of 107. Unless this precaution was taken, 
no condensation with 109 occurred (Scheme 47). 
Encouraged by this result, we decided to extend this approach to the 
condensation of 56 with 58.  Oxidation95 of aldehyde 55 with potassium 
permanganate, followed by treatment of the  resultant acid with N,0­54
 
dimethylhydroxylamine hydrochloride, 1,3-dicyclohexylcarbodiimide (DCC), and 4­
dimethylaminopyridine (DMAP), afforded amide 56 (Scheme 48).96 
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74% 
Scheme 48 
In a separate sequence, ketone 57 was converted to its N,N-dimethylhydrazone 
58,97 and the lithium enolate of 58 was condensed with 56 under conditions used for 
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the reaction of 107 with 109.29  Hydrolysis and spiroketalization2 9 of the 
condensation product 111 proceeded smoothly in the presence of hydrofluoric acid­
acetonitrile complex to give the desired dihydroxy spiroketal 112 (Scheme 49). The 
structure of this substance was confirmed by comparison with material prepared 
independently as described below. 
A sample of benzoate 1137,98 provided by Professor Evans was saponified, 
and the resulting alcohol 114 was oxidized with tetra-n-propylammonium perruthenate 
PMBO 
OH 
1% LiOH- H20,MeOH, rt 
99%  0  QTBS 
114 113 
1. TPAP, NMO, rt (100%) 
2. 20% Pd(OH)2/C, 
H2, EtOH, rt (100%) 
HC 
O  TBAF, THF, rt 
0 
OH  68% 
115, R = OPMB 
112  116, R = OH 
Scheme 50 
(TPAP)99 and 4-methylmorpholine N-oxide (NMO) to yield ketone 115. Reductive 
debenzylation100 of this material gave hydroxy ketone 116 from which the silyl 
protecting group was removed with tetra-n-butylammonium fluoride to furnish 112 56 
(Scheme 50). The spiroketal 112 obtained from 113 was identical by comparison of 
TLC, IR, NMR, MS and optical rotation data with the material obtained from 111. 
Since the structure of Evans' spiroketal 1137 was confirmed by comparing the spectral 
characteristics and optical rotation data of his triol 1 synthesized from 113 with the 
same spiroketal derived by degradation of rutamycins A and B, there remains no 
ambiguity with respect to the structure assigned to 112 obtained via linkage of 56 with 
58. 
Pathway C: The Julia Route 
Although our synthesis of the dihydroxy spiroketal 112 was successfully 
completed along lines pioneered by the Evans group, it was decided to explore other 
more innovative routes to this substance in the hope that they would be more efficient. 
To this end, we envisioned that a C27-C28 connection could be established via Julia 
coupling73 of aldehyde 62 and sulfone 63. In this scenario, the required equatorial 
orientation of the hydroxyl group attached to the spiroketal can be preset, thereby 
eliminating a reduction and a protection step. 
Sulfone 63 was easily accessed from iodide 60 through a displacement with the 
lithium anion of methyl phenyl sufone. Aldehyde 62 was obtained via ozonolysis of 
olefin 94, although in a disappointingly low yield. An initial attempt to couple 62 with 
the lithium anion of 63 using standard Julia conditions73 afforded none of the expected 
product. Instead, only recovered sulfone 63 and the a,fi-unsaturated aldehyde 117 
resulting from elimination of the p-methoxybenzyl ether were detected (Scheme 51). 
In further studies, it was found that the presence of a Lewis acid101,102 promoted the 57 
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condensation of 62 and 63. For example, when boron trifluoride etherate101 was 
added to the reaction mixture, the hydroxy sulfone 118 was obtained as a mixture of 
stereoisomers which underwent oxidation to produce the keto sulfone 119 in 24% yield 
over two steps (Scheme 52).  Similarly, when magnesium bromide etherate102 was 
employed as the Lewis acid, 119 was obtained in 15% yield over the same two steps 
(Scheme 53). When reductive desulfonation of 119 was attempted using 2.5% sodium 58
 
amalgam8 1 in ethanol, four products of undetermined structure were isolated. 
However, it could be seen from their proton NMR spectra that these compounds 
contained neither the p-methoxybenzyl ether nor the sulfone group. 
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The unsatisfactory yields obtained in the ozonolysis of 94 and in the Julia 
coupling of 62 with 63, along with the loss of the p-methoxybenzyl ether in the 
desulfonation step, forced us to reconsider our choice of the hydroxyl protecting group 59 
for 92. Specifically, a protecting group was needed which would be easy to install and 
remove, yet would be compatible with the synthetic sequence beyond 92. With these 
requirements in mind, we returned to the tert-butyldimethylsilyl ether as a protecting 
group. Aldehyde 121 was prepared from homoallylic alcohol 92 through protection as 
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its silyl ether 120 followed by ozonolysis. The yield of this sequence greatly exceeded 
that from 92 via its p-methoxybenzyl ether. To our delight, Julia coupling of 121 with 60 
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the lithium anion of sulfone 63 in the presence of boron trifluoride etherate afforded 
hydroxy sulfone 122 in excellent yield. Oxidation of 122 gave keto sulfone 123 as a 
mixture of two stereoisomers in 86% yield using tetra-n-propylammonium perruthenate 
and in quantitative yield (based on recovered starting material) using Swern conditions 
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(Scheme 54).  Clearly, the seemingly minor detail of the alcohol protecting group 
exercises a profound influence on the sequence of reactions from 92. Replacement of 
the p-methoxybenzyl ether by a tert-butyldimethylsilyl ether not only permits more 
efficient ozonolysis of 92 but also facilitates Julia coupling of the derived aldehyde 
121. 
Unexpectedly, reductive desulfonation of 123 was found to be problematic 
under the conventional conditions using either 2.5% sodium amalgam or aluminum 
amalgam103 in ethanol. In the first case, a desulfonated olefin was isolated, whereas 
no reaction was observed in the second.  However, when 123 was treated with 
samarium diiodide,104 the desired pentahydroxy ketone 124 was obtained in excellent 
yield. Exposure of ketone 124 to hydrogen fluoride and acetonitrile effected removal 
of all silyl protecting groups and concomitant spiroketalization to give the trihydroxy 
spiroketal 1 (Scheme 55). 
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The structure of our synthesized spiroketal 1 was again confirmed by 
correlation with the same compound obtained from the benzoate 113 provided by 
Professor Evans. In this case, a modification of the previous sequence from 113 was 
employed that afforded an improved yield of 1. Thus, reductive debenzylation105 of 
113 gave alcohol 125, which was protected as its bissilyl ether 126. The latter 
underwent saponification with 1% lithium hydroxide in methanol to yield alcohol 127, 
which was deprotected using tetra-n-butylammonium fluoride to furnish 1. This 
substance was identical by comparison of TLC, ER, 1H and 13C NMR, MS, and optical 
rotation data with the substance obtained from 124 (Scheme 56). 
TBS 
TBSCI, imidazole, DMF 
rt 
128 TBSCI, imidazole, 112  DMF, rt (86%) 
50% 
+ 
TBS 
28% 
Scheme 57 64
 
Differentiation of Hydroxyl Functions (Further Elaboration) 
of Rutamycin Spiroketal 
Our plan for attaching the polypropionate segment (C3-C15) of rutamycin B to 
the spiroketal portion and completion of the synthesis is shown in Scheme 13.  It 
envisions initial formation of the ester linkage at C25 with final closure of the 
macrocycle across C17-C18. For this purpose, the C19 terminus of the spiroketal was 
to be transformed to a vinyl iodide in anticipation that the final macrocyclization would 
be accomplished via a Stile coupling with the polypropionate subunit. For practical 
reasons, including the fact that a vinyl iodide would be compatible with all subsequent 
chemistry, we chose to install this functionality before forming the ester linkage. The 
hydroxy benzoate 125 appeared to be an ideal substrate for developing this route, and 
efforts therefore focused on bringing forward our synthetic compounds 102 and 1 to 
this intermediate. 
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Correlation of 112 with 125 
Silylation of dihydroxy ketone 112 with tert-butyldimethylsilyl chloride gave 
the desired bis tert-butyldimethylsilyl ether 129 as the minor product along with the 
monohydroxy ketone 128. The latter was converted to 129 in good yield after a second 
silylation (Scheme 57).  Surprisingly, silylation of 116 with tert-butyldimethylsilyl 
triflate in the presence of triethylamine gave the ring-opened product 130 resulting 
from elimination along with 129. Upon treatment with camphorsulfonic acid (CSA), 
130 was converted to 129 and the alcohol 128 (Scheme 58). 
Reduction of ketone 129 with samarium diiodide106 afforded the expected 
equatorial alcohol 127 as a single stereoisomer, and this was protected as its benzoate 
ester 126 (Scheme 59).107 
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Exploratory studies on 129 indicated that selective deprotection of the primary 
tert-butyldimethylsilyl ether was possible with ammonium fluoride in methanol. This 
TBS 
NH4F, Me0H, A 
116 129 
42% based on recovered 129 
Scheme 60 
reaction afforded the alcohol 116 in modest, but acceptable yield (Scheme 60). 
However, similar deprotection of 126 was discouraging, diol 131 being the major 
product of this reaction. Fortunately, treatment of 126 with hydrogen fluoride-pyridine 
gave a much improved yield of the desired primary alcohol 125 (Scheme 61). 
Correlation of 1 with 125 
With our synthesized keto diol 112 successfully correlated with benzoate 125 
derived from Evans' intermediate 113, we next turned our attention to the convergence 
of triol 1 with the same hydroxy benzoate. Precedence suggested that, in the presence 
of silver nitrate,108 a less hindered secondary alcohol can be selectively silylated in 
preference to a more crowded secondary alcohol. However, it was found that, although 
the primary hydroxyl group of 1 could be silylated to give diol 132, the two secondary 
alcohols could not be easily distinguished. After considerable experimentation, it was 
discovered that silylation of 132 using tert-butyldimethylsilyl triflate and 2,6-lutidine at 67
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low temperature109 gave the desired bisilylated spiroketal 127 in acceptable yield 
(Scheme 62).  This alcohol was shown to be identical with 127 obtained from 
reduction of 129 and was converted to 125 via 126 through the procedure described 
above. 
With the acquisition of spiroketal 125, a subunit of rutamycin B containing 
eight of its seventeen stereogenic centers has been prepared.  The absolute 
configuration of these eight centers is firmly established by direct correlation of 125 
with a substance, 113, synthesized independently. Our routes to 125 via dihydroxy 
ketone 112 and triol 1 each permit synthesis of the spiroketal moiety of rutamycin B in 68 
a form that differentiates the three hydroxyl substituents. This last feature becomes 
important in the context of further elaboration of rutamycin B spiroketal towards the 
complete macrolide. 
TBS 
OH TBSCI, pyr, 
AgNO3, THF, n 
0  OH 
1  132 
TBSOTf, 2,6-lutidine,
66%  CH2Cl2, -78°C 
TBS 
127 
Scheme 62 69
 
Chapter III: Approaches Toward the Total Synthesis of Rutamycin B 
The finalized plan for synthesis of rutamycin B shown in Scheme 13 calls for 
the condensation of phosphonate 7 with aldehyde 10 and subsequent aldol coupling of 
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Scheme 63 70 
this assembly with 9. The spirofragment 7 should be accessible from the hydroxy 
benzoate 125, whereas aldehydes 9 and 10 can both be generated from (R)-2­
methylpropanal (133).  The latter provides the stereocenters at C6 and C14 of 
rutamycin B (Scheme 63). 
Synthesis of Phosphonate 7 
The phosphonate 7 was obtained from hydroxy benzoate 125 through a four-
step sequence in which aldehyde 134, derived from Swern oxidation of 125, underwent 
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a Takai36 reaction with chromium(II) chloride and iodoform to give vinyl iodide 135. 
The latter was obtained as a mixture of (E) and (Z) stereoisomers in the ratio 18:1, 71
 
respectively.  Saponification of the benzoate of 135 gave alcohol 136, which was 
acylated with the phosphonoacetyl chloride 137 to furnish 7 (Scheme 64). 
Synthesis of aldehyde 9 (C9-C16 Segment) 
The synthesis of 9 began from alcohol 139, prepared from the hydroxy silyl 
ether 41 of (2S) configuration by a literature procedure.74b Treatment of 133, the 
product of Swern oxidation of 41, with the (E)-crotylboronate 138, derived from (S,S)­
diisopropyl tartrate,74 afforded the syn, anti homoallylic alcohol 139. As shown in 
Figure 11, the ester substituents in the chiral boronate direct the attacking crotyl group 
towards the re face of the carbonyl in a Felkin mode of addition. The anti relationship 
is dictated by the (E) configuration of the crotyl double bond. Before proceeding 
further, the secondary hydroxyl group of 139 was protected as its te rt­
butyldimethylsily1 ether 140 (Scheme 65). 
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Selective cleavage of the primary silyl ether of 140 with ammonium fluoride 
gave the alcohol 141, and a one-carbon homologation of this material was effected 
CO2i-Pr 
H 
(E)-crotyl, re- face (Felkin) addition 
Fig. 11. Transition state for double asymmetric crotylation of aldehyde 133 with (S,S)-Boronate 138 
through a standard five-step sequence that led to the bissilyl ether 146. Thus treatment 
of 141 with p-toluenesulfonyl chloride gave 142 and displacement of the primary 
tosylate with sodium cyanide in dimethyl sulfoxide yielded 143. Reduction of this 
nitrile with diisobutylaluminum hydride afforded aldehyde 144, which was further 
Fi 
0 
H 
Me 
(E)-crotyl, si- face (Felkin) addition 
Fig. 12. Transition state for double asymmetric crotylation of aldehyde 147 with (R,R)-Boronate 148 73
 
reduced to alcohol 145 with sodium borohydride in isopropyl alcohol. Final silylation 
of 145 furnished 146 (Scheme 66). 
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Ozonolytic cleavage of the vinyl group of 146 afforded aldehyde 147 in 
quantitative yield. A second double asymmetric crotylboronation, in this instance with 
the (E)-crotylboronate 148 derived from (R, R)-diisopropyl tartrate, gave 149. Here, 
Felkin addition of the crotyl group is directed by the boronate to the si face of the 
aldehyde, the (E) configuration of the crotyl double bond again dictating an anti 
relationship as shown in Figure 12. Protection of the hydroxyl group of 149 as its 
triethylsilyl (TES) ether 150 was accomplished with triethylsilyl chloride (TESC1) and 
4-dimethylaminopyridine in pyridine, and subsequent ozonolysis of the vinyl group 
delivered aldehyde 9 (Scheme 67). 
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Synthesis of aldehyde 10 (C3-C8 Segment) 
Aldehyde 133 was also the point of departure for the synthesis of 10. Lewis 
acid promoted addition of a 1:1 mixture of (E) and (Z) tri-n-butylcrotylstannanes 
(151)110 to 133 yielded the known syn, syn adduct 152. In contrast to the cyclic 
transition state invoked for boronate addition, crotylstannylation of 133 is not under 
chelation control; product geometry is therefore decided by the Felkin-Anh rule as 
applied to the open transition state shown in Figure 13. Protection of the secondary 
1.  ,,,,nBu3
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alcohol of 152 using tert-butyldimethylsilyl triflate gave di-tert-butyldimethylsilyl 
ether 153, which underwent selective removal of the primary silyl group with 
ammonium fluoride in methanol to give alcohol 154. Swern oxidation of this alcohol 
(E)-crotyl, re-face (Felkin) addition 
Fig. 13. Open transition state for crotylstannylation of aldehyde 133 with stannane 151 
yield aldehyde 155, which was subjected to a Grignard reaction with ethylmagnesium 
bromide to afford alcohol 156 as a 1:1 mixture of stereoisomers. The mixture was 
oxidized with Dess-Martin periodinanel 11 to a single ketone 157, which was ozonized 
to furnish the keto aldehyde 10 (Scheme 68). 
Assembly of Rutamycin B Subunits 
With synthesis of the three principal subunits of rutamycin B completed, 
attention was directed towards their assembly into a seco structure that would require 
only coupling of the chain ends to close the macrocycle. The sequence in which 
connection of the subunits 7, 9 and 10 was envisioned has been discussed above and is 
formalized in Scheme 63. Specifically, our plan entailed initial formation of an ester 
linkage between 7 and 10, which would become the lactone of the macrolide, with final 0 
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closure of the 26-membered ring by connection of olefin termini to forge the diene 
moiety of rutamycin B. 
Coupling of phosphonate 7 with aldehyde 10 was achieved by Wadsworth-
Emmons olefination,32 using lithium diisopropylamide as the base to form the anion of 
7. This yielded ethyl ketone 158, which underwent aldol coupling as its titanium(IV) 
enolate42 with aldehyde 9 to give 159. The stereochemical outcome at C8 and C9 of 
159 is rationalized by the transition state shown in Figure 14 and reflects a 
convergence of effects which favor re (Felkin) attack at the aldehyde carbonyl of 9 by 
H 
,.%P--.....  CI 
/ Me ,,,,,,,
H 0 
,' H 
Ti  CI  H  k 
CI IR' 
I 
CI 
(Z) enolate, re-face (Felkin) addition 
Fig. 14. Chelated transition state for aldol condensation of the titanium enolate of 158 with 
aldehyde 9 
the si face of the (Z) titanium enolate of 158. This stereoselectivity is secured by an 
architecture that invokes complexation of the aldehyde oxygen of 9 with two 
titanium(IV) species to form a bicyclic array that blocks the si face of 9. Our rational is 
based on the assumption that the aldehyde carbonyl of 9 is basic enough to coordinate 
two titanium cations simultaneously112 and that greater stereocontrol and reactivity 
arise from a complex of this type. The factors that predispose this crucial aldol 79
 
condensation to produce the syn, syn configuration across C8-C10 also include the 
presence of a bulky triethylsilyloxy substituent at the /3  carbon of the aldehyde 
component 158. This substituent obstructs the anti-Felkin pathway that frequently 
attends aldol coupling with (Z) enolates.113 Moreover, the configuration of the a' 
chiral center of ketone 158 reinforces the Felkin mode of attack on 9 since the largest 
substituent at this center remains exo in the chelated transition state shown in Figure 
14 whereas the methine hydrogen is endo.52 The aldol condensation product 159 was 
converted to its tert-butyldimethylsilyl ether to provide the hexasilylated structure 160 
in which the alcohol at C11 that must eventually be converted to a ketone is 
differentially protected (Scheme 69). 
The hexasilyl ether 160, which embodies all seventeen of the stereogenic 
centers of rutamycin B, is the furthest stage to which the synthesis has presently 
advanced. This highly functionalized substance now stands ready for conversion to a 
seco intermediate, for which a new macrocyclization protocol is envisioned. Our plan 
is to construct the bisvinyl iodide 161 through a sequence involving selective 
deprotection of the primary alcohol, oxidation to an aldehyde, and a Takai reaction 
with chromium(l) chloride and iodoform.43 It is hoped that cyclization of the diiodo 
compound 161 can be accomplished via nickel(0) catalyzed intramolecular coupling 
using nickel bicyclooctadiene complex." Selective removal of the triethylsilyl 
group114 and oxidation of the resulting secondary alcohol with Dess-Martin 
periodinane (Scheme 70) should provide the tetrasilylated derivative 51 of rutamycin 
B, the final intermediate in Evans' synthesis of the macrolide. Simultaneous removal 
of all four tert-butyldimethylsilyl protecting group was achieved by Evans using 
hydrofluoric acid in dichloromethane with acetonitrile and gave synthetic rutamycin B 
(Scheme 25) in 98% yield. 80 
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Chapter IV: Conclusion 
In the course of this research, a convergent asymmetric approach towards the 
total synthesis of the macrolide rutamycin B was devised that included two successful 
and three failed asymmetric routes to the 1,7-dioxaspiro[5.5]undecanyl segment. 
Several methods for constructing multiple chiral centers were explored in the course of 
a sequence that led to the hydroxy ketone 54. In particular, the allylboronates and 
crotylboronates of Roush proved to be invaluable for stereocontrolled elaboration of 
syn and anti relationships between vicinal centers, as was Brown's chiral 
isopinocampheylborane chemistry. In addition, important transformations were tested 
in complex structural settings that set new limits on their scope and functional group 
compatibility. These include an application of the Wacker oxidation to a terminal 
olefin, where the existence of a free 0-hydroxy group clearly interfered with efficiency; 
selective removal of a primary tert-butyldimethylsilyl ether in the presence of a 
secondary silyl ether; directed reduction of a /3- hydroxy ketone to an anti-1,3-diol with 
tetramethylammonium triacetoxyborohydride; reductive desulfonation of an a-sulfonyl 
ketone with samarium diiodide; and crotylstannylation of an a chiral aldehyde using a 
(E, Z) mixture of crotylstannanes to give a single isomer. Particularly noteworthy is 
the aldol coupling of 9 with the titanium enolate of 158 to furnish 159 with very high 
stereoselectivity. Finally, it can be said that the synthesis of rutamycin B, while not yet 
complete, has been advanced to a stage where a plausible conclusion can be foreseen. 82 
Chapter V: Experimental Section 
General 
Starting materials and reagents were obtained from commercial sources and 
were used without further purification. Solvents were dried by distillation from the 
appropriate drying agents immediately prior to use. Tetrahydrofuran and ether were 
distilled from sodium or potassium and benzophenone under an argon atmosphere. 
Toluene, diisopropylamine, diisopropylethylamine, triethylamine, pyridine and 
dichloromethane were distilled from calcium hydride under argon. All solvents used 
for routine isolation of products and chromatography were reagent grade. Moisture and 
air sensitive reactions were carried out under an atmosphere of argon. Reaction flasks 
were flamed dried under a stream of argon gas and glass syringes were oven dried at 
120 °C prior to use. 
Unless otherwise stated, concentration under reduced pressure refers to a rotary 
evaporator at water aspirator pressure.  Residual solvent was removed by vacuum 
pump at a pressure less than 0.25 mm of mercury. 
Analytical thin layer chromatography (TLC) was conducted using E. Merck 
precoated TLC plates (0.2 mm layer thickness of silica gel 60 F-254). Compounds 
were visualized by ultraviolet light, and/or by heating the plate after dipping in a 3-5% 
solution of phosphomolybdic acid in ethanol, 10% ammonium molybdate in water, a 
1% solution of vanillin in 0.1 M sulfuric acid in methanol or 2.5% p-anisaldehyde in 
88% ethanol, 5% water, 3.5% concentrated sulfuric and 1% acetic acid.  Flash 
chromatography was carried out using either Merck silica gel 60 (230-400 mesh 
ASTM) or Scientific Adsorbents Incorporated silica gel (40 micron partical size). 83
 
Radial chromatography was carried out on individually prepared rotors with layer 
thicknesses of 1, 2, or 4 mm using a Chromatotron manufactured by Harrison 
Research, Palo Alto, California. 
Melting points were measured using a Biichi melting point apparatus. Optical 
rotations were measured with a Perkin-Elmer 243 polarimeter at ambient temperature 
using a 0.9998 decimeter cell with 1 mL capacity. Infrared (IR) spectra were recorded 
with a Nicolet 5DXB FT-IR spectrometer.  Proton and carbon nuclear magnetic 
resonance (NMR) spectra were obtained using either a Bruker AC-300 or a Bruker 
AM-400 spectrometer. All chemical shifts are reported in parts per million (ppm) 
downfield from tetramethylsilane using the 8 scale. 1H NMR spectral data are reported 
in the order: chemical shift, number of protons, multiplicity (s=singlet, d=doublet, 
t=triplet, quartet, m=multiplet and b=broad), and coupling constant (J) in Hertz. 
Chemical ionization (CI) high and low resolution mass spectra (HRMS and 
MS) were obtained using a Finnigan 4023 spectrometer or a Kratos MS-50 
spectrometer with a source temperature of 120 °C and methane gas as the ionizing 
source. Perfluorokerosene was used as a reference. Electron impact (EI) mass spectra 
(HRMS and MS) were obtained with a Varian MAT311 or a Finnegan 4000 
spectometer.  Fast atom bombardment (FAB) mass spectra were obtained using a 
Kratos MS-50 spectometer. Elemental analyses were performed by Desert Analytics, 
Tucson, Arizona. 84
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(45)-3-[(2R)-4-Cyano-2-ethy1-1-oxobutan-1-y1]-4-(phenylmethyl)-1,3-oxazolidin-2­
one (68). To a solution of titanium tetrachloride (1.0 M in dichloromethane, 15.45 mL, 
15.45 mmol) in dichloromethane (15 mL) under argon at room temperature was added 
titanium(IV) isopropoxide (1.53 mL, 5.15 mmol). The resulting solution was stirred 
for 15 min at room temperature and cooled to 0°C. A solution of 14 (5.10 g, 20.6 
mmol) in dichloromethane (30 mL) was added dropwise via cannula followed by 
diisopropylethylamine (4.33 mL, 24.8 mmol). This mixture was stirred for 1 h at 0°C 
and acrylonitrile (2.72 mL, 41.3 mmol) was added dropwise. The resultant mixture 
was stirred for 18.5 h at room temperature and dichloromethane (300 mL) and 1 N 
sodium bisufate solution (300 mL) were added. This mixture was stirred for 30 min 
and separated. The aqueous layer was extracted three times with dichloromethane (200 
mL), and the combined organic layers were dried (magnesium sulfate). Removal of the 
solvent followed by chromatography of the residue on silica gel, using 30% ethyl 
acetate in hexane as eluant, yielded 5.27 g (85%) of 68 as a colorless oil: [a ]p2 -20.1° 
(c 1.15, CHC13); IR (neat) 2970, 2936, 1778, 1693, 1454, 1391, 1214, 1012 cm-1; 1H 
NMR (CDC13, 300MHz) 8 0.93 (3H, t, J = 7 Hz), 1.48-1.62 (1H, m, J = 7 Hz), 1.68­
1.81 (1H, m, J =7 Hz), 1.82-1.93 (1H, m), 2.07-2.19 (1H, m, J = 8 Hz), 2.37 (2H, t, J = 
7 Hz), 2.74-2.81 (1H, dd, J = 13, 10 Hz), 3.29-3.35 (1H, dd, J = 13, 4 Hz), 3.73-3.82 
(1H, quint, J = 7 Hz), 4.19 (2H, t, J = 3 Hz), 4.64-4.71 (1H, dq, J = 7, 4 Hz), 7.19-7.22 
(2H, m), 7.28-7.35 (3H, m); 13C NMR (CDC13, 75MHz) 8 11.2, 15.0, 24.8, 26.7, 37.9, 85
 
43.3, 55.5, 66.2, 119.1, 127.3, 128.9(2C), 129.3(2C), 135.1, 153.0, 174.6; Anal. Calcd 
for C17H20203: C, 67.98; H, 6.71; N, 9.33. Found: C, 67.59; H, 6.66; N, 9.43. 
CCN
 
(4R)-4-(Hydroxymethyppentanenitrile (69). To a solution of 68 (1.30 g, 4.30 mmol) 
in tetrahydrofuran (30 mL) under argon at 0°C was added a solution of lithium 
borohydride (2.0 M in tetrahydrofuran, 2.38 mL, 4.76 mmol). The resulting solution 
was stirred for 16 h at room temperature and quenched with methanol (3 mL). This 
mixture was stirred for 3 h and water (30 mL) was added. The resultant mixture was 
extracted three times with ether (50 mL), and the combined ethereal extracts were dried 
(magnesium sulfate). Removal of the solvent followed by chromatography of the 
residue on silica gel, using 50% ether in hexane as eluant, yielded 578 mg (76%) of 67 
and 369 mg (67%) of 69 as a colorless oil: [at -7.1° (c 0.97, CHC13); IR (neat) 3419 
(br), 2963, 2933, 2878, 2247, 1460, 1049 cm-1; 1H NMR (CDC13, 300MHz) 8 0.93 
(3H, t, J = 7 Hz), 1.32-1.43 (3H, m), 1.54-1.60 (1H, m, J = 6 Hz), 1.61-1.81 (2H, m), 
2.43 (2H, t, J = 8 Hz), 3.52-3.59 (1H, m, J = 5 Hz), 3.63-3.70 (1H, q, J = 5 Hz); 13C 
NMR (CDC13, 75MHz) 6 11.0, 15.0, 23.1, 26.8, 40.8, 64.2, 120.0; Anal. Calcd for 
C7H13NO: C, 66.10; H, 10.30; N, 11.01. Found: C, 66.52; H, 10.22; N, 10.86. 86
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(4R)-4-[[( tent-Butyldimethylsilyl)oxy]methylipentanenitrile (70). To a solution of 
69 (340 mg, 2.67 mmol) in dimethylformamide (6 mL) under argon at 0°C was added 
imidazole (254 mg, 3.74 mmol) followed by a solution of tert-butyldimethylsilyl 
chloride (483 mg, 3.20 mmol) in dimethylformamide (1.5 mL). The resulting solution 
was stirred for 2 d at room temperature and water (20 mL) was added. This mixture 
was extracted three times with ether (20 mL), and the combined ethereal extracts were 
dried (magnesium sulfate). Removal of the solvent followed by chromatography of the 
residue on silica gel, using 50% ether in pentane as eluant, yielded 585 mg (91%) of 70 
as a colorless oil: [a]p -3.5° (c 0.95, CHC13); IR (neat) 2958, 2932, 2883, 2860, 2247, 
1467, 1255, 1097, 838 cm-1; 1H NMR (CDC13, 300MHz) 6 0.04 (6H, s), 0.89 (9H, s), 
0.91 (3H, t, J = 8 Hz), 1.20-1.41 (2H, m, J = 7 Hz), 1.49-1.58 (1H, m), 1.61-1.79 (2H, 
m), 2.41 (2H, t, J = 8 Hz), 3.45-3.51 (1H, dd, J = 10, 6 Hz), 3.57-3.62 (1H, dd, J = 10, 
4 Hz); 13C NMR (CDC13, 75MHz) 8 -5.7, -5.6, 11.1, 15.0, 18.0, 23.2, 25.7(3C), 27.2, 
40.9, 64.4, 120.1; Anal. Calcd for C13H27NOSi: C, 64.66; H, 11.27; N, 5.80. Found: 
C, 64.90; H, 11.32; N, 5.68. 
TBS 
H 
0 
(4R)-41[(tert-Butyldimethylsilyl)oxy]methyl]hexanal (64). To a solution of 70 (130 
mg, 0.540 mmol) in hexane (6 mL) under argon at -78°C was added a solution of 
diisobutylaluminum hydride (1 M in hexane, 0.650 mL, 0.650 mmol) dropwise. The 87 
resulting solution was stirred for 2 h at -78°C, quenched with methanol (1 mL) and 
saturated ammonium chloride solution (50 mL) was added. This mixture was stirred 
for 2 h at room temperature, diluted with ether (100 mL) and separated. The ether 
layer was washed with 0.6 N hydrochloric acid solution (60 mL) and brine (60 mL). 
The aqueous washings were extracted three times with ether (60 mL), and the 
combined ethereal extracts were dried (magnesium sulfate). Removal of the solvent 
yielded 123 mg (93%) of 64 as a pale yellow oil which was used without purification: 
IR (neat) 2958, 2932, 2883, 2859, 1728, 1467, 1254, 1084, 838 cm-1; 1H NMR 
(CDC13, 300MHz) 6 0.03 (6H, s), 0.86-0.91 (3H, m), 0.89 (9H, s), 1.28-1.45 (3H, m), 
1.59-1.73 (2H, m), 2.42-2.48 (2H, dt, J = 8, 2 Hz), 3.44-3.56 (2H, dq, J = 10, 6 Hz), 
9.77 (1H, t, J = 2 Hz); 13C NMR (CDC13, 75MHz) 6 -5.5(2C), 11.2, 18.2, 23.1, 23.5, 
25.9(3C), 41.4, 41.5, 64.8, 202.9. 
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HO 
(3S,4S,7R)-7-[(tert-Butyldimethylsilypoxymethy1]-4-hydroxy-3-methy1-1-nonene 
(72).  To a suspension of potassium tert-butyloxide (15.0 g, 0.134 mol) in 
tetrahydrofuran (70 mL) under argon at -78°C was added cis-2-butene (11.0 mL, 0.123 
mol) dropwise via cannula, followed by n-butyllithium (1.6 M in hexane, 64.0 mL, 
0.102 mol). The resulting mixture was stirred for 1 h at -78°C, allowed to warm to 
-25°C, and stirred for 45 min at -25°C. After the mixture was recooled to -78°C, 
triisopropyl borate (23.6 mL, 0.102 mol) was added dropwise. This mixture was 
stirred for 30 min at -78°C and quenched with 1 N hydrochloric acid solution (40 mL). 
The resultant mixture was thoroughly stirred with additional 1 N hydrochloric acid 88
 
solution (140 mL) and extracted with ethyl acetate, and the combined organic layers 
were added to powdered 4A molecular sieves (50 g) and diethanolamine (8.66 mL, 
89.0 mmol) under argon at room temperature. This mixture was stirred for 3 h and 
filtered with an ethyl acetate rinse. Removal of the organic solvent from the filtrate 
gave 11.4 g of crude (Z)-crotylamine complex as a white solid which was recrystallized 
from dichloromethane and ether. The colorless crystalline material was stored under 
argon. 
To a rapidly stirred suspension of the (Z)-crotylamine complex (1.90 g, 11.2 
mmol) in ether (36 mL) under argon at room temperature was added (S,S)-diisopropyl 
tartrate (2.39 mL, 11.2 mmol). The mixture was stirred for 5 min, brine (36 mL) was 
added, and rapid stirring was continued for 5 min. The mixture was extracted three 
times with ether (60 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent gave 3.29 g of 71 as a colorless oil which was used 
immediately. 
To a mixture of 71 (3.29 g, 11.0 mmol) and powdered 4A molecular sieves (5 
g) in toluene (20 mL) under argon at -78°C was added a solution of 64 (0.650 g, 2.66 
mmol) in toluene (4 mL) dropwise. The resulting mixture was stirred for 2.5 d at 
-78°C. A 1 N sodium hydroxide solution (50 mL) was added and the mixture was 
stirred for 1.5 h at room temperature. The cloudy mixture was extracted three times 
with ether (80 mL), and the combined organic layers were washed with brine and dried 
(magnesium sulfate). Removal of the solvent followed by chromatography of the 
residue on silica gel, using 10% ethyl acetate in hexane as eluant, gave 0.676 g (85%) 
of 72 as a colorless oil: [42, -15.7° (c 0.85, CHC13); IR (neat) 3379 (br), 2958, 2932, 
2890, 2860, 1466, 1253, 1094, 837 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 
0.88 (3H, d, J = 7 Hz), 0.89 (9H, s), 1.02 (3H, d, J = 7 Hz), 1.21-1.58 (8H, m), 2.23­
2.34 (1H, m, J = 7 Hz), 3.45-3.50 (3H, m, J = 5 Hz), 5.05-5.12 (2H, dd, J = 12, 6, 1 89 
Hz), 5.74-5.86 (1H, m, J = 7, 2 Hz); 13C NMR (CDC13, 75MHz) 8 -5.5(2C), 11.1, 
13.9, 18.2, 23.5, 25.8(3C), 26.8, 31.1, 41.9, 43.2, 65.1, 75.1, 115.0, 141.1; FIRMS (CI) 
m/z 301.2561 (calcd for C17H3602Si + H-F: 301.2564); Anal. Calcd for C17H3602Si: 
C, 67.93; H, 12.07. Found: C, 68.00; H, 12.23. This compound was contaminated by a 
small amount (de 5:1 by 13C NMR) of a second stereoisomer. 
TBS 
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(35,4S,7R)-4-[( tert-Butyldimethylsilypoxy]-7-[( tert-butyldimethylsily1)oxymethyl]­
3-methyl-1-nonene  (73).  To a solution of 72 (116 mg, 0.390 mmol) in 
dichloromethane (4 mL) under argon at 0°C was added triethylamine (0.136 mL, 0.975 
mmol) dropwise, followed by tert-butyldimethylsilyl triflate (0.125 mL, 0.546 mmol). 
The resulting mixture was stirred for 1 h at 0°C and saturated sodium bicarbonate 
solution (20 mL) was added. This mixture was extracted three times with ether (40 
mL), and the combined organic layers were washed with water (100 mL) and dried 
(magnesium sulfate). Removal of the solvent followed by chromatography of the 
residue on silica gel, using 5% ethyl acetate in hexane as eluant, produced 153 mg 
(97%) of 73 as a pale yellow oil: [aff -11.7° (c 1.13, CHC13); IR (neat) 2967, 2934, 
2891, 2859, 1473, 1306, 1090, 826 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (12H, 
m), 0.87 (3H, d, J = 7 Hz), 0.89 (18H, 2s), 0.96 (3H, d, J = 7 Hz), 1.19-1.43 (7H, m), 
2.24-2.33 (1H, m, J = 7 Hz), 3.45-3.53 (3H, dd, J = 12, 5 Hz), 4.96-5.03 (2H, dd, J = 
10, 1 Hz), 5.79-5.91 (1H, dq, J = 7, 3 Hz); 13C NMR (CDC13, 75MHz) 8 -5.5, -4.5, 
-4.3, -3.1, 11.1, 14.8, 18.1(2C), 23.4, 25.6(6C), 28.9, 31.0, 42.2, 42.5, 65.1, 76.2, 113.5, 90 
141.7; HRMS (CI) m/z 415.3426 (calcd for C23H5002Si2 + H+: 415.3429); Anal. 
Calcd for C23H5002Si2: C, 66.59; H, 12.15. Found: C, 66.74; H, 12.29. 
H 
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(2R,3S,6R)-3-[( tert-Butyldimethylsilyl)oxy]-6-[(tert-butyldimethylsilypoxymethyl]­
2-methyloctanal (55). A stream of ozone was passed through a solution of 73 (179 
mg, 0.430 mmol) in dichloromethane (3.5 mL) and methanol (1.5 mL) at -78°C for 5 
min. The excess ozone was purged with argon for 30 min, a catalytic amount of 
potassium bicarbonate and dimethyl sulfide (3 mL) was added, and the mixture was 
stirred at room temperature for 23 h. The solvent was removed under reduced pressure 
and the residue was purified on silica gel, using 2% ethyl acetate in hexane as eluant, to 
yield 173 mg (96%) of 55 as a colorless oil: [42, -18.7° (c 2.70, CHC13); IR (neat) 
2957, 2932, 2889, 2859, 1729, 1467, 1254, 1089, 834 cm-1; 1H NMR (CDC13, 
300MHz) S 0.03 (6H, s), 0.05 (3H, d, J = 10 Hz), 0.86 (9H, s), 0.87 (3H, d, J = 7 Hz), 
0.88 (9H, s), 1.05 (3H, d, J = 7 Hz), 1.10-1.59 (7H, m), 2.42-2.50 (1H, m), 3.42-3.52 
(2H, dq, J = 10, 6 Hz), 4.05-4.11 (1H, dt, J = 7, 4 Hz), 9.76 (1H, s); 13 C NMR 
(CDC13, 75MHz) 8 -5.6, -5.5, -4.8, -4.3, 7.4, 11.1, 17.9, 18.2, 23.3, (25.7, 25.8)(6C), 
26.5, 31.6, 41.9, 51.0, 64.8, 72.4, 205.4; MS (CI) m/z 416 (M+), 415, 401, 359, 343, 
301, 227, 199, 173, 135, 119, 95; HRMS (CI) m/z 359.2438 (calcd for C22H48O3Si2 
C4H9: 359.2439). 91
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(2R)-2-R(tert-Butyldimethylsilly1)oxy]methyl]-1-(p-toluenesulfonyloxy)propane 
(75). To a solution of 74 (12.67 g, 62.10 mmol) in pyridine (120 mL) at 0°C was added 
p-toluenesulfonyl chloride (17.76 g, 93.15 mmol). The resulting mixture was stirred 
for 23 h at room temperature and was quenched with water (6 mL). This mixture was 
added to water (400 mL) and ether (700 mL), and the layers were separated. The 
aqueous layer was extracted three times with ether (400 mL), and the combined 
ethereal extracts were washed with 1 N hydrochloric acid solution (500 mL), saturated 
sodium bicarbonate solution (500 mL) and brine (500 mL), and was dried (magnesium 
sulfate). Removal of the solvent gave 20.39 g of crude 75 as a yellow oil. A small 
sample was purified on silica gel, using 10% ethyl acetate in hexane as eluant: IR 
(neat) 2956, 2932, 2885, 2858, 1364, 1307, 1025, 839 cm-1; 1H NMR (CDC13, 
400MHz) 8 -0.02 (6H, s), 0.81 (9H, s), 0.87 (3H, d, J = 7 Hz), 1.93 (1H, m), 2.44 (3H, 
s), 3.42 (1H, dd, J = 10, 7 Hz), 3.48 (1H, dd, J = 10, 5 Hz), 3.92 (1H, dd, J = 10, 6 Hz), 
4.01 (1H, dd, J = 10, 6 Hz), 7.32 (2H, d, J = 8 Hz), 7.79 (2H, d, J = 8 Hz); 13C NMR 
(CDC13, 100MHz) 8 -5.9(2C), 12.9, 18.1, 21.7, 25.7(3C), 35.5, 63.7, 72.1, 128.3(2C), 
130.1(2C), 131.5, 144.6; Anal. Calcd for C17H3004SSi: C, 56.94; H, 8.43. Found: C, 
56.98; H, 8.56. 
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(2R)-21[(tert-Butyldimethylsilypoxy]methyl]-1-iodopropane (76). A stirred 
solution of 75 (20.39 g) and sodium iodide (17.07 g, 113.9 mmol) in acetone (300 mL) 92
 
under argon was heated at reflux for 20 h and allowed to cool to room temperature. 
The mixture was filtered and the filtrate was washed with saturated sodium thiosulfate 
solution (100 mL), water (100 mL), and brine (100 mL) and was dried (magnesium 
sulfate). Removal of the solvent gave 16.89 g of crude 76 as a pale yellow oil. A small 
sample was purified on silica gel, using 10% ethyl acetate in hexane as eluant: IR 
(neat) 2956, 2929, 2896, 2858, 1471, 1257, 838 cm-1; 1H NMR (CDC13, 300MHz) S 
0.06 (6H, s), 0.90 (9H, s), 0.96 (3H, d, J = 7 Hz),1.62 (1H, m), 3.22-3.33 (2H, m), 3.41 
(1H, dd, J = 10, 7 Hz), 3.52 (1H, dd, J = 10, 5 Hz); 13C NMR (CDC13, 75MHz) 8 
-5.5(2C), 13.8, 17.2, 18.2, 25.8(3C), 37.9, 66.6. 
PhSOOTBS 
(2R)-24[(tert-Butyldimethylsilyl)oxy]methyl]-1-propylphenylsulfone (77). A 
mixture of 76 (16.89 g) and sodium phenylsulfmate (17.66 g, 107.6 mmol) in 
dimethylformamide (250 mL) under argon was stirred at 37°C for 37 h and allowed to 
cool to room temperature. The solution was diluted with ether (500 mL), and saturated 
sodium bicarbonate solution (500 mL) was added. After separation, the aqueous layer 
was extracted three times with ether (400 mL), and the combined organic extract was 
washed with saturated sodium bicarbonate solution (500 mL) and brine (500 mL), and 
was dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 15% to 20% 
ethyl acetate in hexane, to yield 14.30 g (81% from 74) of 77 as a pale yellow oil: 
[ar -2.5° (c 1.53, CHC13); IR (neat) 2956, 2930, 2885, 2858, 1472, 1307, 1025, 839 
cm-1; 1H NMR (CDC13, 400MHz) 8 -0.03 (3H, s), -0.02 (3H, s), 0.83 (9H, s), 1.05 
(3H, d, J = 7 Hz), 2.19 (1H, m), 2.84 (1H, dd, J = 14, 8 Hz), 3.34 (1H, dd, J = 10, 6 93
 
Hz), 3.40 (1H, dd, J = 14, 4 Hz), 3.53 (1H, dd, J = 10, 5 Hz), 7.53-7.66 (3H, m), 7.90­
7.92 (2H, m); 13C NMR (CDC13, 100MHz) S -5.6(2C), 16.7, 18.1, 25.8(3C) 31.6, 
59.0, 66.4, 127.8(2C), 129.2(2C), 133.5, 140.1; Anal. Ca lcd for C16H2803SSi: C, 
58.49; H, 8.59. Found: C, 58.41; H, 8.76. 
OH SO2Ph 
Hydroxy Sulfone (78). To a solution of 77 (7.00 g, 23.7 mmol) in tetrahydrofuran (70 
mL) under argon at -78°C was added n-butyllithium (1.6 M in hexane, 17.5 mL, 26.1 
mmol) dropwise.  The resulting mixture was stirred for 20 min at -78°C and 
hexamethylphosphoramide (4.98 mL, 28.4 mmol) was added. The mixture was stirred 
for 10 min at -78°C and a solution of propylene oxide (2.24 mL, 32 mmol) in 
tetrahydrofuran (45 mL) was added dropwise via cannula. The reaction flask was 
placed in an ice-water bath and the mixture was stirred for 4 h at 0°C. The reaction was 
quenched with saturated ammonium chloride solution (161 mL), and the mixture was 
extracted three times with ether (200 mL). The combined ethereal extracts were 
washed with brine (500 mL) and were dried (magnesium sulfate). Removal of the 
solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 20% to 40% ethyl acetate in hexane, to yield 12.7 g (92%) of 78 as a 
colorless oil: IR (neat) 2957, 2930, 2886, 2858, 1472, 1289, 1085, 838 cm-1; 1H NMR 
(CDC13, 300MHz) 5 -0.08 (3H, s), -0.03 (3H, s), 0.82 (9H, s), 0.93 (3H, d, J = 7 Hz), 
1.14 (3H, d, J = 6 Hz), 1.60-1.69 (1H, m), 2.11-2.20 (2H, m), 2.64 (1H, d, J = 4 Hz), 
3.32 (1H, t, J = 10 Hz), 3.42 (1H, dd, J = 10, 5 Hz), 3.66 (1H, dt, J = 8, 2 Hz), 3.80­
3.86 (1H, m), 7.53-7.67 (3H, m), 7.87-7.90 (2H, m); 13C NMR (CDC13, 75MHz) 8 94
 
-5.6(2C), 10.4, 18.0, 23.4, 25.7(3C), 31.6, 34.4, 61.0, 64.9, 6C.5, 128.5(2C), 129.2(2C), 
133.6, 138.6; Anal. Ca lcd for C19H3404SSi: C, 59.02; H, 8.86. Found: C, 59.01; H, 
9.01. 
OH 
Hydroxy Silyl Ether (79). A mixture of 78 (5.36 g, 13.9 mmol) and sodium amalgam 
(2.5%, 192 g, 208 mmol) in ethanol (130 mL) under argon was stirred for 21 h at room 
temperature and the solvent was decanted. The residue was washed twice with ethanol 
(100 mL), and the combined ethanol washings were added to saturated ammonium 
chloride solution (250 mL). The mixture was extracted three times with ether (300 
mL), and the combined ethereal extracts were dried (sodium sulfate). Removal of the 
solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 20% to 40% ethyl acetate in hexane, to yield 2.80 g (92%) of 79 as a 
colorless oil: 1R (neat) 3354 (bd), 2958, 2932, 2891, 2859, 1467, 1254, 1097, 839 cm­
1; 1H NMR (CDC13, 300MHz) 8 0.04 (6H, s), 0.87 (3H, d, J = 7 Hz), 0.89 (9H, s), 
1.19 (3H, d, J = 6 Hz), 1.41-62 (5H, m), 3.37-3.43 (2H, m), 3.72-3.80 (1H, m); 13C 
NMR (CDC13, 75MHz) 8 -5.5(2C), 16.7, 18.2, 23.2, 25.8(3C), 29.1, 35.6, 36.6, 68.1, 
68.2; Anal. Calcd for C i3H3002Si: C, 63.35; H, 12.27. Found: C, 63.46; H, 12.49. 95
 
(5S)-5-[[(tert-Butyldimethylsilypoxy]methyl]hex-2-one (80). A solution of 79 (5.19 
g, 21.1 mmol), pyridinium chlorochromate (7.28 g, 33.8 mmol), and sodium acetate 
(0.42 g, 5.00 mmol) in dichloromethane (250 mL) under argon was stirred for 5 h at 
room temperature and was diluted with ether (250 mL). The mixture was passed 
through a column of Florisil and the residue in the reaction flask was sonicated three 
times, each for 5 min, with ether (250 mL). The ethereal solution was passed through 
the same column of Florisil and combined with the previous column eluant. Removal 
of the solvent followed by chromatography of the residue on silica gel, using 15% ethyl 
acetate in hexane as eluant, yielded 4.70 g (92%) of 80 as a colorless oil: [a  -9.2° (c 
2.13, CHC13); IR (neat) 2956, 2932, 2890, 2860, 1719, 1468, 1254, 1093, 839 cm-1; 
1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 0.86 (3H, d, J = 7 Hz), 0.89 (9H, s), 1.32­
1.44 (1H, m), 1.52-1.62 (1H, m, J = 6 Hz), 1.63-1.75 (1H, m), 2.13 (3H, s), 2.24-2.48 
(2H, m), 3.40-3.42 (2H, dd, J = 6, 1 Hz); 13C NMR (CDC13, 75MHz) 8 -5.5(2C), 16.4, 
18.2, 25.8(3C), 27.3, 29.6, 35.2, 41.5, 67.9, 209.2; Anal. Calcd for C13H2802Si: C, 
63.87; H, 11.54. Found: C, 63.81; H, 11.63. 
012 
TBS 
2-[(3S)-4-[( tert-Butyldimethylsilypoxy]-3-methylbutan-1-y1]-2-methy1-1,3-dioxala­
ne (81). A stirred solution of 80 (304 mg, 1.24 mmol), ethylene glycol (310 mg, 6.20 
mmol), and p-toluenesulfonic acid (2 mg) in benzene (60 mL) under argon was heated 96
 
at reflux for 5 d using a Dean-Stark trap to remove water. The mixture was allowed to 
cool to room temperature and was washed with 2.5% sodium bicarbonate solution (50 
mL) and brine (50 mL), and was dried (magnesium sulfate). Removal of the solvent 
followed by chromatography of the residue on silica gel, using 8% ethyl acetate in 
hexane as eluant, gave 310 mg (87%) of 75 as a colorless oil: keg -4.8° (c 0.85, 
CHC13); IR (neat) 2955, 2933, 2882, 2860, 1458, 1378, 1254, 1091, 840 cm-1; 1H 
NMR (CDC13, 300MHz) 5 0.03 (6H, s), 0.88 (3H, d, J = 4 Hz), 0.89 (9H, s), 1.08-1.20 
(1H, m), 1.31 (3H, s), 1.43-1.74 (4H, m), 3.34-3.39 (1H, dd, J = 10, 6 Hz), 3.42-3.46 
(1H, dd, J = 10, 6 Hz), 3.90-3.96 (4H, m); 13C NMR (CDC13, 75MHz) 5 -5.4(2C), 
16.7, 18.3, 23.7, 25.9(3C), 27.4, 35.9, 36.6, 64.6(2C), 68.1, 110.3; Anal. Calcd for 
C15H3203Si: C, 62.44; H, 11.18. Found: C, 62.67; H, 11.39. 
OL? 
)1-1 
2-[(3S)-3-(Hydroxy)methylbutan-l-y1]-2-methyl -1,3-dioxalane (82). A solution of 
81 (1.51 g, 5.22 mmol) and tetra-n-butylammonium fluoride (1.0 M in tetrahydrofuran, 
11 mL, 11 mmol) in tetrahydrofuran (15 mL) under argon was stirred for 5 h at room 
temperature. The mixture was diluted with ether (50 mL) and was washed with brine 
(50 mL), and was dried (magnesium sulfate). Removal of the solvent followed by 
chromatography of the residue on silica gel, using 50% ethyl acetate in hexane as 
eluant, yielded 876 mg (97%) of 82 as a colorless oil: [a]p -8.1° (c 1.12, CHC13); IR 
(neat) 3419 (br), 2978, 2952, 2876, 1459, 1378, 1065, 859 cm-1; 1H NMR (CDC13, 
400MHz) 8 0.91 (3H, t, J = 7 Hz), 1.20-1.27 (1H, m), 1.31 (3H, s), 1.46-1.65 (4H, m), 
1.68-1.76 (1H, m), 3.44-3.49 (2H, dq, J = 13, 6 Hz), 3.89-3.97 (4H, m); 13C NMR 97
 
(CDC13, 100MHz) 8 16.5, 23.7, 27.1, 35.8, 36.3, 64.6(2C), 68.0, 110.2; MS (EI) m/z 
173 (M+-1), 157, 113, 95. 
.,.....N.  H 
Ou)  0 
2-Methyl-2[(3S)-3-(methyl)butan-4-a1-1-y1]-1,3-dioxalane (83).  To a solution of 
oxalyl chloride (1.02 mL, 11.8 mmol) in dichloromethane (0.7 mL) under argon at 
-78°C was added dimethyl sulfoxide (1.68 mL, 23.5 mmol). The mixture was stirred 
for 5 min and a solution of 82 (280 mg, 1.61 mmol) in dichloromethane (10 mL) was 
added dropwise via cannula.  Stirring was continued for 1 h at -78°C, after which 
triethylamine (9.07 mL, 58.8 mmol) was added. The mixture was stirred for 5 min at 
-78°C, allowed to warm to room temperature for 1 h, and was diluted with ether (50 
mL). The solution was washed with brine (50 mL), the aqueous wash was extracted 
three times with ether (50 mL), and the combined ethereal extracts were dried 
(magnesium sulfate). Removal of the solvent followed by chromatography of the 
residue on silica gel, using 30% ether in pentane as eluant, gave 228 mg (82%) of 76 as 
a pale yellow oil:  [ a ] +13.7° (c 1.08, CHC13); IR (neat) 2981, 1725, 1378, 1220, 
1068, 857 cm-1; 1H NMR (CDC13, 300MHz) 8 1.09 (3H, d, J = 7 Hz), 1.32 (3H, s), 
1.42-1.89 (4H, m), 2.31-2.39 (1H, m), 3.89-3.96 (4H, m), 9.61 (1H, d, J = 2 Hz); 13C 
NMR (CDC13, 75MHz) 8 13.3, 23.7, 24.6, 36.2, 46.1, 64.6(2C), 109.6, 204.8. This 
aldehyde was taken to the next step without purification. 98 
°Lis  6H 
[2(3S,4S)]-2-[4-Hydroxy-3-(methyl)hept-6-en-l-y1]-2-methy1-1,3-dioxalane (85). 
Method A. To a stirred suspension of magnesium (1.40 g, 60.0 mmol) in ether (10 mL) 
under argon at room temperature was added a solution of ally! bromide (7.20 g, 60.0 
mmol) in ether (30 mL) dropwise over a period of 1.5 h. The solution refluxed gently 
during addition and was used for the next step without purification. 
To a flask containing ether (25 mL) under argon at -78°C was added 
simultaneously but separately a solution of trimethyl borate (2.84 g, 27.3 mmol) in 
ether (25 mL) and the freshly prepared solution of allylmagnesium bromide dropwise 
over 30 min with stirring. The mixture was stirred for 2 h at -78°C and was warmed to 
0°C. A solution of 2 N hydrochloric acid (25 mL) was added dropwise, and the 
mixture was warmed to room temperature, stirred for 10 min, and partitioned. The 
aqueous layer was extracted once with dichloromethane (50 mL)  and twice with ether 
(50 mL), and the combined organic layers were dried (sodium sulfate). After filtration, 
the volume of the solution was reduced to 100 mL. (R,R)-Diisopropyl tartrate (3.00 g, 
128 mmol) was added and the mixture was stirred for 14 h at room temperature. 
Removal of the solvent followed by distillation under reduced pressure (115°-118°C at 
1.5 mmHg) gave 2.18 g (30%) of 84 as a colorless oil. 
To a mixture of 84 (1.32 g, 4.60 mmol) and powdered 4A molecular sieves (1.0 
g) in toluene (8 mL) under argon at -78°C was added a solution of 83 (400 mg, 2.32 
mmol) in toluene (8 mL) via cannula. The mixture was stirred for 40 h at -78°C and 
was quenched with 2 N sodium hydroxide solution (20 mL). This mixture was stirred 
for 2 h at room temperature and extracted three times with ether (50 mL), and the 
combined organic layers were washed with water (50 mL) and dried (magnesium 99
 
sulfate). Removal of the solvent followed by chromatography of the residue on silica 
gel, using 25% ethyl acetate in hexane as eluant, gave 390 mg (78%) of 85 as a 
colorless oil:  [at2 -18.5° (c 0.85, CHC13); IR (neat) 3461 (br), 2978, 2940 2880, 
1460, 1378, 1068, 857 cm-1; 1H NMR (CDC13, 300MHz) 8 0.89 (3H, d, J = 7 Hz), 
1.22-1.29 (1H, m), 1.31 (3H, s), 1.47-1.76 (5H, m), 2.16-2.30 (2H, m), 3.52-3.56 (1H, 
m), 3.88-3.95 (4H, brs), 5.09-5.16 (2H, m), 5.75-5.88 (1H, m);  13C NMR (CDC13, 
75MHz) 8 13.8, 23.6, 27.2, 36.7, 37.8, 38.9, 64.5(2C), 73.6, 110.1, 117.6, 135.4; MS 
(CI) m/z 214 (M+), 211, 153, 135, 95; HRMS (EI) m/z 214.1567 (calcd for Ci2H2203:
 
214.1570). This compound was contaminated by a small amount (de 4:1 by  1H NMR)
 
of a second stereoisomer.
 
Method B. To a solution of borane methyl sulfide (2.0 M in tetrahydrofuran, 1.2 mL,
 
2.4 mmol) in tetrahydrofuran (4.8 mL) under argon at -10°C was added (+)-2-carene 
(0.84 mL, 5.3 mmol) dropwise. The mixture was sealed under argon and stored for 24 
h at 0°C, during which time a white solid formed. The supernatant liquid was removed 
via cannula and the residual solid was washed with ice-cold ether. The solid was dried 
under high vacuum at room temperature for 20 h. 
To a suspension of this 2-isocaranylborane in tetrahydrofuran (1.1 mL) under 
argon at 0°C was added methanol (0.28 mL) dropwise over a period of 15 min  with 
vigorous stirring. The mixture was stirred for 5 h, the solvent was removed, and the 
oily residue was dried under high vacuum for 16 h. 
To a solution of this methoxyborane in ether (3 mL) under argon at -78°C was 
added a solution of allymagnesium bromide (1.0 M in ether, 2.1 mL, 2.1 mmol) 
dropwise over a period of 15 min. Stirring was continued for 15 min at -78°C and the 
mixture was allowed to warm to room temperature. The clear ethereal solution of 86 
was used immediately in the next step. 100 
To the solution of 86 in ether under argon at -78°C was added a solution of 83 
(57 mg, 0.33 mmol) in ether (1.5 mL) dropwise. The mixture was stirred for 3 h at 
-78°C and quenched by addition of 3 N NaOH solution (0.5 mL) followed by 30% 
hydrogen peroxide solution (1 mL). The mixture was allowed to warm to room 
temperature and was heated at reflux for 3 h. After cooling to room temperature, the 
mixture was partitioned and the aqueous layer was extracted three times with ether (15 
mL). The combined ethereal extracts were washed with water (20 mL) and brine (20 
mL), and were dried (magnesium sulfate).  Removal of the solvent followed by 
chromatography of the residue on silica gel, using 30% ethyl acetate in hexane as 
eluant, produced 34 mg (48%) of 85 (de 8.6:1 by 13C NMR) as a colorless oil. 
.7: 
01 
TBSO 
[2(3S,4S)]-2-[4-[( tert-Butyldiamethylsily1)oxy]-3-methylhept-6-en-l-y1]-2-methy1­
1,3-dioxalane (87). To a solution of 85 (51 mg, 0.24 mmol) in dichloromethane (2 
mL) under argon at 0°C was added triethylamine (0.10 mL, 0.72 mmol) and tert­
butyldimethylsilyl triflate (0.083 mL, 0.36 mmol). The solution was stirred for 1.25 h 
at 0°C and saturated sodium bicarbonate solution (20 mL) and ether (20 mL) were 
added. After separation, the aqueous layer was extracted three times with ether (20 
mL), and the combined ethereal extracts were dried (magnesium sulfate). Removal of 
the solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 100% to 2% ethyl acetate in hexane to yield 62 mg (80%) of 87 as a 
colorless oil: [a f -10.2° (c 0.83, CHC13); IR (neat) 2954, 2929, 2883, 2857, 1472, 
1376, 1254, 1065, 835 cm-1; 1H NMR (CDC13, 300 MHz) 6 0.04 (3H, s), 0.06 (3H, s), 101 
0.88 (9H, s), 0.82-0.90 (3H, m), 1.12-1.23 (1H, m), 1.31 (3H, s), 1.47-1.60 (3H, m), 
1.63-1.68 (1H, m), 2.16-2.22 (2H, m), 3.54-3.61 (1H, m), 3.88-3.96 (4H, m), 4.98-5.01 
(2H, m), 5.77 (1H, m); 13C NMR (CDC13, 75MHz) 8 -5.4, -4.6,  13.8, 18.0, 23.7, 
(25.8, 25.9)(3C), 37.3, 37.7, 38.2, 38.9, 64.5(2C), 75.3, 110.2, 116.3, 135.8; MS (CI) 
nz/z 329 (M++1), 313, 287, 275, 233, 185, 159, 153, 147, 95; HRMS (CI) m/z 329.2512 
(calcd for Ci8H3603Si + H+: 329.2513). 
Or

Lfs TBSO  0 
[2(3S,4S)]-2-[4-[(tert-butyldimethylsilypoxy]-3-methylhept-6-on-l-y1]-2-methy1­
1,3-dioxalane (88). A stream of oxygen was passed through a stirred suspension of 
palladium chloride (3.4 mg, 0.019 mmol) and copper(I) chloride (19 mg, 0.19 mmol) in 
N, N-dimethylformamide (7 mL) and water (1 mL) for 2 h at room temperature. A 
solution of 87 (62 mg, 0.19 mmol) in N, N-dimethylformamide (3.5 mL) and water 
(0.5 mL) was added and was stirred for 3.5 h with oxygen passing through, during 
which the brown mixture became a clear pale brown solution containing green 
preciptate. Saturated ammoniun chloride solution (20 mL) was added, and the solution 
turned to a jade color and was extracted three times with ether (20 mL). The combined 
ethereal extracts were washed with brine (20 mL) and water (20 mL), and were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatograghy of the 
residue on silica gel, with gradient elution from 10% to 20% ethyl acetate in hexane, to 
yield 40 mg (60%) of 88 as a colorless oil: [at -29.1° (c 2.25, CHC13); IR (neat) 
2958, 2930, 2881, 2860, 1726, 1384, 1263, 1076, 838 cm-1; 1H NMR (CDC13, 300 
MHz) 8 -0.02 (3H, s), 0.05 (3H, s), 0.85 (9H, s), 0.81-0.88 (4H, m), 1.04-1.14 (1H, m), 102 
1.31 (3H, s), 1.43-1.60 (2H, m), 1.61-1.74 (2H, m), 2.14 (3H, s), 2.34-2.41 (1H, dd, J = 
15, 4 Hz), 2.55-2.62 (1H, dd, J = 16, 8 Hz), 3.90-3.97 (4H, m), 4.12 (1H, m); 13C 
NMR (CDC13, 75MHz) 8 -4.8(2C), 14.7, 17.9, 23.6, 25.7, 25.9(3C), 31.6, 37.3, 39.1, 
47.1, 64.5(2C), 72.2, 110.0, 208.1; MS (CI) m/z 345 (M++1), 329, 287, 213, 185, 169, 
151, 87, 69; FIRMS (CI) m/z 345.2461 (calcd for Ci8H3604Si + FI÷: 345.2457). 
C.>r
 Li)  OH 0 
[2(3S,4S)]-2-[4-Hydroxy-3-(methyphept-6-on-l-y1]-2-methyl-1,3-dioxalane (89). 
Method A. To a solution of 88 (24 mg, 0.070 mmol) in tetrahydrofuran (2 mL) in a 
Nalgene tube at 0°C was added a freshly prepared hydrofluoric acid-pyridine stock 
solution [Aldrich HFpyridine solution (4 mL) in pyridine (5 mL) and tetrahydrofuran 
(20 mL), 6 mL]. The solution was stirred from 0°C to room temperature for 1.5 d, after 
which a saturated sodium bicarbonate solution (6 mL) was added and the mixture was 
stirred for 1 h. The mixture was diluted with ether and washed with saturated sodium 
bicarbonate solution (15 mL). The aqueous wash was extracted three times with ether 
(15 mL), and the combined ethereal extracts were dried (magnesium sulfate). Removal 
of the solvent was followed by chromatography of the residue on silica gel, with 
gradient elution from 20% to 70% ethyl acetate in hexane, to yield 13 mg (78%) of 89 
as a colorless oil: [a ] -32.0° (c 0.50, CHC13); IR (neat) 3481 (br), 2958, 2938, 2881, 
1713, 1361, 1066, 857 cm-1; 1H NMR (CDC13, 300MHz) 8 0.87 (3H, d, J = 7 Hz), 
1.15-1.26 (1H, m), 1.28 (3H, s), 1.38-1.74 (4H, m), 2.16 (3H, s), 2.53-2.57 (2H, m), 
2.88 (1H, brs), 3.85-3.96 (5H, m); 13C NMR (CDC13, 75MHz) 8 14.3, 23.7, 26.8, 103
 
30.8, 36.7, 38.0, 47.2, 64.5(2C), 70.3, 110.1, 210.0; Anal. Calcd for C12H2204: C, 
62.58; H, 9.63. Found: C, 62.70; H, 9.43. 
Method B. To a solution of (1S)-(-)-(a)-pinene (10 mL, 63 mmol) (dried over calcium 
hydride and filtered through a plug of glass wool) in tetrahydrofuran (7 mL) under 
argon at room temperature was added a solution of borane-methylsulfide complex (10 
M in dimethylsulfide, 5.4 mL, 54 mmol) over a period of 20 min, during which the 
internal temperature of the reaction was kept below 27°C. A small amount of the 
product crystalized during addition. Therefore, after addition, the mixture was heated 
to 50°C for 10 min to dissolve most of the solid particles and was allowed to stand 
under argon at room temperature for 20 h and then cooled to 0°C for 2 h.  The 
supernatant was removed via cannula and the white crystals were broken up with a 
needle, washed twice with dry ice-cold ether, and dried under a stream of argon. This 
solid was stored under argon at -25°C. 
To a suspension of the above (+)-diisopinocampheylborane (756 mg, 2.64 
mmol) in hexanes (0.6 mL) under argon at 0°C was added trifluoromethanesulfonic 
acid (0.234 mL, 2.64 mmol) dropwise. The cooling bath was removed, and the two-
phase mixture was stirred for 2.5 h at room temperature. A 60% conversion was 
assumed and an aliquot (0.428 mL, 0.813 mmol) of the upper layer was removed and 
used for the next step immediately. 
To a solution of (+)-diisopinocampheylborane trifluoromethanesulfonate (1.9 M 
in hexane, 0.428 mL, 0.813 mmol) in dichloromethane (3 mL) under argon at -78°C 
was added diisopropylethylamine (0.197 mL, 1.13 mmol) and acetone (0.053 mL, 
0.723 mmol). The clear solution was stirred for 2.5 h at -78°C, and a solution of crude 
83 (0.452 mmol) in dichloromethane (1.5 mL) was added via cannula. The mixture 
was allowed to slowly warm to -25°C and was stirred for 1.5 d at -25°C. The reaction 
was quenched by adding the mixture to a separatory funnel containing ether (20 mL) 104
 
and pH 7 buffer solution (20 mL). The phases were separated and the aqueous phase 
was extracted three times with ether (20 mL). The combined organic layers were 
concentrated and taken up in methanol (8 mL) and pH 7 buffer solution (1.5 mL) at 
0°C. A 30% hydrogen peroxide solution (2 mL) was added and the cooling bath was 
removed. The mixture was stirred for 2 h at room temperature, diluted with water and 
extracted three times with dichloromethane (15 mL). The combined organic layers 
were washed with saturated sodium bicarbonate solution (20 mL) and brine (20 mL), 
and were dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 25% to 75% 
ethyl acetate in hexane, to yield 65.7 mg (63% from 82) of 89 as a colorless oil. This 
compound was contaminated by a small amount (de 9.7:1 by 13C NMR) of a second 
stereoisomer. 
6H OH
 
[2(3S,4S,6R)]-244,6-Dihydroxy-3-(methypheptan-1-y1]-2-methy1-1,3-dioxalane 
(90). To a stirred solution of tetramethylammonium triacetoxyborohydride (189 mg, 
0.720 mmol) in acetonitrile (1 mL) and acetic acid (1 mL) under argon at -40°C was 
added dropwise a solution of 89 (27.0 mg, 0.120 mmol) in acetonitrile (1.4 mL). The 
slurry was stirred for 30 min at -40°C and at -23°C for 20 h, after which it was 
quenched by addition of 0.5 N aqueous sodium potassium tartrate (2 mL). The mixture 
was stirred at room temperature for 30 min, diluted with dichloromethane (20 mL), and 
washed with saturated sodium bicarbonate solution (20 mL). The aqueous wash was 
extracted three times with dichloromethane (20 mL), and the combined organic layers 105 
were dried (sodium sulfate). Removal of the sovent was followed by chromatography 
of the residue on silica gel, with gradient elution from 40% to 80% ethyl acetate in 
hexane, to yield 24.2 mg (91%) of 90 as a colorless oil: [ar, -28.7° (c 0.65, CHC13); 
IR (neat) 3421, 3390, 2963, 2934, 2879, 1459, 1378, 1254, 1064 cm-1; 1H NMR 
(C6D6, 300 MHz) 8 0.94 (3H, d, J = 6 Hz), 1.11 (3H, d, J = 6 Hz), 1.32 (3H, s), 1.24­
1.82 (7H, m), 2.71 (2H, brs), 3.55 (4H, s), 3.67-3.88 (1H, m), 3.96-4.07 (1H, m); 13C 
NMR (C6D6, 75MHz) 8 14.6, 23.7, 24.1, 27.6, 37.3, 39.4, 42.2, 64.6, 65.4(2C), 71.2, 
110.4; MS (CI) m/z 231 (M+-1), 215, 197, 171, 153, 135, 113; HRMS (CI) mk 
215.1646 (calcd for Ci2H2404 - OH: 215.1648). This compound was contaminated 
by a small amount (de 11:1 by 13C NMR) of a second stereoisomer. 
c>(...jo  6..0 
t-Bif-Lt-Bu 
2(3S)-2-[3-[(4S,6R)-2,2-Di-tert-butylsilylene-6-methy1-1,3-dioxan-4-yl]butan-l-y1]­
2-methyl-1,3-dioxalane  (91). To a solution of 90 (35 mg, 0.15 mmol) in 
dichloromethane (2.5 mL) under argon at 0°C was added dropwise 2,6-lutidine (0.052 
mL, 0.45 mmol) and di-tert-butylsilyl bis(trifluoromethanesulfonate) (0.066 mL, 0.18 
mmol). The solution was stirred for 1.5 h at 0°C and for 2 h at room temperature, was 
recooled to 0°C, and was quenched by addition of saturated sodium bicarbonate 
solution (1 mL). The mixture was diluted with ether (20 mL) and was washed with 
saturated sodium bicarbonate solution (20 mL). The aqueous wash was extracted three 
times with ether (20 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent followed by chromatography of the residue on silica 
gel, using 10% ethyl acetate in hexane as eluant, gave 35 mg (62%) of 91 as a colorless 106 
oil: IR (neat) 2965, 2935, 2882, 2860, 1473, 1379, 1136, 1102, 981 cm-1; 1H NMR 
(C6D6, 300MHz) 8 0.97 (3H, d, J = 6 Hz), 1.14 (18H, d, J = 3 Hz), 1.16 (3H, d, J = 8 
Hz), 1.35 (3H, s), 1.39-1.44 (3H, m), 1.66-1.95 (4H, m), 3.52-3.59 (4H, m), 4.01-4.06 
(1H, qd, J = 10, 2 Hz), 4.21-4.31 (1H, m, J = 7, 3 Hz); 13C NMR (C6D6, 75MHz) 8 
14.6, 21.1, 21.6, 23.7, 24.0, (27.5, 27.6)(6C), 27.7, 37.4, 37.9, 39.8, 64.7(2C), 67.8, 
71.2, 110.3; MS (CI) m/z 373 (M++1), 372 (M+), 371, 358, 331, 315, 269, 229, 197, 
153, 113; HRMS (CI) m/z 373.2773 (calcd for C2OH4004Si + H+: 373.2775). 
y'/../y.

0 
(")-S
t-BL Lt-Bu 
(5S)-5-[(4S,6R)-2,2-Di-tert-butylsilylene-6-methyl-1,3-clioxan-4-yl]hexan-2-one (57) 
A stirred solution of 91 (18 mg, 0.048 mmol) and pyridinium p 
toluenesulfonate (4.3 mg, 0.017 mmol) in acetone (1 mL) and water (0.2 mL) was 
heated at reflux for 4 h. The mixture was allowed to cool to room temperature and was 
extracted three times with ether (10 mL). The combined ethereal extracts were washed 
with water (20 mL) and dried (magnesium sulfate). Removal of the solvent followed 
by chromatography of the residue on silica gel, using 15% ethyl acetate in hexane as 
eluant, gave 15 mg (90%) of 57 as a colorless oil: IR (neat) 2965, 2934, 2888, 2856, 
1718, 1472, 1140, 899; 1H NMR (CDC13, 300MHz) 8 0.90 (6H, d, J = 6 Hz), 0.99 
(18H, s), 1.29 (3H, d, J = 6 Hz), 1.36-1.49 (3H, m), 1.76-1.85 (1H, m), 2.00-2.10 (1H, 
ddd, J = 14, 10, 6 Hz), 2.15 (3H, s), 2.42-2.54 (2H, m), 4.00-4.05 (1H, qd, J = 12, 2 
Hz), 4.36-4.45 (1H, m, J = 7, 2 Hz); 13C NMR (CDC13, 75MHz) 8 13.8, 20.7, 21.3, 
23.4, 27.0(6C), 27.2, 29.8, 37.5, 38.7, 41.5, 67.7, 71.1, 209.0; MS (CI) m/z 329 107 
(M++1), 313, 287, 271, 203, 153, 113; HRMS (CI) m/z 329.2512 (calcd for 
C18H3603Si + H-F: 329.2513). 
TBS 
(2R,5S,6S,75)-14(tert-Butyldimethylsilyl)oxy]-5-[[(tert-butyldimethylsilyl)oxy]met­
hyl]-2-ethyl-7-hydroxy-6-(methyl)dec-9-ene (92). To a suspension of (-)-B­
methoxydiisopinocampheylborane (200 mg, 0.632 mmol) in ether (2.5 mL) under 
argon at -78°C was added dropwise allylmagnesium bromide solution (1.0 M in ether, 
0.632 mL, 0.632 mmol). The mixture was stirred for 15 min at -78°C and for 1 h at 
room temperature, and was recooled to -78°C. A solution of 55 (201 mg, 0.482 mmol) 
in ether (4 mL) was added and the mixture was stirred for 2 h at -78°C and 2 h at room 
temperature. A 3 N sodium hydroxide solution (2.5 mL) followed by a 30% hydrogen 
peroxide solution (2.5 mL) were added, and the mixture was heated at reflux for 3 h. 
After cooling, the mixture was diluted with ether (20 mL) and washed with water (20 
mL) and brine (20 mL). The aqueous washings were extracted three times with ether 
(30 mL), and the combined ethereal extracts were dried (sodium sulfate). Removal of 
the solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 100% hexane to 2% ethyl acetate in hexane, to yield 203 mg (92%) of 92 
as a colorless oil: [oc]p +16.4° (c 1.35, CHC13); IR (neat) 3466 (br), 2956, 2931, 2897, 
2858, 1456, 1254, 1094, 837 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 0.09 
(6H, s), 0.87-0.91 (5H, m), 0.89 (18H, s), 1.09-1.38 (6H, m), 1.42-1.65 (3H, m), 2.16­
2.35 (2H, m, J = 6 Hz), 2.82 (1H, br), 3.41-3.53 (2H, dq, J = 10, 5 Hz), 3.77-3.83 (2H, 
m), 5.06-5.14 (2H, m), 5.75-5.89 (1H, m, J = 7, 3 Hz); 13C NMR (CDC13, 75MHz) 8 108
 
-5.5, -5.5, -4.7, -3.7, 5.5, 11.1, 17.9, 18.2, 23.1, 25.8(6C), 26.0, 31.7, 38.8, 39.7, 42.0, 
64.9, 74.3, 77.9, 117.0, 135.4; MS (CI) m/z 459 (M++1), 458, 457, 443, 401, 359, 309, 
269, 227, 195, 177, 159, 115, 107; HRMS (CI) m/z 459.3690 (calcd for C25H54O3Si2 
+ H+: 459.3691). This compound was contaminated by a small amount (de 3:1 by 13C 
NMR) of a second stereoisomer. 
TBS 
TBSO  OPMB 
(2R,5S,6S,7S)-1-[(tert-Butyldimethylsilyl)oxy]-5-[[(tert-butyldimethylsilypoxy]met­
hyl]-2-ethy1-6-methyl-7-[[(4-methoxyphenyl)methoxy]methyl]dec-9-ene (94). To a 
slurry of sodium hydride (60% dispersion in mineral oil, 210 mg, 5.25 mmol) in ether 
(15 mL) under argon at 0°C was added p-methoxybenzyl alcohol (6.68 mL, 52.5 mmol) 
over a period of 15 min. The mixture was stirred for 15 min at 0°C until all solids had 
been dissolved. Trichloroacetonitrile (5.12 mL, 50.0 mmol) was added and the brown 
solution was stirred for 30 min at 0°C and 1 h at room temperature. The solvent was 
removed under reduced pressure and the residue was added to pentane (10 mL) and 
methanol (0.5 mL), and the mixture was shaken vigorously. The mixture was filtered 
through a short column of Celite which was rinsed with pentane. The combined 
organic solution was concentrated, and the residue was distilled under high vacuum to 
give 2.50 mL of 93 (135°C at 0.7 torr) as a colorless oil which was stored under argon 
at -25°C. 
To a solution of 92 (45 mg, 0.098 mmol) in ether (1 mL) under argon at 0°C 
was added 93 (0.034 mL, 0.16 mmol), followed by 1% triflic acid solution (0.0043 mL, 
0.00049 mmol). The solution was stirred for 10 min at 0°C and additional p­109
 
methoxybenzyl trichloroacetimidate (0.034 mL) was added twice, at 10 min intervals. 
The reaction was quenched by addition of saturated sodium bicarbonate solution (3 
mL), stirred for 10 min at room temperature, and diluted with ether (15 mL). The 
organic layer was separated and washed with saturated sodium bicarbonate solution (10 
mL) and water (10 mL), and was dried (magnesium sulfate). Removal of the solvent 
was followed by chromatography of the residue on silica gel, with gradient elution 
from 1% to 3% ethyl acetate in hexane, to yield 56 mg (98%) of 85 as a colorless oil: 
[ ] -4.0° (c 1.32, CHC13); IR (neat) 2956, 2931, 2889, 2858, 1614, 1456, 1251, 1091, 
837 cm-1; 1H NMR (CDC13, 300MHz) 8 0.02 (6H, s), 0.04 (6H, d, J = 7 Hz), 0.83­
0.96 (6H, m), 0.88 (9H, s), 0.89 (9H, s), 1.09-1.51 (7H, m), 1.69-1.74 (1H, m), 2.35­
2.44 (2H, m, J =7 Hz), 2.82 (1H, br), 3.44-3.50 (3H, m), 3.64-3.71 (1H, m), 3.78-3.81 
(3H, m), 4.36 (1H, d, J = 11 Hz), 4.54 (1H, d, J = 11 Hz), 5.04-5.08 (2H, m), 5.78-5.90 
(1H, m), 6.83-6.88 (2H, m, J = 9 Hz), 7.07-7.28 (2H, m, J = 9 Hz); 13C NMR (CDC13, 
75MHz) 8 -5.5, -5.3, -4.6, -3.9, 9.5, 11.1, 18.0, 18.2, 23.2, 25.9(6C), 31.5, 35.9, 40.2, 
42.1, 55.2, 65.0, 71.2, 73.5, 78.9, 113.5(2C), 116.7, 129.1(2C), 131.1, 135.2, 158.9; 
MS (CI) m/z 579 (M++1), 578, 565, 564, 522, 521, 442, 401, 359, 309, 269, 227, 149, 
121; HRMS (CI) m/z 521.3484 (calcd for C33H62O4Si2 C4H9: 521.3484). 
TBS 
TBSO  OPMB 
(4S,5S,6S,9R)-6-[(tert-Butyldimethylsilypoxy]-9-[(tert-butyldimethylsily1)oxymeth­
y1]-5-methy1-4-[[(4-methoxyphenyl)methoxy]methyl]-1,2-oxiranylundecane (59). 
A solution of 94 (41 mg, 0.071 mmol) and m-chloroperoxybenzoic acid (34 mg, 0.14 
mmol) in dichloromethane (1 mL) under argon was stirred for 16 h at room 110
 
temperature. Ether (3 mL) and saturated sodium bicarbonate solution (3 mL) were 
added, and the mixtuer was stirred rapidly for 45 min. The mixture was diluted with 
additional ether (10 mL) and was partitioned. The aqueous layer was extracted three 
times with ether (10 mL), and the combined ethereal extracts were washed with 
saturated sodium bicarbonate solution (15 mL) and brine (15 mL), and were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 5% to 10% ethyl acetate in hexane, to 
yield 31 mg (75%) of 59 as a colorless oil: IR (neat) 2956, 2931, 2899, 2858, 1514, 
1466, 1252, 1091, 836 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 0.04 (6H, d, 
J= 6 Hz), 0.83-0.89 (3H, m), 0.89 (18H, s), 0.97 (3H, d, J = 7 Hz), 1.24-1.52 (6H, m), 
1.75-1.90 (3H, m), 2.46-2.51 (1H, ddd, J= 8, 5, 4 Hz), 2.74-2.81 (1H, td, J. 12, 5 Hz), 
2.98-3.08 (1H, m), 3.45-3.48 (2H, m), 3.57-3.72 (1H, m, J= 6 Hz), 3.78 (2H, s), 3.80 
(3H, s), 4.38-4.56 (2H, m, J. 11, 8 Hz), 6.83-6.88 (2H, d, J. 9 Hz), 7.25-7.28 (2H, d, 
J = 9 Hz); 13C NMR (CDC13, 75MHz) 8 (-5.5, -4.5, -3.9)(4C), 10.0, 11.1, 18.0, 18.2, 
23.2, 25.9(6C), 31.5, 35.7, 41.5, 42.1, 46.9, 49.9, 55.2, 64.9, 71.2, 72.1, 73.4, 78.0, 
113.6(2C), 129.3(2C), 130.8, 159.0; MS (CI) m/z 595 (M++1), 594, 593, 579, 559, 537, 
501, 475, 459, 441, 413, 359, 305, 249, 149, 121; HRMS (CI) m/z 537.3431 (calcd for 
C33H62O5Si2 C4H9: 537.3433). 
Bn0 
TBSO 
(2S,3S)-2-[(Benzyloxy)methy1]-3-Rtert-butyldimethylsilypoxylhex-5-ene (98). To a 
solution of crude 97 (757 mg) in dichloromethane (20 mL) under argon at 0°C was 
added triethylamine (1.44 mL, 10.3 mmol) and tert-butyldimethylsilyl triflate (1.12 
mL, 5.15 mmol). The solution was stirred for 1.75 h at 0°C and diluted with ether (50 111 
mL), and saturated sodium bicarbonate solution (50 mL) was added. After separation, 
the aqueous layer was extracted three times with ether (50 mL), and the combined 
organic layers were dried (magnesium sulfate). Removal of the solvent was followed 
by chromatography of the residue on silica gel, with gradient elution from 100% 
hexane to 3% ethyl acetate in hexane, to yield 699 mg of 98 as a colorless oil: [ag 
-3.7° (c 3.58, CHC13); IR (neat) 2960, 2935, 2890, 2852, 1646, 1472, 1363 1254, 
1094, 921, 837 cm-1; 1H NMR (CDC13, 300 MHz) 8 0.07 (6H, d, J = 6 Hz), 0.91 (9H, 
s), 0.93 (3H, d, J = 6 Hz), 1.91-1.98 (1H, ddd, J = 10, 7, 3 Hz), 2.24-2.30 (2H, m), 
3.28-3.33 (1H, ddd, J = 9, 7 Hz), 3.46-3.51 (1H, dd, J =9, 7 Hz), 3.87-3.92 (1H, dt, J = 
7, 3 Hz), 4.45-4.57 (2H, q, J = 10, 4 Hz), 5.02-5.10 (2H, m), 5.72-5.86 (1H, m, J = 10, 
7 Hz), 7.36 (5H, m); 13C NMR (CDC13, 75MHz) 8 -4.8, -4.1, 10.6, 18.1, 25.8(3C), 
37.4, 39.5, 71.7, 72.9, 73.0, 116.6, 127.3, 127.5(2C), 128.2(2C), 135.3, 138.7; MS (CI) 
m/z 335 (M++1), 334 (Mt), 333, 317, 301, 293, 277, 227, 187, 185, 145, 115; HRMS 
(CI) m/z 277.1623 (calcd. for Cl8H3604Si-C4H9: 277.1625). 
TBSO  0
II 
(4S,5S)-5-[(Benzyloxy)methy1] -4[(tert-butyldimethylsilypoxy]hexan-2-one (99). A 
stream of oxygen was passed through a stirred suspension of palladium chloride (13 
mg, 0.073 mmol) and copper(I) chloride (73 mg, 0.73 mmol) in N, N­
dimethylformamide (14 mL) and water (2 mL) at room temperature for 2.25 h. A 
solution of 98 (0.24 g, 0.73 mmol) in N, N- dimethylformamide in water (3.5:0.5 mL) 
was added and the brown mixture was stirred for 9 h with continuous passage of 
oxygen, during which the color turned to dark green. A saturated ammoniun chloride 
solution (20 mL) was added, and the mixture which had turned to a jade color was 112
 
extracted three times with ether (30 mL). The combined ethereal extracts were washed 
with brine (40 mL) and water (40 mL), and were dried (magnesium sulfate). Removal 
of the solvent was followed by chromatograghy of the residue on silica gel, with 
gradient elution from 100% hexane to 6% ethyl acetate in hexane to yield 0.15 g (85% 
based on recovered 98) of 99 as a colorless oil: [a]o -32.0° (c 2.20, CHC13); IR (neat) 
2960, 2926, 2882, 2852, 1718, 1478, 1361 1256, 1077, 844 cm-1; 1H NMR (CDC13, 
300 MHz) 8 0.00 (3H, s), 0.05 (3H, s), 0.85 (9H, s), 0.90 (3H, d, J = 7 Hz), 1.84-1.91 
(1H, dq, J = 7, 3 Hz), 2.13 (3H, s), 2.48-2.64 (2H, ddd, J = 10, 6, 4 Hz), 3.27-3.32 (1H, 
dd, J = 9, 7 Hz), 3.46-3.51 (1H, dd, J = 9, 7 Hz), 4.29-4.34 (1H, ddd, J = 6, 3, 2 Hz), 
4.48 (2H, d, J = 4 Hz), 7.33 (5H, m); 13C NMR (CDC13, 75MHz) 8 -5.0, -4.6, 11.7, 
18.0, 25.8(3C), 31.3, 39.1, 48.5, 69.1, 72.1, 72.8,  127.3, 127.5(2C), 128.2(2C), 138.5, 
207.5; MS (CI) m/z 349 (M+-1), 335, 293,  243, 201, 187, 159, 145, 96; HRMS (CI) 
m/z 293.1892 (calcd for Ci8H3604Si C4119: 293.1574). 
BnO 
HO  0 
(4S,5S)- 5- Benzyloxymethyl -4- hydroxyhexan -2 -one (100). To a solution of 99 (34 
mg, 0.097 mmol) in tetrahydrofuran (5 mL) in a Nalgene tube at 0°C was added a 
freshly prepared hydrofluoric acid-pyridine stock solution [Aldrich HFpyridine 
solution (4 mL) in pyridine (5 mL) and tetrahydrofuran (20 mL), 8 mL]. The solution 
was stirred at 0°C to room temperature for 2 d, after which a saturated sodium 
bicarbonate solution (6 mL) was added and the mixture was stirred for 1 h. The 
mixture was added to ether (25 mL) and the solution was washed with additional 
saturated sodium bicarbonate solution (20 mL). The aqueous wash was extracted three 
times with ether (20 mL), and the combined organic layers were dried (magnesium 113
 
sulfate). Removal of the solvent was followed by chromatography of the residue on 
silica gel, with gradient elution from 5% to 30% ethyl acetate in hexane, to yield 18 mg 
(78%) of 100 as a colorless oil:  [a]p -18.7° (c 1.57, CHC13); IR (neat) 3470, 2971, 
2926, 2856, 1718, 1456, 1361, 1098 cm-1; 1H NMR (CDC13, 300MHz) 8 0.95 (3H, d, 
J = 7 Hz), 1.82-1.93 (1H, m, J = 5, 3 Hz), 2.17 (3H, s), 2.47-2.60 (1H, dt, J = 17, 3 
Hz), 2.60-2.70 (1H, dd, J = 17 ,  10 Hz), 3.14 (1H, brs), 3.48 (2H, d, J = 6 Hz), 4.19-4.24 
(1H, td, J = 9, 3 Hz), 4.50 (2H, s), 7.27-7.38 (5H, m); 13C NMR (CDC13, 75MHz) 8 
11.3, 30.7, 37.9, 47.5, 69.3, 73.3, 73.5, 127.5, 127.6(2C), 128.3(2C), 138.0, 209.4; MS 
(CI) m/z 237 (M++1), 219, 201, 189, 179, 159, 129, 119, 91; HRMS (CI) m/z 237.1491 
(calcd for Ci4H2003+ H+: 237.1491). 
Bn0 
OH OH 
(2S,3S,5R) -1- Benzyloxy- 2- methylhexan- 3,5 -diol (101).  To a stirred solutiuon of 
tetramethylammonium triacetoxyborohydride (319 mg, 1.21 mmol) in acetonitrile (0.7 
mL) and acetic acid (0.7 mL) under argon at -40°C was added dropwise a solution of 
100 (53.0 mg, 0.224 mmol) in acetonitrile (1.6 mL). The slurry was stirred for 30 min 
at -40°C and at -28°C for 18 h, after which it was quenched by addition of 0.5 N 
sodium potassium tartrate solution (2 mL).  The mixture was stirred at room 
temperature for 30 min, diluted with dichloromethane (20 mL), and washed with 
saturated sodium bicarbonate solution (20 mL). The aqueous wash was extracted three 
times with dichloromethane (20 mL), and the combined organic layers were dried 
(sodium sulfate). Removal of the sovent was followed by chromatography of the 
residue on silica gel, with gradient elution from 10% to 40% ethyl acetate in hexane, to 
yield 43.6 mg (82%) of 101 as a colorless oil: [42 -14.4° (c 1.85, CHC13); IR (neat) 114
 
3416, 3382, 2971, 2911, 2872, 1453, 1367, 1314, 1103, 1070, 977 cm-1; 1H NMR 
(CDC13, 300 MHz) 8 0.93 (3H, d, J = 7 Hz), 1.20 (3H, d, J = 6 Hz), 1.34-1.43 (1H, 
ddd, J = 14, 8, 3 Hz), 1.57-1.70 (1H, ddt, J = 14, 6, 3 Hz), 1.84-1.97 (1H, m), 3.49 (1H, 
brs), 3.50 (1H, brs), 3.49 (2H, d, J = 6 Hz), 4.03-4.13 (2H, m), 4.49 (2H, s), 7.31 (5H, 
m); 13C NMR (CDC13, 75MHz) 811.4, 23.4, 38.3, 41.4, 65.0, 70.5, 73.3, 74.2, 127.5, 
127.6(2C), 128.3(2C), 137.9; MS (CI) m/z 239 (M++1), 219, 203, 179, 160, 143, 113, 
91; HRMS (CI) m/z 239.1648 (calcd for C14H2203 + H+: 239.1648). 
Bn0 
osso 
t-BL(  t-Bu 
(2S)-1-(Benzyloxy)-2-[(4S,6R)-2,2-di-tert-butylsilylene-6-methyl-1,3-clioxan-4-y11­
propane (102). To a solution of 101 (100 mg, 0.420 mmol) in dichloromethane (6 
mL) under argon at 0°C was added 2, 6-lutidine (0.196 mL, 1.68 mmol) and di -tert­
butylsilyl bis(trifluoromethanesulfonate) (0.184 mL, 0.504 mmol). The solution was 
stirred for 1.5 h at 0°C and lh at room temperature, and was recooled to 0°C. The 
reaction was quenched with saturated sodium bicarbonate solution (3 mL), diluted with 
ether (30 mL), and washed with additional saturated sodium bicarbonate solution (30 
mL). The aqueous wash was extracted three times with ether (30 mL), and the 
combined ethereal extracts were dried (magnesium sulfate). Removal of the solvent 
was followed by chromatography of the residue on silica gel, with gradient elution 
from 3% to 15% ethyl acetate in hexane to yield 146 mg (92%) of 92 as a colorless oil: 
[a] +29.2° (c 2.03, CHC13); IR (neat) 2964, 2931, 2891, 2858, 1470, 1370, 1138, 
1098, 985, 899, 826 cm-1; 1H NMR (CDC13, 400MHz) 8 0.94 (3H, d, J = 7 Hz), 1.00 
(18H, d, J . 3 Hz), 1.29 (3H, d, J = 7 Hz), 1.35-1.40 (1H, td, J = 14, 2 Hz), 1.75-1.82 115
 
(1H, m, J = 7 Hz), 2.07-2.15 (1H, m, J = 6 Hz), 3.33-3.37 (1H, dd, J = 9, 6 Hz), 3.52­
3.56 (1H, m, J= 9, 8 Hz), 4.31-4.35 (1H, m, J= 11, 2 Hz), 4.38-4.44 (1H, m, J = 11, 4, 
2 Hz), 4.46-4.55 (2H, q, J = 12 Hz), 7.27-7.32 (1H, m), 7.34-7.47 (4H, m); 13C NMR 
(CDC13, 100MHz) 5 11.2, 20.8, 21.4, 23.6, (27.2, 27.3)(6C), 37.9, 39.8, 67.9, 68.2, 
72.9, 73.3, 127.5, 127.7(2C), 128.3(2C), 138.6; MS (CI) m/z 379 (M1-+1), 363, 321, 
301, 229, 203, 119, 91; HRMS (CI) m/z 379.2667 (calcd for C22H38O3Si + H-E: 
379.2669). 
HO 
6.se 
t-Btr  t-Bu 
(2S)-2-[(4S,6R)-2,2-Di-tert-butylsilylene-6-methy1-1,3-dioxan-4-yl]propan-1-ol 
(103). A round-bottom flask containing 102 (103 mg, 0.272 mmol) and 3% platinum 
on carbon (100 mg) in ethanol (3 mL) at room temperature was evacuated for 10 min, 
after which a hydrogen-filled balloon was attached. This process was repeated three 
times. The mixture was stirred under a hydrogen atmosphere at room temperature for 
3.5 h, and was filtered through a short column of Celite which was rinsed with ethyl 
acetate. Removal of the combined organic solvent from the filtrate was followed by 
chromatography of the residue on silica gel, with gradient elution from 5% to 20% 
ethyl acetate in hexane, to yield 70.0 mg (96%) of 103 as a colorless oil:  [ ar +34.2° 
(c 2.65, CHC13); IR (neat) 3363, 2964, 2938, 2891, 2858, 1469, 1384, 1145, 1045, 985, 
899, 826 cm-1; 1H NMR (CDC13, 300MHz) 5 0.97 (3H, d, J . 7 Hz), 1.00 (18H, d, J = 
2 Hz), 1.30 (3H, d, J = 7 Hz), 1.20-1.40 (1H, m), 1.64-1.75 (1H, m, J = 4 Hz), 2.13­
2.23 (1H, m, J = 10, 6 Hz), 2.69 (1H, m), 3.65-3.78 (2H, m, J = 10, 6 Hz), 4.39-4.48 
(2H, m); 13C NMR (CDC13, 75MHz) 5 10.3, 20.7, 23.3, 27.1(6C), 37.2, 40.2, 67.1, 116 
67.7, 71.5; MS (CI) m/z 289 (M++1), 288 (m+), 287, 273, 269, 231, 203, 189, 113, 84, 
77; HRMS (CI) m/z 289.2200 (calcd for C15H3203Si + 11+: 289.2200). 
(2S)42(4S,6R)-2,2-Di-tert-butylsilylene-6-methy1-1,3-clioxan-4-y1]-1-iodopropane 
(60). A stirred suspension of 103 (58.0 mg, 0.201 mmol), triphenylphosphine (107 mg, 
0.402 mmol), imidazole (55.0 mg, 0.804 mmol) and iodine (102 mg, 0.402 mmol) in 
benzene (dried over calcium hydride, 6.5 mL) under argon was heated at reflux for 6 h 
and allowed to cool to room temperature. The mixture was diluted with ether (40 mL) 
and was washed with saturated sodium thiosulfate solution (30 mL) and saturated 
sodium bicabonate solution (30 mL), and was dried (magnesium sulfate). Removal of 
the solvent followed by chromatography on silica gel, using 2% ethyl acetate in hexane 
as eluant, gave 76.0 mg (96%) of 60 as a pale yellow oil: [a ] +35.2° (c 1.04, CHC13); 
IR (neat) 2972, 2932, 2890, 2859, 1473, 1144, 831 cm-1; 1H NMR (CDC13, 400MHz) 
8 1.00 (9H, s), 1.02 (9H, s), 1.04 (3H, d, J = 7 Hz), 1.33 (3H, d, J = 6 Hz), 1.35-1.54 
(1H, td, J = 14, 2 Hz), 1.65-1.71 (1H, ddd, J = 14, 7, 4 Hz), 3.38-3.42 (1H, dd, J = 10, 
7 Hz), 4.27-4.31 (1H, dt, J = 12, 2 Hz), 4.41-4.44 (1H, dq, J = 6, 2 Hz); 13C NMR 
(CDC13, 100MHz) 8 12.3, 14.6, 20.8, 21.4, 23.5, (27.2, 27.3)(6C), 37.8, 42.0, 67.8, 
69.9; HRMS (CI) m/z 399.1217 (calcd for Ci5H3iIO2Si + H+: 399.1217). 117
 
Attempted coupling reaction of 59 with 60. 
(4S,6R)-2,2-Di-tert-butylsilylene-4-isopropyl-6-methyl-1,3-dioxane (104). 
To a solution of copper(I) cyanide (0.18 g, 2.0 mmol) in tetrahydrofuran (6 mL) 
under argon at -78°C was added lithium thiophene (1.0 M in tetrahydrofuran, 2.0 mL, 
2.0 mmol) dropwise. The solution was stirred for 10 min at -78°C and the cooling bath 
was removed. The mixture was allowed to warm over 10 min, the flask was placed in 
an ice-water bath, and stirring was continued for 2 h at 0°C. The dark brown 2­
thienyl(cyano)copper lithium solution (0.25 M) was used immediately for the next step. 
To a solution of 60 (41.0 mg, 0.103 mmol) in ether (1 mL) under argon at -78°C 
was added tert-butyllithium (1.7 M in pentane, 0.121 mL, 0.206 mmol) dropwise. The 
pale yellow solution was stirred for 5 min and the 2-thienyl(cyano)copper lithium 
solution (0.25 M in tetrahydrofuran, 0.412 mL, 0.103 mmol) was added. The dark 
brown solution was stirred for 10 min at -78°C, the cooling bath was removed partially, 
and the solution was allowed to warm slowly for 5 min. An ice-water bath was 
installed, and the turbid yellow mixture was stirred for 10 min at 0°C and recooled to 
-78°C, during which it became a slightly orange color. A solution of 59 (29.0 mg, 
0.0490 mmol) in ether (0.6 mL) was added dropwise and the mixture was stirred for 10 
min at -78°C. The cooling bath was removed partially and the mixture was allowed to 
warm slowly for 10 min. An ice-water bath was installed and the mixture was stirred 
for 40 min at 0°C. The reaction was quenched by addition of saturated ammonium 
chloride solution (1 mL), stirred for 30 min at room temperature, and ether (20 mL) and 
water (20 mL) were added. After separation, the aqueous layer was extracted three 118
 
times with ether (20 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent was followed by chromatography of the residue on 
silica gel, with gradient elution from 5% to 10% ethyl acetate in hexane, to yield 23.0 
mg of 59, 5.00 mg of 103, and 26.0 mg of 104: IR (neat) 2965, 2933, 2891, 2860, 
1472, 1382, 1105, 826 cm-1; 1H NMR (CDC13, 300MHz) 8 0.90 (3H, d, J= 7 Hz), 
0.92 (3H, d, J =7 Hz), 1.00-1.05 (18H, s), 1.26 (3H, d, J = 7 Hz), 1.40-1.50 (1H, m), 
1.57-1.70 (1H, m), 1.87-2.01 (1H, m), 3.80-3.88 (1H, m), 4.32-4.42 (1H, m). 
PhSO 
o_s( o 
t-Bu  t-Bu 
(2S)-[2(4S,6R)-2,2-Di-tert-butylsilyene-6-methy1-1,3-dioxan-4-yl]propy1-1-phenyl­
sulfone (61). A solution of 60 (50.0 mg, 0.126 mmol) and sodium phenylsulfinate 
(33.0 mg, 0.200 mmol) in N,N-dimethylformamide (1 mL) under argon was stirred for 
25 h at 37°C, allowed to cool to room temperature, and ether (15 mL) and saturated 
sodium bicarbonate solution (15 mL) were added. After separation, the aqueous layer 
was extracted three times with ether (15 mL). The combined organic layers were 
washed with saturated sodium bicarbonate solution (30 mL) and brine (30 mL), and 
were dried (magnesium sulfate). Removal of the solvent followed by chromatography 
of the residue on silica gel, using 12% ethyl acetate in hexane as eluant, gave 43.5 mg 
(84%) of 61 as a colorless oil:  [42, +14.3° (c 0.87, CHC13); IR (neat) 2967, 2934, 
2891, 2859, 1473, 1306, 1090, 826 cm-1; 1H NMR (CDC13, 300MHz) 8 0.94 (9H, s), 
0.96 (9H, s), 1.05 (3H, d, J = 7 Hz), 1.26 (3H, d, J = 7 Hz), 1.29-1.34 (1H, td, J = 14, 2 
Hz), 1.94-2.05 (1H, dq, J = 11, 6 Hz), 2.14-2.22 (1H, m), 2.91-2.99 (1H, dd, J = 14, 7 
Hz), 3.37-3.43 (1H, dd, J = 14, 5 Hz), 4.15-4.20 (1H, td, J = 11, 2 Hz), 4.33-4.42 (1H, 119
 
dquent, J = 6, 2 Hz), 7.53-7.59 (2H, m), 7.61-7.68 (1H, m), 7.91-7.94 (2H, m); 13C 
NMR (CDC13, 75MHz) 8 13.9, 20.7, 21.3, 23.3, (27.1, 27.2)(6C), 34.8, 36.9, 59.6, 
67.5, 70.1, 127.8(2C), 129.2(2C), 133.5, 140.0; MS (CI) m/z 413 (M++1), 412, 355, 
237, 203, 143, 95; HRMS (CI) m/z 413.2181 (calcd for C21H36O4SSi + Il±: 
413.2183). 
=
YYY:
 ),
OH	  SO2  O. .,O 
Ph t-Iikrt-Bu 
Hydroxy Sulfone (105). To a solution of 61 (10 mg, 0.024 mmol) in tetrahydrofuran 
(0.5 mL) under argon at -78°C was added n-butyllithium (1.6 M in hexane, 0.030 mL, 
0.048 mmol) dropwise.  The clear solution was stirred for 20 min and 
hexamethylphosphoramide (0.018 mL, 0.10 mmol) was added. The yellow solution 
was stirred for 15 min and propylene oxide (0.0080 mL, 0.12 mmol) was added. The 
mixture was stirred for 30 min at -78°C and for 1 h at 0°C. The reaction was quenched 
with saturated ammonium chloride solution (0.4 mL) and was extracted three times 
with ether (15 mL). The combined ethereal extracts were washed with brine (25 mL), 
and were dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography on silica gel, with gradient elution of 10% to 35% ethyl acetate in 
hexane, to yield 4.0 mg (40%) of 61 and 7.3 mg (65%, 100% based on recovered 61) of 
105 as a colorless oil. This material was a mixture of four stereoisomers: IR (neat) 
3509, 2967, 2934, 2892, 1472, 1290 cm-1; MS (CI) m/z 473, 472, 471 (M++1), 413, 
285, 229, 203, 151, 143; HRMS (CI) m/z 471.2599 (calcd for C24H42O5SSi + H+: 
471.2602). 120
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6- Methyl -5- hepten -2-one 1,1-Dimethylhydrazone (107). Method A. To a solution 
of 6- methyl -5- hepten -2 -one (106, 0.50 mL) in dichloromethane (3.5 mL) under argon 
at 0°C was added 1,1-dimethylhydrazine (3.5 mL, 46 mmol) dropwise. The solution 
was stirred for 5 min and chlorotrimethylsilane (1.2 mL, 9.3 mmol) was added 
dropwise, during which the reaction temperature was kept below 7°C. The mixture was 
stirred for 50 min at room temperature, recooled to 0°C, and was poured onto crushed 
ice (20 g). The mixture was partitioned between water (20 mL) and dichloromethane 
(20 mL). The aqueous layer was extracted three times with dichloromethane (20 mL), 
and the combined organic layers were dried (sodium sulfate). Removal of the solvent 
gave 0.24 g of crude 107, which was unstable and hydrolyzed to 106 during 
chromatography on silica gel, using 10% ethyl acetate in hexane as eluant: IR (neat) 
2973, 2839, 1667, 1471, 1386 cm-1; 1H NMR (CDC13, 300MHz) 8 1.60 (3H, s), 1.67 
(3H, s), 1.92 (4H, 2s), 2.21 (3H, brs), 2.40 (6H, 2s), 5.10 (1H, m); 13C NMR (CDC13, 
75MHz) 8 16.5, 17.6, 25.6, 38.9, 46.9, 47.9, 123.1, 132.0, 167.5. 
Method B. To a solution of 106 (1.5 mL) in ethanol (4.5 mL) under argon at 
room temperature was add Ll-dimethylhydrazine (3.6 mL, 46 mmol). The solution 
was heated at reflux for 26 h and allowed to cool to room temperature. Excess 1,1­
dimethylhydrazine was removed under reduced pressure to give 0.45 g of a 5:1 mixture 
of 107 and 106, which was used for the next step without purification. 121
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N,2-Dimethyl-N-(methoxy)propanamide (109). A solution of isobutyric acid (108, 
1.05 mL, 11.4 mmol), N,O- dimethylhydroxylamine hydrochloride (3.38 g, 34.1 mmol), 
1,3-dicyclohexylcarbodiimide (6.56 g, 31.8 mmol) and 4-dimethylaminopyridine (4.35 
g, 35.2 mmol) in dichloromethane (25 mL) under argon was stirred at 0°C to room 
temperature for 12 hours and diluted with hexane (50 mL). The mixture was filtered 
through a pad of Celite which was rinsed with hexane. The organic layers were 
combined, and removal of the solvent was followed by chromatography of the residue 
on silica gel, with gradient elution from 5% to 25% ethyl acetate in hexane, to yield 
589 mg (40%) of 109 as a pale yellow oil: 1H NMR ( CDC13, 300MHz): S 1.10 (6H, 
d, J= 7 Hz), 2.95 (1H, m, J= 7 Hz), 3.17 (3H, s), 3.68 (3H, s); 13C NMR (CDC13, 75 
MHz): 8 18.9, 29.6, 32.1, 178.1. 
(4Z)-2,9-Dimethy1-51(2,2-dimethyphydrazino]octa-4,8-dien-3-one (110). To a 
solution of diisopropylamine (0.468 mL, 3.57 mmol) in tetrahydrofuran (2 mL) under 
argon at -30°C was added methyllithium (1.4 M in ether, containing less than 0.05 M 
halide, 2.30 mL, 3.17 mmol) dropwise. The colorless solution was warmed to 0°C, 
stirred for 10 min, recooled to -5°C, and a brown solution of crude 107 (445 mg) in 
tetrahydrofuran (2 mL) was added via cannula. The dark red mixture, which was 
bright yellow at the side, was stirred for 45 min at 0°C and was cooled to -78°C. The 122
 
mixture was transferred dropwise into a precooled (-55°C) solution of 109 (465 mg, 
3.55 mmol) in tetrahydrofuran (2.5 mL) via cannula. The mixture was stirred for 20 h 
at -45°C, cooled to -78°C, and was added to a rapidly stirred biphasic mixture 
consisting of saturated ammonium chloride solution (20 mL) and ether (20 mL) at 0°C 
via cannula, and was stirred for 15 min. After separation, the aqueous layer was 
extracted three times with ethyl acetate (20 mL), and the combined organic layers were 
dried (sodium sulfate). Removal of the solvent was followed by chromatography on 
silica gel, with gradient elution from 5% to 40% ethyl acetate in hexane, to yield 51.0 
mg (25% based on the purity of 107) of 110 as a colorless oil: IR (neat) 2964, 1609, 
1576 cm-1; 1H NMR (CDC13, 300MHz) 6 1.06 (6H, d, J = 7 Hz), 1.61 (3H, s), 1.68 
(3H, s), 2.24 (2H, m), 2.35 (2H, m), 2.44 (1H, m, J = 7 Hz), 2.53 (3H, s), 4.85 (1H, s), 
5.14 (1H, m), 11.13 (1H, brs); 13C NMR (CDC13, 75MHz) 6 17.5, 19.7, 25.6, 27.1, 
31.9, 39.3, 48.7, 90.4, 123.1, 132.5, 166.8, 202.4. 
TBS
 
Me
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(2R,3S,6R)-3-[( tert-Butyldimethylsily0oxy]-64[(tert-Butyldimethylsilypoxy]meth­
yl]-N,2-dimethyl-N-(methoxy)octanamide (56). A solution of 55 (108 mg, 0.259 
mmol), 5% sodium phosphate monobasic solution (pH 4.17, 3.00 mL), and potassium 
permanganate solution (1 M, 4.50 mL) in tert-butanol (1.5 mL) was stirred vigorously 
for 5 h at room temperature. The reaction was quenched by addition of saturated 
sodium bisulfite solution (1.5 mL), dichloromethane (20 mL), and saturated 
ammonium chloride solution (20 mL).  After separation, the aqueous layer was 
extracted three times with dichloromethane (20 mL), and the combined organic layers 123
 
were dried (sodium sulfate). Removal of the solvent gave 120 mg of a crude acid 
which was used without purification. 
To a solution of the acid (120 mg) in dichloromethane (8 mL) under argon at 
0°C was added N, O- dimethylhydroxylamine hydrochloride (86.0 mg, 0.860 mmol), 4­
dimethylaminopyridine (110 mg, 0.890 mmol), and 1,3- dicyclohexylcarbodiimide (167 
mg, 0.800 mmol). This homogeneous mixture was stirred for 9 h at room temperature, 
diluted with hexane (20 mL), filtered through a pad of Celite and rinsed with hexane. 
Removal of the combined organic solvent was followed by chromatography on silica 
gel, with gradient elution from 5% to 12% ethyl acetate in hexane, to yield 91.0 mg 
(74% from 55) of 56 as a colorless oil:  [ at2 -2.0° (c 0.82, CHC13); IR (neat) 2957, 
2932, 2893, 1668, 1466, 1254 cm-1; 1H NMR (CDC13, 300MHz) 8 0.02 (6H, s), 0.05 
(6H, s), 0.88 (20H, m), 1.13 (3H, d, J = 7 Hz), 1.32 (6H, m), 1.45 (2H, m), 2.96 (1H, 
br), 3.16 (3H, s), 3.45 (2H, m), 3.68 (3H, s), 3.92 (1H, m); 13C NMR (CDC13, 
75MHz) 6 (-5.5, -4.6, -4.2)(4C), 10.9, 11.1, 14.2, 18.2, 23.3, 24.8, 25.9(6C), 33.0, 40.3, 
42.4, 61.2, 65.3, 73.5, 73.6, 176.5; MS (CI) m/z 476 (Mt), 460, 419, 418, 283, 260, 
227, 115; FIRMS (CI) m/z 418.2811 (calcd for C24H53NO4Si2 -C4H9: 418.2810). 
N,  6 
NMe2 
t-Bd It -Bu 
(5S)-5-[(4S,6R)-2,2-Di-tert-butylsilylene-6-methyl-1,3-dioxan-4-y1]-2-hexanone 1,1­
Di- methylhydrazone (58). Method A. To a solution of 57 (9.0 mg, 0.027 mmol) in 
dichloromethane (0.8 mL) under argon at 0°C was added 1,1-dimethylhydrazine (0.025 
mL, 0.33 mmol) dropwise.  The solution was stirred for 5 min and 
chlorotrimethylsilane (0.0070 mL, 0.054 mmol) was added dropwise, during which the 124
 
reaction temperature was kept below 7°C. The mixture was stirred for 50 min at room 
temperature, recooled to 0°C and was poured onto crushed ice (10 g). The mixture was 
partitioned between water (15 mL) and dichloromethane (15 mL). The aqueous layer 
was extracted three times with dichloromethane (15 mL), and the combined organic 
layers were dried (sodium sulfate). Removal of the solvent gave 11 mg of a crude 
mixture of 57 and 58 as an oil, which was used without purification: ER (neat) 1729 
(C=0), 1643 (C=N) cm-1; 1H NMR (CDC13, 300MHz) 8 0.92 (3H, d, J = 7 Hz), 1.00 
(18H, S), 1.29 (3H, d, J = 6 Hz), 1.29-1.52 (2H, m), 1.73 (2H, m), 1.92 (0.8H, s), 1.95 
(2.2H, s), 2.03 (1H, m), 2.10-2.30 (2H, m), 2.40 (1.3H, s), 2.43 (4.7H, s), 3.85-4.12 
(1H, m), 4.40 (1H, m); 13C NMR (CDC13, 75MHz) 8 13.9, 16.3, 20.7, 21.3, 23.5, 
(27.2, 27.3)(6C), 30.1, 36.9, 37.4, 39.0, 47.0, 47.5, 67.7, 71.0, 167.9. 
Method B. To a solution of 57 (23 mg, 0.070 mmol) in ethanol (1 mL) under 
argon at room temperature was added 1,1-dimethylhydrazine (0.022 mL, 0.28 mmol). 
The solution was heated at reflux for 21 h and allowed to cool to room temperature. 
Excess 1,1-dimethylhydrazine was removed under reduced pressure and the residue 
was dissolved in toluene (5 mL). Removal of the solvent gave 25 mg of a mixture of 
57 and 58, which was used without purification. 
TBS 
9  0 HN,NMe  O. .,0 
TBS  2t -Bu  t - -Bu 
(Z)-(2S,8R,9S,12R)-9-[( tert-Butyldimethylsilypoxy]-12-[(tert-butylclimethylsilyl)ox­
ymethyl]-2-[(4S,6R)-2,2-di-tert-butylsilylene-6-methyl-1,3-dioxan-4-y1]-8-methy1-5­
(2,2-dimethylhydrazino)-5-tetradecan-7-one  (111).  To a solution of 
diisopropylamine (0.021 mL, 0.091 mmol) in tetrahydrofuran (0.7 mL) under argon at 125
 
-30°C was added methyllithium (1.35 M in ether, containing less than 0.05 M halide, 
0.060 mL, 0.081 mmol) dropwise. The colorless solution was warmed to 0°C, stirred 
for 10 min, recooled to -4°C, and was added dropwise of a solution of crude 58 (25 mg, 
as a mixture with 57) in tetrahydrofuran (0.7 mL). The yellow solution was stirred for 
50 min at -2°C to 2°C, cooled to -78°C, and was transferred into a precooled (-57°C) 
solution of 56 (26 mg, 0.055 mmol) via cannula. The pale yellow solution was stirred 
for 20 h at -45°C, for 1.5 h at -30°C and for 19 h at -18°C. The mixture was recooled to 
-78°C and was transferred into a rapidly stirring biphasic solution of ether (20 mL) and 
saturated ammonium chloride solution (20 mL) at 0°C via cannula. The mixture was 
stirred for 15 min and was partitioned. The aqueous layer was extracted three times 
with ethyl acetate (20 mL), and the combined organic layers were dried (sodium 
sulfate). Removal of the solvent was followed by chromatography of the residue on 
silica gel, with gradient elution from 5% to 30% ethyl acetate in hexane, to yield 5.6 
mg (67% based on recovered 56) of the unstable vinylogous amide 101 as a colorless 
oil: 1H NMR (CDC13, 300 MHz) 8 0.02 (12H, s), 0.87 (21H, m), 0.91 (3H, d, J = 6 
Hz), 0.95 (3H, d, J = 6 Hz), 1.01 (18H, s), 1.06 (3H, d, J = 7 Hz), 1.21-1.36 (8H, m), 
1.41-1.51 (4H, m), 1.80 (1H, m), 2.01 (2H, m), 2.30-2.50 (3H, m), 2.53 (3H, s), 3.40­
3.50 (2H, m), 3.86-3.95 (1H, m), 4.00-4.10 (1H, m), 4.40 (1H, m), 4.90 (1H, m), 11.29 
(1H, s); 13C NMR (CDC13, 75 MHz) 8 (-5.5, -4.8, -4.4)(4C), 11.1, 12.7, 13.9, 18.0, 
18.2, 20.7, 21.3, 23.2, 23.4, 25.5, (25.9, 26.0)(6C), 26.1, (27.0, 27.1, 27.2)(6C), 37.5, 
38.7, 39.2, 41.1, 41.5, 42.2, 48.7, 65.2, 67.7, 70.7, 71.1, 74.8, 92.1, 167.2, 200.1. 126
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(2S,3R,6R,8S,9S)-3,9-Dimethy1-84(R)-2-hydroxy-1-propyl]-2-[(R)-3-(hydroxymet­
hyl)-1-pentyl]-1,7-dioxaspiro[5.5]undecan-4-one (112). Method A. A solution of 
111 (3.6 mg, 0.0046mmol) in a hydrofluoric acid-acetonitrile-water stock solution {9:1 
[95:5 (CH3CN/48%HF)]/H20, 0.5 mL} was stirred for 5 d at room temperature, during 
which time an additional 0.2 mL of the stock solution was added at 20 h and 47 h. The 
solution was added to saturated aqueous sodium bicarbonate (2 ml) and water (8 ml). 
The mixture was extracted once with ethyl acetate (15 mL) and twice with ether (15 
mL), and the combined organic layers were dried (magnesium sulfate). Removal of the 
solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 15% to 70% ethyl acetate in hexane, to yield 1.2 mg (73%) of 112 as a 
colorless oil: [47 -89.0° (c 0.10, CHC13); IR (neat) 3389, 3382, 2964, 2938, 2878, 
1716, 1457, 1377, 1304, 1251, 1085, 972 cm-1; 1H NMR (CDC13, 300MHz) 8 0.89 
(6H, m), 0.98 (1H, d, J = 7 Hz), 1.08 (3H, d, J = 7 Hz), 1.13 (3H, d, J = 6 Hz), 1.16­
1.40 (3H, m), 1.41-1.49 (3H, m), 1.51-1.71 (7H, m), 2.08-2.22 (1H, m, J= 5 Hz), 2.26­
2.60 (1H + 2'0111, m), 2.30 (1H, d, J = 14 Hz), 2.50 (1H, d, J = 14 Hz), 3.43-3.60 (2H, 
dtd, J = 24, 11, 6 Hz), 3.78-3.91 (1H, m, J = 6, 2 Hz), 3.98-4.06 (2H, m); 13C NMR 
(CDC13, 75MHz) 8 10.5, 11.0, 11.3, 23.3, 24.8, 26.1, 26.5, 28.0, 29.4, 30.2, 41.8, 42.4, 
47.9, 48.3, 63.9, 67.8, 70.6, 74.6, 98.9, 210.9; MS (CI) m/z 357 (M++1), 355, 339, 268, 
255, 227, 211, 197, 185, 173, 155, 95; HRMS (CI) m/z 357.2639 (calcd for C20113605 
+ 11+: 357.2642). 127
 
Method B.  A solution of 116 (460 mg, 0.977 mmol) and tetra-n­
butylammonium fluoride (2.05 mL, 2.05 mmol) in tetrahydrofuran (15 mL) under 
argon was stirred for 8.5 h at room temperature. The mixture was added to ether (45 
mL) and the solution was washed with brine (50 mL). The aqueous wash was 
extracted with ethyl acetate (50 mL) and twice with ether (50 mL), and the combined 
organic layers were dried (sodium sulfate). Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 30% to 60% 
ethyl acetate in hexane, to yield 236 mg (68%) of 112 as a colorless oil: [a]  -105.5° 
(c 1.13, CHC13). 
(2S,3S,4S,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-[(tert-butyldimethylsilyl)oxy]-1-propyl] 
-2-{(R)-3-[[(4-methoxyphenypmethoxy]methyl]-1-pentyll-1,7-dioxaspiro[5.5]unde­
can-4-ol (114). A suspension of 113 (1.24 g, 1.78 mmol) and lithium hydroxide 
monohydrate (0.618 g, 14.2 mmol) in methanol (80 mL) was stirred for 18 h at room 
temperature. The mixture was added to ether (120 mL) and the solution was washed 
with saturated ammonium chloride solution (150 mL) and brine (150 mL). The 
aqueous washs was extracted three times with ether (200 mL), and the combined 
organic layers were dried (magnesium sulfate). Removal of the solvent was followed 
by chromatography of the residue on silica gel, with gradient elution from 20% to 30% 
ethyl acetate in hexane, to yield 1.04 g (99%) of 114 as a colorless oil: [a]2 -43.7° (c 128 
1.22, CHC13); IR (neat) 3436, 2957, 2938, 2858, 1616, 1516, 1463, 1377, 1251, 1178, 
1091, 979 cm-1; 1H NMR (CDC13, 300MHz) 8 0.04 (6H, s), 0.81 (3H, d, J = 7 Hz), 
0.87 (9H, s), 0.88 (3H, d, J = 10 Hz), 0.92 (3H, d, J = 7 Hz), 1.16 (3H, d, J = 6 Hz), 
1.23-1.42 (6H, m), 1.44-1.49 (2H, m), 1.50-1.67 (6H + OH, m), 1.68-1.74 (1H, dd, J= 
12, 5 Hz), 1.80-1.85 (1H, m), 2.01-2.13 (1H, tt, J = 13, 4 Hz), 3.32 (2H, d, J = 6 Hz), 
3.51-3.55 (1H, m), 3.72-3.82 (2H, m), 3.79 (3H, s), 4.15-4.19 (1H, m), 4.42 (2H, s), 
6.84 (2H, d, J = 8 Hz), 7.24 (2H, d, J= 8 Hz); 13C NMR (CDC13, 75MHz) 8 -4.7, -4.5, 
3.9, 10.8, 10.9, 18.0, 23.5, 24.3, 25.8(3C), 26.4, 27.7, 29.5, 29.6, 29.7, 37.9, 39.0, 39.8, 
43.2, 55.1, 67.1, 67.3, 69.1, 71.1, 72.5, 72.6, 97.4, 113.6(2C), 129.0(2C), 130.1, 158.9; 
MS (CI) m/z 592 (M+), 591, 535, 517, 453, 439, 397, 325, 227, 159, 121, 95; HRMS 
(CI) m/z 591.4081 (calcd for C34H6006Si - H+: 591.4083). 
(25,3R,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-[( tert-butyldimethylsilyl)oxy]-1-propyl] -2­
{(R)-3-[[(4-methoxyphenyOmethoxy]methyl]-1-penty1}-1,7-dioxaspiro[5.5]undecan 
-4-one (115). A suspension of 114 (1.03 g, 1.74 mmol), powdered activated 4A 
molecular sieves (2.00 g), 4-methylmorpholine N-oxide (0.365 g, 2.61 mmol), and 
tetra-n-propylammonium perruthenate (34.0 mg, 0.0870 mmol) in dichloromethane (10 
mL) under argon was stirred for 1.25 h at room temperature. The mixture was filtered 
through a short column of silica gel and the column was rinsed with dichloromethane. 
Removal of the combined organic solvent followed by chromatography of the residue 129
 
on silica gel, using 8% ethyl acetate in hexane as eluant, gave 1.02 g (100%) of 115: 
[a] -56.9° (c 1.82, CHC13); IR (neat) 2975, 2931, 2884, 2858, 1722, 1516, 1463, 
1251, 1091, 1038, 979 cm-1; 1H NMR (CDC13, 300MHz) 8 0.02 (6H, d, J = 1 Hz), 
0.86 (9H, s), 0.87 (3H, d, J = 5 Hz), 0.92 (3H, d, J = 7 Hz), 1.07 (3H, d, J = 7 Hz), 1.10 
(3H, d, J = 6 Hz), 1.27 (3H, m), 1.30-1.53 (3H, m), 1.56-1.70 (7H, m), 2.04-2.16 (1H, 
m, J = 7 Hz), 2.25-2.34 (1H, m), 2.30 (1H, d, J = 13 Hz), 2.50 (1H, d, J = 14 Hz), 3.32 
(2H, m, J = 4 Hz), 3.71-3.78 (2H, m), 3.80 (3H, s), 3.79-3.90 (1H, m), 4.42 (2H, s), 
6.86 (2H, d, J = 9 Hz), 7.26 (2H, d, J = 8 Hz); 13C NMR (CDC13, 75MHz) 8 -4.6, -4.4, 
10.9,  11.0,  14.0,  18.0, 22.6, 23.5, 24.2, 25.8(3C), 26.4, 27.4, 28.7, 29.4, 31.5,  39.8, 
42.9, 48.3, 55.2, 67.1, 70.0, 70.6, 72.5, 72.6, 99.0 113.6(2C), 129.0(2C), 130.7, 159.0, 
210.4; MS (CI) m/z 591 (M++1), 589, 575, 533, 471, 413, 341, 283, 229, 159, 121, 95; 
HRMS (CI) m/z 591.4081 (calcd for C34H6006Si + H+: 591.4082). 
H 
°?r14'0  OTBS 
(2S,3R,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-hydroxy-1-propy1]-2-[(R)-3-[(tert-butyldi­
methylsilypoxymethyl]-1-pentyl]-1,7-dioxaspiro[5.5]undecan-4-one (116).  A 
suspension of 20% palladium hydroxide on carbon (63 mg, 0.085 mmol) and 95% 
ethanol (7 mL) at room temperature was evacuated under reduced pressure for 10 min 
and the flask was filled with hydrogen using a balloon. This process was repeated 
three times. A solution of 115 (1.0 g,1.7 mmol) in 95% ethanol (7 mL) was added, and 
the solution was stirred under a hydrogen atmosphere for 1.75 h at room temperature, 130 
filtered through a short column of Celite which was rinsed with ether. Removal of the 
combined organic solvent from the filtrate was followed by chromatography of the 
residue on silica gel, with gradient elution from 10% to 30% ethyl acetate in hexane, to 
yield 0.80 g (100%) of 116 as a colorless oil:  [a],232 -68.7° (c 1.45, CHC13); IR (neat) 
3449, 2957, 2931, 2884, 2864, 1716, 1464, 1384, 1251, 1085, 979 cm-1; 1H NMR 
(CDC13, 400MHz) 8 0.02 (6H, s), 0.85 (9H, s), 0.88 (3H, d, J = 6 Hz), 0.91 (3H, d, J = 
7 Hz), 1.08 (3H, d, J = 7 Hz), 1.11 (3H, d, J = 6 Hz), 1.22-1.34 (2H, m), 1.36-1.51 (6H, 
m), 1.54-1.79 (6H, m), 2.04-2.13 (1H, m, J = 6 Hz), 2.29 (1H, d, J = 14 Hz), 2.30-2.34 
(1H, m), 2.48 (1H, d, J = 14 Hz), 3.53-3.59 (2H, m), 3.72-3.79 (2H, m), 3.83-4.11 (1H, 
m); 13C NMR (CDC13, 100MHz) 8 -4.6, -4.3, 10.7, 11.0,  15.2, 18.0, 23.2,  24.3, 
25.8(3C), 26.4, 27.0, 28.9, 29.2, 29.4, 42.1, 43.0, 48.1, 48.3, 65.0, 65.8, 67.2, 70.7, 
99.1, 210.3; MS (CI) m/z 471 (M++1), 455, 413, 395, 369, 325, 297, 283, 229,  185, 
159, 109; HRMS (CI) m/z 471.3507 (calcd for C26H5005Si + H+: 471.3506). 
TBS 
O o o 
I I 
TBS PMB 
(3S,4S,5S,8R)-5-[(tert-Butyldimethylsilyl)oxy]-8-[(tert-butyldimethylsilypoxymeth­
y1]-4-methy1-3-[(4-methoxyphenyl)methoxy]decanal (62). A stream of ozone was 
passed through a stirred solution of 94 (80 mg, 0.14 mmol) in dichloromethane (5 mL) 
and methanol (1 mL) at -78°C for 5 min. The excess ozone was purged with argon for 
25 min, a catalytic amount of potassium bicarbonate and dimethyl sulfide (3 mL) were 
added, and the mixture was stirred at room temperature for 34 h. Removal of the 
solvent followed by chromatography of the residue on silica gel, using 5% ethyl acetate 
in hexane as eluant, gave 38 mg (47%) of 62 as a colorless oil: IR (neat) 2957, 2927, 131
 
2891, 2860, 1730, 1617, 1514, 1478, 1257, 1103, 846 cm-1; 1H NMR (CDC13, 
400MHz) 8 0.03 (12H, m), 0.86 (3H, m), 0.89 (18H, s), 0.96 (3H, d, J = 7 Hz), 1.33 
(5H, m), 1.50 (2H, m), 1.82 (1H, m), 2.70 (2H, m), 3.46 (2H, m), 3.69 (1H, m), 3.80 
(3H, s), 3.93 (1H, m), 4.45 (2H, m), 6.86 (2H, d, J = 9 Hz), 7.21 (2H, d, J = 8.7 Hz), 
9.80 (1H, t, J = 2 Hz); 13C NMR (CDC13, 100MHz) 8 -5.5, -4.4, -4.4, -3.8, 10.4, 11.2, 
18.1, 18.3, 23.3, (25.8, 25.9, 25.9)  (6C), 26.4, 31.5, 41.4, 42.2, 46.8, 55.2, 65.0, 71.7, 
73.4, 75.7, 113.8(2C),  129.4(2C), 130.4, 159.2, 202.0; MS (CI) m/z 580 (Mt), 579, 
565, 523, 505, 427, 393, 385, 359, 301, 227, 121; HRMS (CI) m/z 579.3903 (calcd for 
C32H6005Si2 - H+: 579.3903). 
PhS02 
0, 0 
t-BiLt-BU 
(3S)-[3(4S,6R)]-2,2-Di-tert-butylsilylene-6-methyl-1,3-dioxan-4-yl]butyl phenyl 
sulfone (63).  To a solution of methyl phenyl sulfone (56 mg, 0.36 mmol) in 
tetrahydrofuran (1.5 mL) under argon at -78°C was added n-butyllithium (1.51 M in 
hexane, 0.24 mL, 0.36 mmol) dropwise. The pale yellow solution was stirred for 25 
min at -78°C and an ice-water bath was installed. Hexamethylphosphoramide (0.10 
mL, 0.84 mmol) was added, and the mixture was stirred for 35 min at 0°C and for 1 h 
at room temperature, and was recooled to 0°C. A solution of 60 (35 mg, 0.087 mmol) 
in tetrahydrofuran (1 mL) was added dropwise and the mixture was stirred for 1 h at 
0°C and was quenched by addition of saturated ammonium chloride solution (1 mL). 
The mixture was extracted three times with ether (20 mL), and the combined ethereal 
extracts were washed with brine (40 mL) and dried (magnesium sulfate). Removal of 
the solvent was followed by chromatography of the residue on silica gel, with gradient 132
 
elution from 5% to 10% ethyl acetate in hexane, to yield 35 mg (95%) of 63 as a 
colorless oil:  [a]g2 +13.8° (c 1.11, CHC13); 11Z (neat) 2974, 2935, 2891, 2867, 1484, 
1313, 1089, 830 cm-1; 1H NMR (CDC13, 300MHz) 8 0.88 (3H, d, J = 7 Hz), 0.94 
(18H, s), 1.23-1.33 (1H, td, J = 20, 2 Hz), 1.26 (3H, d, J = 7 Hz), 1.50-1.71 (2H, m), 
1.82-2.05 (2H, m), 3.07-3.26 (2H, m, J = 14, 6 Hz), 3.99-4.03 (1H, m, J = 10, 2 Hz), 
4.34-4.42 (1H, dquent, J = 6, 2 Hz), 7.52-7.58 (2H, m), 7.61-7.67 (1H, m), 7.89-7.92 
(2H, m); 13C NMR (CDC13, 75MHz) S 13.4, 20.6, 21.3, 23.3, 26.1, (27.1, 27.2)(6C), 
37.1, 38.0, 54.5, 67.6, 70.5, 128.0(2C), 129.2(2C), 133.5, 139.1; MS (CI) m/z 427 
(M++1), 425, 369, 285, 251, 203, 109, 97; HRMS (CI) m/z 427.2338 (calcd for 
C22H38O4SSi + Ill': 427.2339). 
Attempted coupling of 62 with 63. 
(4S,5S,8R)-5-[( tert-Butyldimethylsilypoxy]-8-[( tert-butyldimethylsilypoxymethyl]­
4-methyldec-2-en-1-al (117). To a solution of 63 (10 mg, 0.024 mmol) in 
tetrahydrofuran (1 mL) under argon at -78°C was added n-butyllithium (1.55 M in 
hexane, 0.017 mL, 0.026 mmol) dropwise. The yellow solution was stirred for 30 min 
at -78°C and a solution of 62 (9.0 mg, 0.015 mmol) in tetrahydrofuran (1 mL) was 
added during a period of 10 min. The pale yellow solution was stirred for 10 min at 
-78°C and for 24 h at room temperature, and was quenched by addition of saturated 
ammonium chloride solution (0.5 mL). The mixture was diluted with ether (15 mL) 
and was washed with saturated ammonium chloride solution (15 mL) and brine (15 
mL). The aqueous wash was extracted three time with ether (20 mL), and the 133
 
combined organic layers were dried (magnesium sulfate). Removal of the solvent was 
followed by chromatogrphy of the residue on silica gel, with gradient elution from 2% 
to 10% ethyl acetate in hexane to yield 9.0 mg of 63 and 2.5 mg of 117 as a colorless 
oil:  [R. (neat) 2957, 2935, 2896, 2857, 1697, 1618, 1521, 1251 cm-1; 1H NMR 
(CDC13, 300MHz) 8 0.01-0.10 (12H, m), 0.91 (3H, m), 0.95 (18H, s), 1.04 (3H, m), 
1.21-1.54 (6H, m), 2.63 (1H, m), 3.42 (2H, m), 3.62 (1H, m), 6.14 (1H, m), 6.87 (1H, 
m), 9.52 (1H, m). 
TBS 
Ph  02 
O  o  OH  6,s.,0 
TBS PMB  t-BLCI't-Bu 
Hydroxy Sulfone (118). Method A. To a solution of 63 (32 mg, 0.075 mmol) in 
tetrahydrofuran (1 mL) under argon at -78°C was added n-butyllithium (1.55 M in 
hexane, 0.048 mL, 0.075 mmol) dropwise. The yellow solution was stirred for 25 min 
at -78°C, freshly distilled trifluoroboron etherate (0.010 mL, 0.075 mmol) was added, 
and the solution was stirred for 10 min. A solution of 62 (35 mg, 0.060 mmol) in 
tetrahydrofuran (1 mL) was added dropwise over a period of 15 min, and the pale 
yellow solution was stirred for 3 h at -78°C and for 2 h at room temperature. The 
reaction was quenched by addition of saturated ammonium chloride solution (0.5 mL), 
diluted with ether (20 mL), and was washed with saturated ammonium chloride 
solution (15 mL) and brine (15 mL). The aqueous wash was extracted three times with 
ether (20 mL), and the combined organic layers were dried (magnesium sulfate). 
Removal of the solvent was followed by chromatogrphy of the residue on silica gel, 
with gradient elution from 2% to 10% ethyl acetate in hexane, to yield 10.5 mg (30%) 
of 62, 28 mg of a mixture of 118 and 63 which was used for the next step without 134
 
purification, and 6 mg of pure 118 as a colorless oil: IR (neat) 3537, 2963, 2935, 2900, 
2857, 1518, 1478, 1254, 1154, 1093 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (12H, 
m), 0.68 (3H, m), 0.88 (27H, m), 0.96 (19H, m), 1.24 (14H, m), 1.60 (5H, m), 1.96 
(1H, m), 3.48 (2H, m), 3.66 (1H, m), 3.80 (3H, s), 4.35 (2H, m), 6.85 (2H, d, J = 9 Hz), 
7.18 (2H, d, J = 9 Hz), 7.56 (3H, m), 7.90 (2H, m); MS (FAB) m/z 1007 (M++1), 1006 
(M+), 986, 950, 888, 868, 838, 812, 738, 720, 696, 642, 626, 596, 581, 538, 509, 463, 
455, 419; HRMS (FAB) m/z 1007.632 (calcd for C54H9809SSi3+H-1-: 1007.632). 
Method B. The same procedure was used as described above. A solution of 63 (17 
mg, 0.040 mmol) in tetrahydrofuran (0.8 mL), a solution of 62 (10 mg, 0.017 mmol) in 
tetrahydrofuran (0.8 mL), n-butyllithium (1.50 M in hexane, 0.033 mL, 0.050 mmol) 
and magnesium bromide etherate (13 mg, 0.050 mmol), gave 5.1 mg of 62 and 15 mg 
of a mixture of 118 with 63 which was used for the next step without purification. 
TBS 
Ph  02 
9  O o  6,  _0 
TBS PMB  t-Bu  t-Bu 
Keto Sulfone (119). Method A. A suspension of the mixture of 118 and 63 (34 mg), 
excess powdered activated 4A molecular sieves, 4-methylmorpholine N-oxide, and 
tetra- n- propylammonium perruthenate in dichloromethane (2.5 mL) under argon was 
stirred for 2 h at room temperature. The solution was filtered through a short plug of 
Celite which was rinsed with dichloromethane. Removal of the combined organic 
solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 3% to 9% ethyl acetate in hexane to yield 17 mg (56%) of 63 and 7.3 mg 
(24% based on 63, Method A) of 119 as a colorless oil: IR (neat) 2962, 2936, 2900, 
2860, 1730, 1516, 1476, 1331, 1256, 1155, 1088, 844 cm-1; 1H NMR (CDC13, 135
 
400MHz) S 0.03 (12H, m), 0.88 (22H, m), 0.94 (22H, m), 1.22 (17H, m), 1.70 (4H, m), 
3.11 (1H, m), 3.46 (2H, m), 3.69 (1H, m), 3.80 (3H, s), 3.94 (2H, m), 4.30 (2H, m), 
4.42 (2H, m), 6.85 (2H, d, J = 8 Hz), 7.14 (2H, d, J = 8 Hz), 7.43 (1H, m), 7.52 (1H, 
m), 7.63 (1H, m), 7.74 (2H, m); 13C NMR (CDC13, 100MHz) 8 -5.4, -4.4, -4.3, -3.8, 
9.9, 10.0, 11.1, 12.4, 15.0, 18.1, 18.3, 20.7, 21.4, 23.2, 23.3, 25.9 (9C), 27.2 (6C), 29.8, 
31.8, 36.1, 36.8, 36.9, 40.9, 42.2, 55.2, 65.1, 67.6, 69.6, 71.3, 72.3, 75.4, 113.6, 
113.7(2C), 128.8(2C), 129.1(2C), 129.5(2C), 130.9, 134.1, 159.0, 201.5; MS (FAB) 
m/z 1004 (M+), 1003, 947, 890, 810, 736, 611, 553, 509, 477, 413; HRMS (FAB) m/z 
1003.601 (calcd for C54H9609SSi3-H+: 1003.000); 
Method B. The same procedure was used as described above. From 15 mg of the 
mixture of 118 and 63 there was obtained 4.2 mg (25%) of 63 and 1.5 mg (15% based 
on 63, Method B) of 119. 
TBS 
./ 
0  OTBS 
1 
TBS 
(2R,5S,6R,7S)-1,5,7- Tri-[ (tert-butyldimethylsilyl)oxy]-2-ethy1-6-(methyl)dec-9-ene 
(120). To a solution of 92 (130 mg, 0.283 mmol) in dichloromethane (2.5 mL) under 
argon at 0°C was added 2,6-lutidine (0.132 mL, 1.13 mmol) and tert-butyldimethylsilyl 
triflate (0.100 mL, 0.425 mmol). The solution was stirred for 1 h at 0°C, diluted with 
ether (20 mL), and was washed with saturated aqueous sodium bicarbonate (20 mL). 
The aqueous wash was extracted three times with ether (20 mL), and the combined 
ethereal extracts were dried (magnesium sulfate). Removal of the solvent followed by 
chromatography of the residue on silica gel, using 100% hexane as eluant, gave 151 
mg (93%) of 120 as a colorless oil: [ar, -4.4° (c 1.19, CHC13); lR (neat) 2958, 2928, 136 
2892, 2857, 1474, 1261, 1093 cm-1; 1H NMR (CDC13, 300 MHZ) 8 0.02 (6H, s), 0.03 
(6H, s), 0.04 (6H, s), 0.87 (27H, s), 0.88 (3H, s), 0.89 (3H, s), 1.26 (6H, m), 1.43 (2H, 
m), 1.62 (1H, m, J = 12, 7 Hz), 2.29 (2H, dd, J = 6 Hz), 3.47 (2H, d, J = 5 Hz), 3.68 
(1H, q, J = 6 Hz), 3.75 (1H, q, J = 6 Hz), 5.00 (2H, dd, J = 12, 3 Hz), 5.76 (1H, m); 
13C  NMR (CDC13, 75 MHz) 8 -5.5, -5.5, -4.6, -4.0, -3.9, -3.0, 9.2, 11.0, (18.0, 
18.2)(3C), 23.3, 25.6, 25.9 (9C), 31.9, 39.5, 40.2, 42.3, 65.0, 72.2, 72.8, 116.6, 134.9; 
MS (CI) m/z 571 (M+-1), 557, 515, 433, 383, 359, 259, 227, 185, 95; HRMS (CI) m/z 
571.4397 (calcd for C31116405Si2-H+: 571.4400). 
TBS 
0  O 0 
TBS TBS 
(3S,4R,5S,8R)-3,5-Dit(tert-butyldimethylsilyl)oxy]-8-[[(tert-butyldimethypoxy]me­
thyll-4-(methypdecan-1-al (121). A stream of ozone was passed through a stirred 
solution of 120 (45 mg, 0.078 mmol) in dichloromethane (3 mL) and methanol (0.6 
mL) at -78°C for 5 min. The excess ozone was purged with argon for 25 min, a 
catalytic amount of potassium bicarbonate and dimethyl sulfide (2 mL) were added, 
and the solution was stirred at room temperature for 34 h. Removal of the solvent 
followed by chromatography of the residue on silica gel, using 5% ethyl acetate in 
hexane as eluant, gave 40 mg (88%) of 121 as a colorless oil:  [ocf +2.0° (c 3.50, 
CHC13); lR (neat) 2959, 2930, 2896, 2862, 1733, 1479, 1259, 1098, 844 cm-1; 1H 
NMR (CDC13, 300MHz) 8 0.03 (18H, m), 0.87 (3H, s), 0.88 (27H, s), 0.91 (3H, s), 
1.31 (5H, m), 1.47 (2H, m), 1.71 (1H, m, J = 17, 7, 4 Hz), 2.61 (2H, dt, J = 5, 2 Hz), 
3.46 (2H, d, J = 4 Hz), 3.76 (1H, dt, J = 6, 4 Hz), 4.15 (1H, q, J = 11, 5 Hz), 9.82 (1H, 
t, J = 3 Hz); 13C NMR (CDC13, 75MHz) 8 -5.5, -5.5, -4.5, -4.4, -4.4, -3.8, 9.9, 11.1, 137 
17.9, 18.0, 18.2, 23.2, 25.6, (25.7, 25.8, 25.9)(9C), 31.9, 42.1, 42.2, 48.8, 64.9, 69.6, 
72.4, 202.5; MS (CI) m/z 559 (M-F-13), 517, 443, 385, 359, 345, 301, 253, 227, 189, 
171, 129; HRMS (CI) m/z 559.4036 (calcd for C30H6604Si3 CH3: 559.4036). 
TBS 
Ph 02 
0 0  OH  6.  .,0 
. "Sl. TBS TBS  t-Bu  t - -Bu 
Hydroxy Sulfone (122). To a solution of 63 (37 mg, 0.090 mmol) in tetrahydrofuran 
(1 mL) under argon at -78°C was added n-butyllithium (1.58 M in hexane, 0.057 mL, 
0.090 mmol) dropwise. The yellow solution was stirred for 45 min, freshly distilled 
trifluoroboron etherate (0.011 mL, 0.090 mmol) was added dropwise, and the mixture 
was stirred for 5 min. A precooled (-78°C) solution of 121 (20 mg, 0.035 mmol) in 
tetrahydrofuran (0.8 mL) was added dropwise via cannula, and the pale yellow solution 
was stirred for 3 h at -78°C and for lh at room temperature. The reaction was 
quenched by addition of saturated ammonium chloride solution (1 mL), diluted with 
ether (20 mL), and was washed with saturated ammonium chloride solution (20 mL) 
and brine (20 mL). The aqueous wash was extracted three times with ether (30 mL), 
and the combined ethereal extracts were dried (magnesium sulfate). Removal of the 
solvent was followed by chromatogrphy of the residue on silica gel, with gradient 
elution from 5% to 10% ethyl acetate in hexane, to yield 3.0 mg of 121, 15 mg of 63, 
and 30 mg (86%) of 122 as a colorless oil: IR (neat) 3535, 2956, 2933, 2899, 2859, 
1480, 1263, 1260, 1160, 1093, 844 cm-1; 1H NMR (CDC13, 300MHz) 8 0.04 (18H, 
m), 0.71 (4H, dd, J = 13, 7 Hz), 0.89 (33H, m), 0.99 (18H, s), 1.26 (10H, m), 1.48 (4H, 
m), 1.75 (3H, m), 2.01 (3H, m), 3.04 (1H, m), 3.48 (2H, m), 3.75 (1H, m), 3.98 (2H, 
m), 4.29 (1H, m), 4.38 (1H, m), 7.56 (2H, m), 7.63 (1H, m), 7.88 (2H, m); 13C NMR 138 
(CDC13, 75MHz) 8 -5.5, -4.7, -4.5, -4.3, -3.9, -3.8, 9.3, 9.8, 11.1, 12.9, 17.9, 18.0, 18.2, 
20.7, 21.3, 23.3, 24.6, (25.8, 25.9) (9C), 26.5, (27.1, 27.2) (6C), 31.7, 37.3, 37.4, 42.5, 
65.3, 66.1, 67.6, 70.0, 70.6, 70.9, 73.1, 128.5(2C), 129.1(2C), 133.7, 138.2; MS (FAB) 
m/z 1002 (M++1), 1001 (Mt), 986, 943, 869, 812, 737, 679, 625, 595, 567, 463, 419, 
359, 269, 227. 
TBS 
Ph  02 
o 6 o 
TBS TBS  t-BLr-`t-eu 
Keto Sulfone (123). Method A. A suspension of 122 (6.5 mg, 0.0065 mmol), an 
excess of powdered activated 4A molecular sieves, 4-methylmorpholine N-oxide and 
tetra-n-propylammonium perruthenate in dichloromethane (1 mL) under argon was 
stirred for 2.5 h at room temperature. The mixture was filtered through a short plug of 
Celite which was rinsed with dichloromethane. Removal of the combined organic 
solvent from the filtrate was followed by chromatography of the residue on silica gel, 
with gradient elution from 3% to 9% ethyl acetate in hexane, to yield 5.6 mg (86%) of 
123 as a colorless oil:  FR (neat) 2959, 2938, 2892, 2867, 1723, 1475, 1331, 1264, 
1149, 1097, 845 cm-1; 1H NMR (CDC13, 300MHz) 8 0.02 (18H, m), 0.83 (9H, s), 0.88 
(9H, s), 0.89 (9H, s), 0.94 (18H, s), 0.80-0.97 (8H, m), 1.24 (3H, d, J = 7 Hz), 1.21­
1.40 (7H, m), 1.49 (3H, m), 1.65 (1H, m), 1.80 (1H, m), 2.03 (2H, m), 2.64-3.01 (1H, 
2dd, J = 20, 6 Hz), 3.10-3.32 (1H, 2dd, J= 20, 6 Hz), 3.47 (2H, m), 3.84 (1H, m), 3.95 
(1H, m), 4.13 (1H, dd, J = 11.7, 3.1 Hz), 4.25 (1H, m), 4.36 (1H, m), 7.53 (2H, m), 
7.66 (1H, m), 7.77 (2H, m); 13C NMR (CDC13, 75MHz) 8 -5.5, -4.7, -4.5, -4.3, -4.1, 
-3.7, 9.4, 11.1, 12.5, 17.9, 18.1, 18.2, 20.6, 21.3, 23.2, 23.3, 25.5, (25.8, 25.9) (9C), 
26.0, (27.1, 27.2) (6C), 31.2, 36.9, 41.0, 42.3, 49.9, 51.4, 65.1, 67.9, 68.2, 69.8, 71.2, 139
 
72.9, 128.8, 129.2, 134.0, 136.5, 200.5; MS (FAB) m/z 999 (M++1), 997, 941, 887, 
867, 735, 728, 643, 611, 595, 575, 549, 519, 503, 429, 413, 323, 253, 217, 201, 181. 
Method B. To a solution of oxalyl chloride (0.010 mL, 0.11 mmol) in dichloromethane 
(0.70 mL) under argon at -78°C was added dimethyl sulfoxide (0.061 mL, 0.22 mmol) 
and the solution was stirred for 5 min at -78°C. A solution of 122 (11 mg, 0.011 mmol) 
in dichloromethane (0.4 mL) was added and stirring was continued for 1  h. 
Triethylamine (0.039 mL, 0.28mmol) was added and the mixture was stirred for 5 min 
at -78°C and allowed to warm to room temperature for 1 h. The mixture was dissolved 
in ether (20 mL) and the solution was washed with brine (20 mL). The aqueous wash 
was extracted three times with ether (20 mL), and the combined organic layers were 
dried (sodium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 5% to 8% ethyl acetate in hexane, to 
yield 6.5 mg of 122 and 4.5 mg (45%, 100% based on recovered 122) of 123 as a 
colorless oil. 
TBS 
9  e? o  6,s.,o 
TBS TBS  t-Bir-it-Bu 
(2S,7S,8R,9S,12R)-7,9-Di-[( tert-butyldimethylsilypoxy]-12-[(tert-butyldimethylsily 
Doxyme-thyl]-2-[(4S,6R)-2,2-di-tert-butylsilylene-6-methyl-1,3-dioxan-4-y1]-8-meth 
yltetra-decan-5-one (124). A flame-dried flask under argon at room temperature was 
charged with samarium (900 mg, 6.00 mmol). The flask was evacuated under high 
vacuum for 15 min and was filled with argon. This process was repeated three times. 
Freshly distilled tetrahydrofuran (30 mL) and diiodomethane (0.244 mL, 3.00 mmol) 
were added with vigorous stirring under argon at room temperature and the dark blue 140 
solution was stirred for an additional 1 h. This stock solution could be stored for 2.5 
month under argon. 
To a solution of 123 (14.5 mg, 0.0145 mmol) in tetrahydrofuran (1.6 mL) and 
methanol (0.8 mL) under argon at -78°C was added a freshly prepared solution of 
samarium diiodide (0.10 M in tetrahydrofuran, 0.580 mL, 0.0580 mmol). The reaction 
flask was covered with foil and the blue mixture was stirred for 30 min at -78°C and 
allowed to warm to room temperature for 1 h. The mixture was added to ether (20 mL) 
and the mixture was washed with saturated potassium carbonate solution (20 mL). The 
aqueous wash was extracted three times with ether (20 mL), and the combined ethereal 
extracts were dried (magnesium sulfate). Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 2% to 5% ethyl 
acetate in hexane, to yield 11.0 mg (89%, 97% based on recovered 123) of 124 as a 
colorless oil:  [c(]1232 +19.8° (c 0.85, CHC13); IR (neat) 2963, 2932, 2896, 2860, 1715, 
1476, 1386, 1257, 1103, 840 cm-1; 1H NMR (CDC13, 400 MHz) 8 -0.01 (3H, s), 0.03 
(6H, s), 0.06 (6H, s), 0.07 (3H, s), 0.83 (3H, d, J = 7 Hz), 0.84-0.91 (6H, m), 0.86 (9H, 
s), 0.89 (9H, s), 0.90 (9H, s), 1.00 (18H, s), 1.15-1.36 (5H, m), 1.29 (3H, d, J = 7 Hz), 
1.37-1.53 (5H, m), 1.60-1.67 (1H, m), 1.70-1.81 (1H, m), 2.00-2.08 (1H, ddd, J = 16, 
10, 6 Hz), 2.34-2.54 (2H, m), 2.56-2.68 (2H, ddd, J = 20, 16, 4 Hz), 3.48 (2H, ddd, J = 
15, 10, 6 Hz), 3.83 (1H, q, J = 6 Hz), 4.00 (1H, td), 4.21 (1H, q, J= 6 Hz), 4.39 (111, m, 
J = 12, 6, 2 Hz); 13C NMR (CDC13, 100 MHz) 8 -5.5, -5.4, -4.5, -4.4, -4.2, -3.6, 9.9, 
11.1, 13.9, 18.0, 18.1, 18.3, 20.8, 21.3, 23.3, 23.5, 25.8, (25.9,  26.0)(9C), 26.8, 
27.3(6C), 32.2, 37.7, 38.9, 41.9, 42.3, 42.4, 47.9, 65.1, 67.7, 70.1, 71.4, 72.1, 209.9; 
MS (CI) m/z 858 (Mt), 844, 802, 728, 670, 630, 596, 538, 498, 471, 359, 269, 227, 
199, 147, 115; HRMS (CI) m/z 801.5738 (calcd for C46H98O6Si4 -C4H9: 801.5739). 141
 
H 
H 
0 
(2S,3S,4S,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-hydroxy-1-propy1]-2-[(R)-3-(hydroxy­
methyl)-1-pentyl]-1,7-clioxaspiro[5.5]undecan-4-ol (1). Method A. To a Nalgene 
vial containing 124 (10 mg, 0.010 mmol) at room temperature was added a stock 
solution of 48% hydrofluoric acid-acetonitrile (1:7, 3 mL). The mixture was stirred for 
48 h, dissolved in ether (20 mL) and was washed with brine (15 mL) and water (15 
mL). The aqueous wash was extracted with once ethyl acetate (20 mL) and twice with 
ether (20 mL), and the combined organic layers were dried (sodium sulfate). Removal 
of the solvent was followed by chromatography of the residue on silica gel, with 
gradient elution from 40% to 95% ethyl acetate in hexane to yield 3.4 mg (82%) of 1 as 
a white solid: [47 -82.5° (c 0.16, CHC13). 
Method B. A solution of 127 (127 mg, 0.220 mmol) and tetra-n-butylammonium 
fluoride (1.0 M in tetrahydrofuran, 1.10 mL, 1.10 mmol) in tetrahydrofuran (8 mL) 
under argon was stirred for 24 h at room temperature. The solution was dissolved in 
ether (30 mL) and was washed with brine (30 mL). The aqueous wash was extracted 
once with ethyl acetate (30 mL) and twice with ether (30 mL), and the combined 
organic layers were dried (sodium sulfate). Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 40% to 90% 
ethyl acetate in hexane to yield 77.0 mg (98%) of 1 as a white solid: [a]p -82.8° (c 
1.01, CHC13); IR (neat) 3350 (br), 2964, 2940, 2876, 1455, 1386, 1059, 976 cm-1; 1H 
NMR (CDC13, 300MHz) 8 0.82 (3H, d, J = 7 Hz), 0.87 (3H, m), 0.90 (3H, d, J = 8 Hz), 
1.19 (3H, d, J = 6 Hz), 1.24 (2H, t, J = 7 Hz), 1.30-1.65 (12H, m), 1.68-1.74 (1H, dd, J 142 
= 13, 5 Hz), 1.82-1.86 (1H, m), 2.03-2.16 (1H, m), 2.56-2.58 (3H, br), 3.44-3.50 (1H, 
dd, J = 11, 4 Hz), 3.55-3.60 (1H, dd, J = 11, 4 Hz), 3.71-3.97 (1H, m), 4.03-4.77 (2H, 
m); 13C NMR (CDC13, 75MHz) 8 3.9, 11.1, 11.3, 23.3, 24.5, 26.4, 26.6, 29.0, 29.7, 
30.7, 37.7, 38.9, 41.9, 42.3, 64.4, 64.5, 67.2, 67.3, 71.2, 97.4; MS (CI) m/z 358 (Mt), 
341,  323,  270,  228,  211,  171,  113, 95; HRMS (CI) m/z 358.2717 (calcd for 
C20113805: 358.2720). 
OBz 
O 
OTBS 
(2S,3S,4S,6R,8S,9S)-4-(Benzoyloxy)-3,9-dimethy1-8-[(R)-2-[(tert-butyldimethylsily­
poxy]-1-propyl]-2-[(R)-3-(hydroxymethyl)-1-penty11-1,7-dioxaspiro[5.5]undecane 
(125). Method A. From 113: To a round-bottom flask containing 20% palladium 
hydroxide on carbon (9.00 mg, 0.0120 mmol) in 95% ethanol (1 mL) under hydrogen 
at room temperature was added a solution of 113 (130 mg, 0.187 mmol) in 95% 
ethanol (1 mL). The solution was stirred for 1 h at room temperature, the excess 
hydrogen was removed under reduced pressure, and the flask was filled with argon. 
The mixture was filtered through a pad of Celite and the pad was rinsed with ether. 
Removal of the combined organic solvents from the filtrate followed by 
chromatography of the residue on silica gel, using 20% ethyl acetate in hexane as 
eluant, furnished 105 mg (97%) of 113 as a colorless oil: [a  -57.6° (c 1.12, CHC13); 
IR (neat) 3442, 2956, 2933, 2881, 1720, 1276, 1252 cm-1; 1H NMR (CDC13, 
300MHz) 8 0.06 (6H, s), 0.88 (9H, s), 0.92 (3H, m), 1.23 (6H, m), 1.42 (7H, m), 1.60 143
 
(7H, m), 1.74 (1H, d, J = 12 Hz), 1.92 (1H, dd, J = 12, 5 Hz), 2.03 (2H, s), 2.08 (1H, 
m), 2.18 (1H, m), 3.55 (2H, m), 3.80 (3H, m), 4.10 (1H, q, J = 7 Hz), 5.51 (1H, td, J = 
12, 5 Hz), 7.43 (2H, m), 7.54 (1H, m), 8.02 (2H, m); 13C NMR (CDC13, 75MHz) 8 
-4.6, -4.4, 5.0, 10.8, 10.9, 14.1, 18.0, 20.9, 23.1, 24.4, 25.8(3C), 26.3, 27.2, 29.5, 29.6, 
35.1, 35.7, 42.1, 43.2, 60.3, 65.0, 67.2, 70.7, 71.2, 97.4, 128.2(2C), 129.3(2C), 130.5, 
132.7, 165.5; MS (FAB) m/z 599 (M++23), 577 (M+), 559, 455, 397, 325, 223, 193, 
159, 105; HRMS (FAB) m/z 599.3742 (calcd for C33H56O6Si + Na: 599.3745). 
125  and  0 
'''0  OH 
131 
(2S,3S,4S,6R,8S,9S)-4-(Benzoyloxy)-3,9-dimethy1-8-[(R)-2-[(tert-butyldimethylsily­
poxy]-1-propyl]-2-[(R)-3-(hydroxymethyl)-1-pentyl]-1,7-dioxaspiro[5.5]undecane 
(125) and ( 2.5,3S,4S,6R,8S,95)-4-(Benzoyloxy)-3,9-dimethy1-8-[(R)-2-hydroxy-l­
propy1]-2-[(R)-3-(hydroxymethyl)-1-pentyl]-1,7-dioxaspiro[5.5]undecane (131). 
Method A. A stirred mixture of 126 (17 mg, 0.025 mmol) and ammonium 
fluoride (9.0 mg, 0.25 mmol) in methanol (4 mL) was heated at reflux for 2 d, allowed 
to cool to room temperature, and was concentrated under reduced pressure. The 
residue was dissolved in ether (10 mL) and the solution was washed with brine (10 
mL). The aqueous wash was extracted three times with ether (10 mL), and the 
combined ethereal extracts were dried (magnesium sulfate). Removal of the solvent 
was followed by chromatography of the residue on silica gel, with gradient elution 144
 
from 15% to 50% ethyl acetate in hexane, to yield 1.5 mg (9%) of 126, 4.5 mg (31%) 
of 125 and 5.4 mg (47%) of 131. Data for 131: [a ]o -58.5° (c 0.22, CHC13); IR (neat) 
3363, 3336, 2964, 2938, 2878, 1716, 1457, 1311, 1277, 1118, 965 cm-1; 1H NMR 
(CDC13, 300MHz) 8 0.89 (3H, d, J = 7 Hz), 0.92 (3H, d, J = 6 Hz), 0.94(3H, d, J = 6 
Hz), 1.24 (3H, d, J = 6 Hz), 1.21-1.29 (1H, m), 1.32-1.49 (7H, m), 1.50-1.76 (24H, m), 
1.78 (3H, d, J = 12 Hz), 1.88-1.94 (1H, dd, J = 12, 5 Hz), 2.09-2.24 (2H, m), 3.50-3.64 
(2H, dq, J = 16, 10, 5 Hz), 3.86-3.90 (1H, dt, J = 10, 6 Hz), 4.07-4.14 (2H, m), 5.47­
5.54 (1H, td, J = 12, 5 Hz), 7.41-7.46 (2H, dd, J = 7 Hz), 7.53-7.59 (1H, m), 8.02-8.04 
(2H, dd, J = 7 Hz); 13C NMR (CDC13, 75MHz) 8 5.0, 11.1, 11.2, 23.4, 24.8, 26.5, 
26.7, 29.1, 29.7, 30.7, 35.0, 35.7, 41.9, 42.6, 64.5, 64.7, 67.3, 70.7, 71.5, 97.4, 
128.2(2C), 129.4(2C), 130.5, 132.8, 165.6; MS (CI) m/z 462 (M+), 445, 397, 374, 341, 
323, 252, 211, 155, 123, 95; HRMS (CI) m/z 462.2890 (calcd for C27114206: 
462.2893). 
Method B. To a stirred solution of 126 (17 mg, 0.025 mmol) in tetrahydrofuran (1.5 
mL) in a Nalgene tube at room temperature was added a freshly prepared hydrofluoric 
acid-pyridine stock solution [Aldrich pyrHF (2.5 g) in pyridine (5.6 mL) and 
tetrahydrofuran (22.4 mL), 1 mL].  The mixture was stirred for 11 h at room 
temperature and quenched by addition of saturated sodium bicarbonate solution (2 
mL). The mixture was extracted three times with ether (10 mL) and the combined 
ethereal extracts were dried (magnesium sulfate). Removal of the solvent was followed 
by chromatography of the residue on silica gel, with gradient elution from 10% to 50% 
ethyl acetate in hexane, to yield 4.8 mg (28%) of 126, 6.2 mg (44%, 61% based on 
recovered 126) of 125, and 1.9 mg (17%) of 131. 145
 
TBS 
OBz 
0 
0  QTBS 
(2S,3S,4S,6R,8S,9S)-4-(Benzoyloxy)-3,9-dimethy1-8-[(R)-2-[(tert-butylclimetbylsily­
poxy]-1-propyl]-2-[(R)-3-[(tert-butyldimethylsilypoxymethyl]-1-pentyl]-1,7-dioxas­
piro[5.5]undecane (126). Method A. From 125. To a solution of 125 (50 mg, 0.087 
mmol) in dichloromethane (2 mL) under argon at 0°C was added triethylamine (0.035 
mL, 0.25 mmol) and tert-butyldimethylsilyl triflate (0.032 mL, 0.14 mmol). The 
solution was stirred for 1 h at 0°C, diluted with ether (15 mL), and was washed with 
saturated aqueous sodium bicarbonate (15 mL). The aqueous wash was extracted three 
times with ether (15 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent followed by chromatography of the residue on silica 
gel, using 10% ethyl acetate in hexane as eluant, gave 58 mg (98%) of 126 as a 
colorless oil:  [a]p -43.4° (c 1.10, CHC13); IR (neat) 2953, 2930, 2890, 1723, 1467, 
1276, 1253 cm-1; 1H NMR (CDC13, 300MHz) 8 0.04 (6H, s), 0.06 (6H, s), 0.87 (2H, 
m), 0.89 (18H, s), 0.93 (3H, d, J = 7 Hz), 0.94 (3H, d, J = 7 Hz), 1.22 (3H, d, J = 6 Hz), 
1.23 (2H, m), 1.38 (6H, m), 1.62 (6H, m), 1.74 (1H, d, J = 12 Hz), 1.90 (1H, dd, J = 13, 
5 Hz), 2.15 (1H, m), 2.20 (1H, m), 3.49 (2H, d, J = 5 Hz), 3.80 (3H, m), 5.51 (1H, td, J 
= 12, 5 Hz), 7.43 (2H, m), 7.54 (1H, m), 8.02 (2H, m); 13C NMR (CDC13, 75MHz) 8 
-5.5, -4.6, -4.4, -3.0, 5.0, 10.9,  11.0, 18.0, 18.2, 23.1, 24.4, 25.6, (25.8, 25.9)(6C), 26.3, 
27.4,  29.5, 29.6, 29.8,  35.2,  35.7,  42.0, 43.2, 65.3, 67.3, 69.4, 70.7, 71.3,  97.3, 
128.2(2C), 129.4(2C), 130.6, 132.7, 165.6; MS (CI) m/z 690 (Mt), 675, 633, 569, 553, 
511, 431, 389, 325, 267, 123; HRMS (CI) m/z 690.4709 (calcd for C39147006%2: 146 
690.4713). Anal. Calcd for C39H7006Si2: C, 67.77; H, 10.21. Found: C, 67.97; H, 
10.34. 
Method B.  From 127.  A solution of 127 (11.5 mg, 0.02 mmol), 4­
dimethylaminopyridine (0.24 mg, 0.002 mmol), triethylamine (0.011 mL, 0.08 mmol), 
and benzoyl chloride (0.007 mL, 0.06 mmol) in dichloromethane (0.8 mL) under 
argon was stirred for 3 days. This solution was diluted with ether (5 mL) and saturated 
sodium bicarbonate solution (5 mL), and was stirred for 2 h. To this mixture was 
added water, the mixture was extracted with ether, and the combined organic layers 
were dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 5% to 20% 
ethyl acetate in hexane, to yield 12.5 mg (90%) of 126 as a colorless oil. 
TBS 
(2S,3S,4S,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-[( tert-butyldimethylsilyl)oxy]-1-propyl] 
-2-[(R)-3-[(tert-butyldimethylsilypoxy]methyl-1-pentyl]-1,7-dioxaspiro[5.5]undeca­
n-4-ol (127). Method A. From 126. A suspension of 126 (53 mg, 0.077 mmol) and 
lithium hydroxide monohydrate (32 mg, 0.53 mmol) in methanol (3 mL) was stirred for 
10 h at room temperature. The mixture was added to ether (20 mL) and was washed 
with saturated ammonium chloride solution (20 mL) and brine (20 mL). The aqueous 
wash was extracted three times with ether (30 mL), and the combined organic layers 
were dried (magnesium sulfate).  Removal of the solvent was followed by 147
 
chromatography of the residue on silica gel, using 17% ethyl acetate in hexane as 
eluant, to yield 45 mg (100%) of 127 as a colorless oil:  [  -40.9° (c 1.08, CHC13); 
IR (neat) 3376, 2957, 2932, 2894, 1467, 1384, 1253 cm- 1; 1H NMR (CDC13, 
300HMz) 8 0.03 (6H, s), 0.05 (6H, s), 0.83 (3H, d, J = 7 Hz), 0.84-0.87 (3H, d, J = 6 
Hz), 0.88 (9H, s), 0.89 (9H, s), 0.93 (3H, d, J = 7 Hz), 1.17 (3H, d, J = 6 Hz), 1.12-1.44 
(9H, m), 1.47-1.67 (6H, m), 1.69-1.75 (1H, dd, J= 13, 5 Hz), 1.80-1.90 (1H, quintet, J 
= 7 Hz), 2.02-2.14 (1H, tt, J = 13, 5 Hz), 3.47 (2H, d, J = 5 Hz), 3.53-3.57 (1H, m), 
3.72-3.85 (2H, m), 4.15-4.22 (1H, td, J = 12, 5 Hz); 13C NMR (CDC13, 75MHz) 8 (­
5.5, -4.7, -4.5)(4C), 3.9, 10.9, 11.0, 18.0, 18.1, 23.1, 24.3, (25.8, 25.9)(6C), 26.3, 27.4, 
29.5, 29.7, 29.8, 37.9, 39.0, 42.0, 43.2, 65.3, 67.2, 67.3, 69.1, 71.1, 97.3; MS (CI) m/z 
588 (M++2), 587 (M++1), 586 (Mt), 571, 553,  529, 511, 453, 413, 325, 245, 113; 
HRMS (CI) m/z 587.4528 (calcd for C32H66O5Si2 +  587.4529). 
Method B. From 129: A foil-covered flask containing 129 (240 mg, 0.410 mmol) was 
evacuated under high vacuum and filled with argon at room temperature, and was 
charged with tetrahydrofuran (8 mL), isopropyl alcohol (degassed, 0.340 mL, 4.44 
mmol) and samarium diiodide (0.10 M in tetrahydrofuran, 18.0 mL, 1.80 mmol). The 
blue solution was stirred for 5.5 h, diluted with ether (30 mL), and was washed with 
saturated sodium bicarbonate solution (30 mL). The aqueous washing was extracted 
three times with ether (30 mL), and the combined organic layers were washed with 
saturated sodium sulfite solution (50 mL) and brine (50 mL), and were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 10% to 20% ethyl acetate in hexane, to 
yield 18.6 mg (8%) of 129 and 213 mg (88%) of 127 as a colorless oil. 
Method C. From 132: To a solution of 132 (42 mg, 0.089 mmol) in dichloromethane 
(2.5 mL) under argon at -78°C was added a solution of tert-butyldimethylsilyl triflate 
(0.021 mL, 0.089 mmol) and a solution of 2,6-lutidine (0.021 mL, 0.18 mmol) in 148 
dichloromethane (0.7 mL) over a period of 10 min. The mixture was stirred for 2.5 h at 
-78°C, after which methanol (1 mL) was added and the solution was allowed to warm 
to room temperature. The mixture was diluted with dichloromethane (20 mL) and was 
washed with water (20 mL) and brine (20 mL). The aqueous wash was extracted three 
times with ether (30 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent was followed by chromatography of the residue on 
silica gel, with gradient elution from 2% to 50% ethyl acetate in hexane, to yield 20 mg 
(48%) of 132 and 13 mg (25%, 50% based on recovered 132) of 127. 
TBSO 
OH 
0  OH 
132 
(2S,3S,4S,6R,8S,95)-3,9-Dimethy1-8-[(R)-2-hydroxy-1-propy1]-2-[(R)-3-[(tert-butyl­
dimethylsilypoxymethyl]-1-penty1]-1,7-dioxaspiro[5.5]undecan-4-ol (132).  A 
suspension of 1 (71 mg, 0.20 mmol), silver nitrate (74 mg, 0.44 mmol) and pyridine 
(0.080 mL, 0.99 mmol) in tetrahydrofuran (3.5 mL) under argon was stirred for 5 min 
at room temperature, and tert-butyldimethylsilyl chloride (64 mg, 0.44 mmol) was 
added. The cloudy mixture was stirred for 48 h at room temperature and was quenched 
by addition of 5% sodium bicarbonate solution (1 mL). The mixture was added to 
ether (20 mL) and the solution was washed with brine (20 mL) and water (20 mL). 
The aqueous wash was extracted once with ethyl acetate (30 mL) and twice with ether 
(30 mL), and the combined organic layers were dried (sodium sulfate). Removal of the 
solvent was followed by chromatography of the residue on silica gel, with gradient 149 
elution from 2% to 50% ethyl acetate in hexane to yield 43 mg (46%) of 132 and 19 
mg (16%) of 127. 
Data for 132: [at-2 -58.7° (c 0.85, CHC13); 1H NMR (CDC13, 300MHz) 8 0.02 (6H, 
s), 0.81-0.86 (3H, t, J = 7 Hz), 0.87-0.88 (3H, d, J = 3 Hz), 0.88 (9H, s), 0.91 (3H, d, J 
= 7 Hz), 1.21 (3H, d, J = 6 Hz), 1.24-1.45 (9H, m), 1.50-1.75 (7H, m), 1.82-1.90 (2H, 
m), 2.08-2.19 (1H, tt, J = 13, 4 Hz), 3.43-3.52 (2H, dq, J = 10, 6 Hz), 3.64-3.67 (1H, 
m), 3.95-4.08 (2H, m), 4.10-4.18 (1H, td, J= 12, 5 Hz); 13C NMR (CDC13, 75MHz) 8 
-5.5(2C), 3.9, 11.0, 11.2, 18.2, 23.1, 24.0, 25.9(2C), 26.4, 27.0, 29.7, 29.8, 30.6, 37.9, 
38.9, 42.0, 42.0, 65.0, 65.4, 67.4, 67.5, 71.2, 97.3. 
TBS  TBS 
and 
'0  OH  0 OTBS 
= 
128  129 
(2S,3R,6R,8S,9S)-3,9-Dimethy1-81(R)-2-hydroxy-1-propy11-2-[(R)-34(tert-butyldi­
methylsilyl)oxymethyl]-1-penty11-1,7-dioxaspiro-[5.5]undecan-4-one (128) and 
(2S,3R,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-[(tert-butylclimethylsilypoxy]-1-propyl]-2­
[(R)-3-[(tert-butyldimethylsilypoxymethy1]-1-penty1]-1,7-dioxaspiro[5.5]undecan­
4-one (129). A solution of 112 (79 mg, 0.22 mmol), imidazole (42 mg, 0.62 mmol), 
and tert-butyldimethylsilyl chloride (80 mg, 0.53 mmol) in N, N- dimethylformamide 
(5 mL) under argon was stirred for 17 h at room temperature, after which additional 
imidazole (30 mg) and tert-butyldimethylsilyl chloride (48 mg) were added. Stirring 
was continued for 25 h, the mixture was added to ether (30 mL), and the solution was 
washed with brine (30 mL). The aqueous wash was extracted three times with ether 150 
(30 mL), and the combined ethereal extracts were dried (magnesium sulfate). Removal 
of the solvent was followed by chromatography of the residue on silica gel, with 
gradient elution from 5% to 40% ethyl acetate in hexane to yield 52 mg (50%) of 128 
and 36 mg (28%) of 129 as a colorless oil:  [a ]1232 -54.9° (c 1.38, CHC13); IR (neat) 
2957, 2931, 2891, 2858, 1722, 1463, 1384, 1251, 1091 cm-1; 1H NMR (CDC13) 8 0.03 
(6H, s), 0.04 (6H, s), 0.85 (3H, d, J = 6 Hz), 0.86 (9H, s), 0.89 (9H, s), 0.91 (3H, d, J = 
7 Hz), 1.08 (3H, d, J = 7 Hz), 1.12 (3H, d, J = 7 Hz), 1.15-1.29 (2H, m), 1.30-1.53 (6H, 
m), 1.56-1.73 (6H, m), 2.04-2.17 (1H, m, J = 7, 2 Hz), 2.30 (1H, d, J = 14 Hz), 2.49 
(1H, d, J = 14 Hz), 2.32-2.35 (1H, m), 3.44-3.55 (2H, ddd, J = 15, 10, 6 Hz), 3.71-3.78 
(2H, dq, J = 7, 2 Hz), 3.80-3.85 (1H, m, J = 10, 5, 3 Hz); 13C NMR (CDC13) 8 (-5.5,
 
-4.6, -4.4)(4C), 10.6, 10.9, 11.0, 18.0, 18.2, 23.1, 24.3, 25.8(6C), 26.3, 27.2, 28.9, 29.1,
 
29.4, 42.0, 42.9, 48.1, 48.3, 65.1, 67.1, 70.0, 70.7, 99.0, 210.5; MS (CI) m/z 585
 
(M++1), 584 (M+), 569, 527, 451, 437, 369, 341, 327, 283, 271, 241, 229, 187, 159,
 
137, 95; HRMS (CI) m/z 585.4372 (calcd for C32H6405Si2+H+: 585.4372). Anal.
 
Calcd for C32H64O5Si2: C, 65.69; H, 11.03. Found: C, 65.58; H, 10.84.
 
Data for 128: IR (neat) 3489 (br), 2957, 2931, 2884, 2864, 1716, 1463, 1384, 1251,
 
1091, 979 cm-1; 1H NMR (CDC13, 400MHz) 8 0.02 (6H, s), 0.83-0.90 (3H, m), 0.86 
(9H, s), 1.07 (3H, d, J = 7 Hz), 1.15 (3H, d, J = 6 Hz), 1.20-1.48 (8H, m), 1.51-1.75 
(6H, m), 2.11-2.22 (1H, m), 2.27 (1H, d, J= 14 Hz), 2.27-2.36 (1H, m), 2.54 (1H, d, J 
= 14 Hz), 3.42-3.60 (2H, m), 3.89 (1H, brs), 3.93-4.04 (2H, m). 
A solution of 128 (54 mg, 0.12 mmol), imidazole (50 mg, 0.73 mmol), and tert­
butyldimethylsilyl chloride (95 mg, 0.61 mmol) in N, N-dimethylformamide (4 mL) 
under argon was stirred for 7 h at room temperature, diluted with ether (20 mL) and the 
solution was washed with brine (20 mL). The aqueous wash was extracted three times 
with ether (20 mL), and the combined ethereal extracts were dried (magnesium 151
 
sulfate). Removal of the solvent followed by chromatography of the residue on silica 
gel, using 5% of ethyl acetate in hexane as eluant, gave 57.5 mg (86%) of 129. 
TBS 
O 
129  and  0(1-.L1 
"'0  OTBS 
130 
(2S,3R,6R,8S,9S)-3,9-Dimethy1-8-[(R)-2-[(tert-butyldimethylsilyfloxy]-1-propyl]-2­
[(R)-3-[( tert-butyldimethylsilyl)oxymethyl]-1-pentyl]-1,7-dioxaspiro[5.5]undecan­
4-one (129) and [2S,3S,6(4R,5S,8R)]-3-methy1-2-[(R)-2-[(tert-butyldimethylsily1)­
oxy]-1-propy1]-6-[(1E)-5-hydroxy-4-methyl-8-[( tert-butyldimethylsilypoxymethyl]­
1-octe- nyl- 3- one]tetrahydropyran (130). To a solution of 116 (328 mg, 0.697 
mmol) in dichloromethane (13 mL) under argon at 0°C was added triethylamine (0.254 
mL, 1.81 mmol) and tert-butyldimethylsilyl triflate (0.223 mL, 0.975 mmol). The 
solution was stirred for 50 min at 0°C, was quenched by addition of saturated 
ammonium chloride solution (3 mL), and was extracted three times with ether (50 mL). 
The combined ethereal extracts were washed with brine (100 mL), and were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 5% to 30% ethyl acetate in hexane, to 
yield 194 mg (56%) of 130 and 180 mg (44%) of 129. Data for 130: IR (neat) 3469, 
2957, 2931, 2884, 2858, 1663, 1601, 1463, 1384, 1251, 1091 cm-1; 1H NMR (CDC13) 
8 0.03 (6H, s), 0.08 (6H, d, J = 2 Hz), 0.89 (18H, d, J = 1 Hz), 0.90-0.95 (6H, m), 1.02 
(3H, m), 1.23 (3H, d, J = 6 Hz), 1.23-1.39 (5H, m), 1.40-1.51 (4H, m), 1.52-1.60 (2H, 
m, J = 5 Hz), 1.64-1.88 (3H, m), 2.19-2.37 (3H, m), 3.27 (1H, brs), 3.44-3.56 (2H, ddd, 152 
J = 15, 10, 6 Hz), 3.90-3.93 (1H, m, J = 10 Hz), 4.18-4.27 (2H, m), 5.25 (1H, s); 13C 
NMR (CDC13) 8 (-5.5, -5.1, -4.6)(4C), 7.1, 9.6, 11.2, 13.9, 17.8, 18.2, 22.4, 23.3, 25.6, 
25.7, 25.8(3C), 26.1, 27.5, 29.5, 32.6, 38.2, 40.6, 41.6, 42.7, 64.9, 67.6, 70.6, 82.1, 
102.3, 177.3, 198.0; MS (CI) m/z 585 (M++1), 584 (M+), 569, 527, 469, 435, 383, 369 
283, 229, 187, 159, 115, 95; HRMS (CI) m/z 585.4372 (calcd for C32H6405Si2+H+: 
585.4372). 
To a solution of 130 (194 mg, 0.390 mmol) in chloroform (4 mL) at room 
temperature was added (1S)- ( +)- O- camphorsulfonic acid (8.00 mg, 0.0340 mmol). The 
mixture was stirred for 2 h at room temperature, after which additional (1S)-(+)-0­
camphorsulfonic acid (12 mg) was added and the mixture was stirred for 3 d. The 
mixture was added to ether (30 mL) and the solution was washed with brine (30 mL). 
The aqueous wash was extracted three times with ether (30 mL), and the combined 
ethereal extracts were dried (magnesium sulfate). Removal of the solvent was followed 
by chromatography of the residue on silica gel, with gradient elution from 5% to 20% 
ethyl acetate in hexane, to yield 63.0 mg (32%) of 129. 
HO 
OBz 
(2S,35,4S,6R,8S,9S)-4-(Benzoyloxy)-3,9-dimethy1-8-[(R)-2-[(tert-butyldimethylsily­
1)oxy]-1-propy1]-2-[(R)-3-ethy1-3-formylpropy1]-1,7-dioxaspiro[5.5]undecane (134) 
To a solution of oxalyl chloride (0.378 mL, 4.25 mmol) in dichloromethane (20 mL) 
under argon at -78°C was added dimethyl sulfoxide (0.603 mL, 8.50 mmol) and the 153
 
mixture was stirred for 15 min. A solution of 125 (490 mg, 0.850 mmol) in 
dichloromethane (6 mL) was added dropwise, stirring was continued for 30 min, and 
triethylamine (2.40 mL, 17.0 mmol) was added. The solution was stirred for 50 min at 
-78°C, allowed to warm to room temperature for 1 h, and was quenched by addition of 
water (1 mL). The mixture was diluted with ether (30 mL), and was washed with brine 
(30 mL) and water (30 mL). The aqueous wash was extracted three times with ether 
(30 mL), and the combined ethereal extracts were dried (magnesium sulfate). Removal 
of the solvent was followed by chromatography of the residue on silica gel, with 
gradient elution from 5% to 10% ethyl acetate in hexane, to yield 470 mg (96%) of 134 
as a pale yellow oil: IR (neat) 2959, 2933, 2859, 1722, 1274, 1107, 1099, 990 cm-1; 
1H NMR (CDC13, 300 MHz) S 0.06 (6H, s), 0.89 (10H, s), 0.93 (9H, t, J = 8 Hz), 1.22 
(3H, d, J= 6 Hz), 1.35-1.77 (13H, m), 1.84-1.95 (2H, m), 2.07-2.21 (3H, m), 3.74-3.86 
(3H, m), 5.50 (1H, dt, J = 10, 5 Hz), 7.43 (1H, t, J = 7 Hz), 7.55 (1H, t, J = 7 Hz), 8.02 
(1H, d, J = 7 Hz), 9.59 (1H, d, J = 3 Hz); 13C NMR (CDC13, 75MHz) 8 -4.5, -4.3, 5.1, 
10.9,  11.3,  18.0, 21.6, 24.4, 25.4, 25.8(3C), 26.3, 29.5, 29.6, 29.9, 35.2, 35.6, 43.1, 
53.3, 67.2, 69.4, 70.3, 71.1, 97.4,  128.2(2C), 129.4(2C),  130.5, 132.7, 165.6, 204.8; 
MS (FAB) m/z 575 (M++1), 574 (Mt), 557, 517, 469, 453, 395, 325, 267, 221, 193, 
159, 137; HRMS (CI) m/z 575.3405 (calcd for C33H54O6Si + H+: 575.3769). 154
 
OBz 
'40  QTBS
 
(2S,3S,4S,6R,8S,9S)-4-(Benzoyloxy)-3,9-climethy1-8-[(R)-24(tert-butyldimethylsily­
Doxy]-1-propyl]-2-[(R)-3-ethy1-5-(E)-iodo-4-pentenyl]-1,7-dioxaspiro[5.5]undecane 
(135). To a solution of chromium(II) chloride (994 mg, 8.09 mmol) in tetrahydrofuran 
(18 ml) under argon at 0°C was added dropwise a solution of 134 (465 mg, 0.809 
mmol) and iodomethane (701 mg, 1.78 mmol) in tetrahydrofuran (18 mL) via cannula. 
The brown solution was stirred for 2 h at 0°C and for 1 h at room temperature, and was 
quenched by addition of water (5 mL). The resultant deep-green mixture was extracted 
three times with ether (80 mL), and the combined ethereal extracts were washed with 
water (150 mL) and brine (150 mL), and was dried (magnesium sulfate). Removal of 
the solvent was followed by chromatography of the residue on silica gel, with gradient 
elution from 2% to 4% ethyl acetate in hexane, to yield 431 mg (76%) of 135 as a 
colorless oil:  [a]g2 -62.7° (c 6.03, CHC13); IR (neat) 2958, 2931, 1720, 1275, 1255, 
1098, 834 cm-1; 1H NMR (CDC13, 300MHz) 8 0.07 (6H, s), 0.84-0.95 (18H, m), 1.22 
(3H, d, J = 6 Hz), 1.25-1.94 (13H, m), 1.85-2.18 (4H, m), 3.71-3.87 (3H, m), 4.49 (1H, 
dt, J = 12, 5 Hz), 5.96 (1H, d, J = 14 Hz), 6.27 (1H, dd, J = 14, 9 Hz), 7.43 (2H, d, J= 
7 Hz), 7.55 (1H, t, J = 7 Hz), 8.02 (2H, d, J = 7 Hz); 13C NMR (CDC13, 75MHz) 8 
-4.4, -4.2, 5.1, 11.0, 11.5, 18.1, 24.5, 25.9(3C), 26.4, 27.9, 29.6 (2C), 30.2, 31.1, 35.8, 
43.3, 48.7, 67.3, 69.5, 70.4, 71.3, 74.2, 97.5, 128.3(2C), 129.5(2C), 130.6, 132.8, 
150.4, 165.7; MS (FAB) m/z 698 (M+), 697, 683, 641, 577, 519, 451, 431, 389, 325, 
267, 229, 205, 193, 159, 105; HRMS (FAB) m/z 698.2863 (calcd for C34H55IO5Si: 155
 
698.2865). This compound was contaminated by a small amount of the Z stereoisomer 
(EIZ 18.4:1 by 13C NMR). 
H 
O 
QTBS 
(2S,3S,4S,6R,8S,9S)-3,9-Dimethy1-84(R)-2-[(tert-butyldimethylsilyl)oxy]-1-propyl] 
-2-[(R)-3-ethy1-5-(E)-iodo-4-penteny1]-1,7-dioxaspiro[5.5]undecan-4-ol (136).  A 
suspension of 135 (65 mg, 0.093 mmol) and lithium hydroxide monohydrate (8.5 mg, 
0.20 mmol) in methanol (0.4 mL), tetrahydrofuran (0.4 mL) and water (0.2 mL) was 
stirred for 20 h at room temperature. The mixture was added to ether (20 mL) and the 
solution was washed with water (20 mL) and brine (20 mL). The aqueous wash was 
extracted three times with ether (30 mL), and the combined ethereal extracts were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silics gel, with gradient elution from 5% to 20% ethyl acetate in hexane, to 
yield 56 mg (100%) of 136 as a colorless oil: [a r -45.4° (c 2.08, CHC13); IR (neat) 
3383 (br), 2957, 2932, 2885, 1459, 1253, 970, 833 cm-1; 1H NMR (CDC13, 300MHz) 
8 0.05 (6H, s), 0.80-0.94 (18H, m), 1.17 (3H, d, J = 6 Hz), 1.23-1.74 (14H, m), 1.80 
(1H, m), 1.93-2.05 (2H, m), 3.55 (1H, m), 3.71 (1H, dt, J= 7, 2 Hz), 3.80 (1H, m), 4.17 
(1H, dt, J = 12, 5 Hz), 5.95 (1H, d, J = 14 Hz), 6.26 (1H, dd, J = 14, 9 Hz); 13C NMR 
(CDC13, 75MHz) 8 -4.6, -4.4, 4.0, 10.9, 11.5, 18.0, 24.3, 25.8(3C), 26.4, 27.0, 29.5, 
29.6, 30.2, 31.1, 38.0, 39.0, 43.2, 48.7, 67.1, 67.2, 69.2, 70.8, 74.0, 97.4, 150.4; MS 156
 
(FAB) m/z 595 (Mt), 577, 519, 443, 421, 345, 325, 227, 193, 159, 137; HRMS (FAB) 
m/z 595.2677 (calcd for C27H51IO4Si + lit: 595.2681). 
(2S,3S,4S,6R,8S,9S)-4-[(Diethylphosphonoacetyl)oxy]-3,9-dimethy1-8-[(R)-2-[(tert­
butyldimethylsilypoxy]-1-propyl]-2-[(R)-3-ethy1-5-(E)-iodo-4-pentenyl]-1,7-dioxa­
spiro[5.5]undecane (7). A solution of triethyl phosphonoacetate (5.0 g, 22 mmol) and 
potassium hydroxide (1.5 g, 24 mmol) in ethanol (3.5 mL) and water (1.4 mL) was 
stirred for 15 h at room temperature. The volatile components were removed under 
reduced pressure and the residue was dissolved in water (20 mL). The mixture was 
extracted twice with ether (30 mL), and the combined organic layers were washed with 
water (40 mL) and acidified to pH 1 using 2 N hydrochloric acid, and brine (50 mL) 
was added.  After separation, the aqueous layer was extracted three times with 
dichloromethane (50 mL), and the combined organic layers were dried (magnesium 
sulfate). Removal of the solvent gave 3.0 g (69%) of crude acid as a pale yellow oil. 
To a solution of the acid (700 mg, 3.57 mmol) in dichloromethane (6 mL) at 
0°C was added oxalyl chloride (0.477 mL, 5.36 mmol) dropwise and the mixture was 
stirred for 10 min at 0°C and for 22 h at room temperature. Removal of the solvent 
gave 766 mg of crude 137 which was used without purification. 157
 
To a solution of 136 (313 mg, 0.526 mmol), 4-(dimethylamino)pyridine (480 
mg, 3.93 mmol), and pyridine (0.607 mL, 7.85 mmol) in dichloromethane (10 mL) 
under argon at 0°C was added dropwise a solution of crude 137 (766 mg) in 
dichloromethane (3 mL). The yellow solution was stirred for 1 h at 0°C and was 
quenched by addition of saturated sodium bicarbonate solution (5 mL). The mixture 
was diluted with dichloromethane (30 mL) and was washed with saturated sodium 
bicarbonate solution (30 mL), water (30 mL) and brine (30 mL). The aqueous wash 
was extracted three times with dichloromethane (80 mL), and the combined organic 
layers were dried (magnesium sulfate).  Removal of the solvent followed by 
chromatography of the residue on silica gel, using 40% ethyl acetate in hexane as 
eluant, gave 392 mg (96%) of 7 as a pale oil: [a]o -42.8° (c 0.56, CHC13); IR (neat) 
2958, 2952, 1735, 1273, 1257, 1057, 1028, 971 cm-1; 1H NMR (CDC13, 300MHz) 8 
0.04 (6H, s), 0.82-0.90 (18H, m), 1.17 (3H, d, J. 6 Hz), 1.24-1.63 (19H, m), 1.71-1.78 
(2H, m), 1.86-2.08 (3H, m), 2.91 (1H, d, J p, H = 22 Hz), 3.62 (1H, m), 3.69 (1H, dt, J 
= 7, 2 Hz), 3.80 (1H, m), 4.15 (1H, quint, J = 7 Hz), 5.26 (1H, dt, J = 12, 5 Hz), 5.94 
(1H, d, J = 14 Hz), 6.26 (1H, dd, J = 14, 9 Hz); 13C NMR (CDC13, 75MHz) 8 -4.5, 
-4.3, 4.8, 11.0, 11.5, 16.3 (d, J p, c = 6 Hz)(2C), 18.1, 24.4, 25.9(3C), 26.3, 27.0, 29.6, 
30.1, 31.0, 34.5 (d, J p, c = 134 Hz), 35.0, 35.5, 43.2, 48.7, 62.6 (d, J p, c = 6 Hz)(3C), 
67.1, 69.4, 70.2, 72.2, 74.2, 97.4, 150.3, 164.9 (d, J p, c = 6 Hz); MS (FAB) m/z 773 
(M++1), 772 (M+), 771, 715, 672, 645, 577, 519, 345, 325, 253, 193; HRMS (FAB) 
m/z 773.3078 (calcd for C33H62IO8PSi +  773.3074). 158
 
TBS 
OTBS 
(2R,3R,4R)-1,3-Dit(tert-butyldimethylsilypoxy]-2,4-(dimethyphex-5-ene (140). 
To a solution of oxalyl chloride (18.3 mL, 205 mmol) in dichloromethane (350 
mL) under argon at -78°C was added dimethyl sulfoxide (25 mL, 352 mmol). The 
mixture was stirred for 45 min at -78°C, and a solution of crude 41 (12.0 g, 58.7 mmol) 
in dichloromethane (100 mL) was added dropwise via cannula. Stirring was continued 
for 1 h, after which triethylamine (82.0 mL, 587 mmol) was added. The mixture was 
stirred for 45 min at -78°C, allowed to warm to room temperature for 1 h, quenched by 
addition of water (30 mL), and was diluted with pentane (800 mL). The solution was 
washed with brine (800 mL) and water (800 mL). The aqueous wash was extracted 
once with pentane (800 mL) and twice with ether (800 mL), and the combined organic 
layers were dried (sodium sulfate). Removal of the solvent gave crude 133 as a yellow 
oil which was used without purification: [at2 -7.5° (c 2.00, CHC13). 
To a solution of the (E)-crotylboronate diethanolamine complex (18.8 g, 111 
mmol) in ether (400 mL) under argon at room temperature was added D-(S, S)­
diisopropyl tartrate (24.1 mL, 111 mmol). The mixture was rapidly stirred for 10 min 
and a saturated sodium chloride solution (400 mL) was added. Stirring was continued 
for 10 min and the mixture was partitioned. The aqueous layer was extracted three 
times with ether (400 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent gave 138 as a viscous pale yellow oil which was used 
immediately. 
A mixture of crude 138 (111 mmol) and powdered activated 4A molecular 
sieves (30.0 g) in toluene (400 mL) under argon was stirred for 15 min at room 
temperature and cooled to -78°C. A solution of crude 133 (58.7 mmol) in toluene (60 159
 
mL) was added dropwise via cannula over a period of 1 h, and the mixture was stirred 
for 2.5 d at -78°C and quenched by addition of 1 N sodium hydroxide solution (330 
mL). The mixture was stirred for 2.5 h at room temperature and was diluted with ether 
(800 mL). The solution was washed with water (80 mL) and brine (800 mL), the 
aqueous wash was extracted three times with ether (800 mL), and the combined 
ethereal extracts were dried (sodium sulfate). Removal of the solvent gave crude 
alcohol 139 as a yellow oil which was used without purification: IR (neat) 3500, 2958, 
2898, 1472, 1255, 1094 cm-1; 1H NMR (CDC13, 300MHz) 8 0.06 (6H, s), 0.89 (9H, 
s), 0.93 (3H, d, J =3 Hz), 0.96 (3H, d, J = 3 Hz), 1.80 (1H, m), 2.27 (1H, m), 3.53 (1H, 
dd, J = 9, 2 Hz), 3.71 (2H, m), 5.10 (2H, m), 5.83 (1H, m); 13C NMR (CDC13, 
75MHz) 8 -5.7, -5.7, 9.3, 16.5, 18.1, 25.7, 36.2, 41.6, 68.1, 76.5, 114.9, 141.9; MS (CI) 
m/z 259 (M++1), 241, 205, 109; HRMS (CI) m/z 259.2094 (calcd for C14H3002Si + 
H+: 259.2093). 
To a solution of crude 139 (58.7 mmol) and imidazole (8.10 g, 117 mmol) in 
dimethylformamide (60 ml) at room temperature was added a solution of tert­
butyldimethylsilyl chloride (13.0 g, 83.7 mmol) in dimethylformamide (20 mL). The 
mixture was stirred for 4 d at room temperature, after which additional tert­
butyldimethylsilyl chloride (3.00 g) and imidazole (2.00 g) were added. Stirring was 
continued for 2 d, the mixture was diluted with ether (200 mL), and the solution was 
washed with water (200 mL). The aqueous wash was extracted three times with ether 
(200 mL), and the combined ethereal extracts were dried (magnesium sulfate). 
Removal of the solvent was followed by chromatography of the residue on silica gel, 
with gradient elution from 2.5% to 10% ethyl acetate in hexane, to yield 13.0 g (66% 
from 41) of 140 as a colorless oil: [a]p -3.4° (c 5.94, CHC13); IR (neat) 2957, 2930, 
2889, 2858, 1472, 1255, 1050 cm-1; 1H NMR (CDC13, 300MHz) 6 0.03 (6H, s), 0.04 
(6H, s), 0.84 (3H, d, J = 7 Hz), 0.89 (9H, s), 0.90 (9H, s), 0.99 (3H, d, J = 7 Hz), 1.76 160
 
(1H, m), 2.34 (1H, m), 3.37 (1H, dd, J = 10, 7 Hz), 3.46 (1H, dd, J = 10, 7 Hz), 4.97 
(2H, m), 5.83 (1H, m); 13C NMR (CDC13, 75MHz) 8 -5.3, -5.3, -4.1, -3.7, 11.7, 17.0, 
18.3, 18.4, (25.9, 26.2)(6C), 39.2, 43.0, 66.0, 75.3, 113.9, 142.2; MS (CI) m/z 373 
(M++1), 357, 317, 257, 199, 109; HRMS (CI) m/z 373.2958 (calcd for C20H4402Si2 
+ H+: 373.2958). This compound was contaminated by ca 25% (4:1 by 13C NMR) of 
a second stereoisomer. 
HC°L7' 
OTBS 
(2R,3R,4R)-3-[(tert-Butyldimethylsilyl)oxy]-1-hydroxy-2,4-(dimethyphex-5-ene 
(141). A stirred solution of 140 (13.0 g, 34.9 mmol) and ammonium fluoride (13.0 g, 
349 mmol) in methanol (200 mL) was heated at reflux for 12 h and allowed to cool to 
room temperature. The solvent was removed under reduced pressure and the residue 
was dissolved in 10% ethyl acetate in hexane (10 mL). The solution was 
chromatographed on silica gel, with gradient elution from 15% to 75% ethyl acetate in 
hexane, to yield 7.65 g (85%) of 141 as a colorless oil :  [a]p +0.97° (c 2.36, CHC13); 
IR (neat) 3355 (br), 2960, 2932, 2887, 2859, 1475, 1254, 1044, 838 cm-1; 1H NMR 
(CDC13, 300MHz) 8 0.07 (6H, d, J = 3 Hz), 0.88 (3H, d, J = 7 Hz), 0.91 (9H, s), 1.03 
(3H, d, J = 7 Hz), 1.86-1.96 (2H, m), 2.36-2.47 (1H, m), 3.46 (1H, dd, J = 11, 6 Hz), 
3.61-3.68 (2H, m), 4.98-5.07 (2H, m), 5.86-5.97 (1H, ddd, J = 18, 10, 8 Hz); 13C NMR 
(CDC13, 75MHz) 8 -4.2, -4.1, 12.3, 18.0, 18.2, 25.9(3C), 39.6, 41.7, 65.7, 76.5, 114.3, 
141.5; HRMS (CI) m/z 259.2094 (calcd for C14H3002Si + H+: 259.2093); Anal. 
Calcd for C14H3002Si: C, 65.07; H, 11.71.  Found: C, 65.15; H, 11.47.  This 
compound was contaminated by ca 7% (13.4:1 by 13C NMR) of a second 
stereoisomer. 161
 
OTBS
 
(2R,3R,4R)-3-[( tert-Butyldimethylsilyl)oxy]-2,4-dimethy1-1-(p-toluenesulfonyloxy)­
hex-5-ene (142). To a solution of 141 (7.65 g, 29.6 mmol) in pyridine (80 mL) under 
argon at 0°C was added p-toluenesulfonyl chloride (8.46 g, 44.4 mmol).  The mixture 
was stirred for 30 h at 0°C and was allowed to warm to room temperature.  The 
reaction was quenched by addition of water (100 mL) and the mixture was stirred for 
10 min. Ether (500 mL) and water (500 mL) were added and the layers were separated. 
The aqueous layer was extracted three times with ether (500 mL), and the combined 
ethereal extracts were washed with 1 N hydrochloric acid solution (500 mL), water 
(500 mL), and saturated sodium bicarbonate solution (500 mL), and were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 5% to 10% ethyl acetate in hexane, to 
yield 11.2 g (92%) of 141 as a pale yellow oil:  [a]232 -3.2° (c 3.65, CHC13); IR (neat) 
3355 (br), 2959, 2929, 2884, 2859, 1605, 1475, 1373, 1259, 1189, 971 cm-1;  1H NMR 
(CDC13, 400MHz) 8 -0.04 (3H, s), 0.02 (3H, s), 0.84 (9H, s), 0.87 (3H, d, J =7 Hz), 
0.95 (3H, d, J = 7 Hz), 1.92-2.03 (1H, m), 2.24-2.33 (1H, m), 2.44 (1H, s), 3.43-3.57 
(1H, m), 3.85-3.98 (2H, dd, J = 9, 6 Hz), 4.93-4.97 (2H, m), 5.70-5.81 (1H, m), 7.34 
(2H, d, J = 8 Hz), 7.77 (2H, d, J = 8 Hz); 13C NMR (CDC13, 100MHz) 8 -4.3, -4.0, 
12.1, 17.5, 18.2, 21.5, 25.9(3C), 36.9, 42.2, 73.3, 75.6, 114.7, 127.9(2C), 129.7(2C), 
133.3, 140.9, 144.5; MS (CI) m/z 413 (M++1), 401, 397, 355, 315, 271, 229, 185, 109; 
FIRMS (CI) m/z 413.2181 (calcd for C21H36O4SSi + H+: 413.2182). This compound 
was contaminated by ca 25% (3:1 by 13C NMR) of a second stereoisomer. 162
 
CN OTBS
 
(2R,3S,4R)-3-[(tert-Butyldimethylsilyl)oxy]-2,4-(dimethyl)hex-5-enenitrile (143). A 
solution of 142 (11.1 g, 27.0 mmol) and sodium nitrate (3.06 g, 59.4 mmol) in dimethyl 
sulfoxide (45 mL) under argon was stirred for 2.5 d at room temperature, and was 
diluted with water (50 mL). The mixture was extracted three times with hexane (50 
mL), and the combined organic layers were washed with water (100 mL) and dried 
(magnesium sulfate). Removal of the solvent gave 6.81 g (94%) of 143 as a pale 
yellow oil: [ar -4.6° (c 1.61, CHC13); IR (neat) 2959, 2929, 2888, 2859, 2243, 1640, 
1473, 1369, 1259, 1047, 835 cm-1; 1H NMR (CDC13, 400MHz) 8 0.09 (6H, s), 0.92 
(9H, s), 1.03 (3H, d, J = 7 Hz), 1.07 (3H, d, J= 7 Hz), 2.01-2.09 (1H, m), 2.24-2.31 
(1H, dd, J= 17, 9 Hz), 2.38 (1H, m), 2.42-2.48 (1H, dd, J= 17, 9 Hz), 3.45-3.58 (1H, 
m), 5.00-5.06 (2H, m), 5.78-5.90 (1H, m, J = 9 Hz); 13C NMR (CDC13, 100MHz) 8 
-4.1, -4.0, 15.3, 18.0, 18.2, 21.5, 26.0(3C), 35.5, 41.7, 77.4, 114.9, 119.4, 140.9; HRMS 
(CI) m/z 268.2097 (calcd for C15H29NOSi + H+: 268.2098); Anal. Calcd for 
C15H29NOSi: C, 67.35; H, 10.93; N, 5.24. Found: C, 67.25; H, 11.12; N, 5.22. This 
compound was contaminated by ca 30% (2.5:1 by 13C NMR) of a second 
stereoisomer. 
OHC  OTBS 
(3R,4S,5R)-44(tert-Butyldimethylsilypoxy]-3,5-(dimethyphept-6-en-1-al (144). To 
a solution of 143 (5.20 g, 19.4 mmol) in toluene (80 mL) under argon at -78°C was 163 
added diisobutylaluminum hydride (1.0 M in hexane, 58.3 mL, 58.3 mmol) dropwise 
over a period of 1 h. The solution was stirred for 3 h at -78°C and methanol (18 mL) 
was added dropwise. The mixture was stirred for 20 min at room temperature and 
transferred to a flask, via cannula, containing ether (300 mL) and saturated ammonium 
chloride solution (300 mL). The solution was stirred for 5 h, diluted with ether (300 
mL), and partitioned. The ethereal layer was washed with 0.6 N hydrochloric acid 
solution (300 mL) and water (300 mL). The aqueous washings were extracted three 
times with ether (200 mL), and the combined ethereal extracts were dried (magnesium 
sulfate). Removal of the solvent was followed by chromatography of the residue on 
silica gel, with gradient elution from 2% to 5% ethyl acetate in hexane, to yield 3.87 g 
(75%) of 144 as a colorless oil: [aV -6.7° (c 0.93, CHC13); IR (neat) 2959, 2930, 
2890, 2859, 1730, 1470, 1262, 1047, 841 cm-1; 1H NMR (CDC13, 300MHz) S 0.05 
(6H, d, J=5 Hz), 0.91 (9H, s), 0.93 (3H, d, J= 6 Hz), 1.02 (3H, d, J= 7 Hz), 2.21-2.32 
(2H, m), 2.33-2.44 (1H, m), 2.58-2.67 (1H, m), 3.39-3.51 (1H, td, J = 26, 5 Hz), 4.95­
5.03 (2H, m), 5.82-5.94 (1H, m), 9.71 (1H, t, J= 2 Hz); 13C NMR (CDC13, 75MHz) 8 
-4.1, -4.0, 15.8, 18.2, 18.8, 25.9(3C), 32.7, 41.4, 47.7, 78.5, 114.2, 141.5, 202.7; MS 
(CI) m/z 271 (M++1), 255, 215, 199, 139, 121; HRMS (CI) m/z 271.2093 (calcd for 
C i5H3002Si + H-F: 271.2094). This compound was contaminated by ca 8% (12:1 by 
13C NMR) of a second stereoisomer. 
flYOTBS 
HO 
(3R,45,5R)-4-[(tert-Butyldimethylsilyl)oxy]-1-hydroxy-3,5-(dimethyl)hept-6-ene 
(145). A suspension of 144 (3.23 g, 11.9 mmol) and sodium borohydride (1.38 g, 35.8 164
 
mmol) in isopropanol (70 mL) under argon was stirred for 1 h at 0°C. An aqueous 
solution of Rochelle salt (20 mL) in water (10 mL) was added, and the mixture was 
stirred for 40 min at room temperature and diluted with ether (150 mL). The organic 
layer was separated and was washed with aqueous Rochelle salt (100 mL) and water 
(100 mL). The aqueous wash was extracted three times with ether (100 mL), and the 
combined ethereal extracts were dried (magnesium sulfate). Removal of the solvent 
followed by chromatography of the residue on silica gel, using 10% ethyl acetate in 
hexane, as eluant, afforded 2.81 g (87%) of 145 as a colorless oil:  [a] +6.1° (c 1.33, 
CHC13); IR (neat) 3340 (br), 2959, 2930, 2886, 2857, 1474, 1260, 1057, 841 cm-1; 1H 
NMR (CDC13, 300MHz) 8 0.04 (6H, d, J = 5 Hz), 0.90 (9H, s), 0.91 (3H, d, J = 6 Hz), 
0.99 (3H, d, J = 7 Hz), 1.34-1.50 (1H, m), 1.67-1.83 (2H, m), 1.85 (1H, s), 2.34-2.45 
(1H, m), 3.37-3.43 (1H, m, J = 9, 5 Hz), 3.53-3.75 (2H, m), 4.93-5.01 (2H, m), 5.80­
5.93 (1H, m); 13C NMR (CDC13, 75MHz) 8 -3.9, -3.8, 15.6, 17.1, 18.1, 26.0(3C), 
34.4, 36.8, 41.9, 61.5, 79.5, 113.8, 142.0; MS (CI) m/z 271 (M-E-1), 255, 217, 199, 159, 
141, 123; HRMS (CI) m/z 271.2094 (calcd for C15H3202Si - 271.2095). This 
compound was contaminated by ca 30% (2.5:1 by  13C NMR) of a second 
stereoisomer. 
TBsoOTBS
 
(3R,4S,5R)-1,4-Dit(tert-butyldimethylsilypoxy]-3,5-(dimethyphept-1-ene (146). 
To a suspension of 145 (0.735 g, 2.70 mmol) and imidazole (0.743 g, 10.8 mmol) in 
dimethylformamide (20 mL) under argon at 0°C was added tert-butyldimethylsilyl 
chloride (0.839 g, 5.40 mmol). The mixture was stirred for 15 h at room temperature, 165
 
diluted with ether (100 mL), and washed with water (100 mL). The aqueous wash was 
extracted three times with ether (100 mL), and the combined ethereal extracts were 
dried (magnesium sulfate). Removal of the solvent was followed by chromatography 
of the residue on silica gel, with gradient elution from 100% hexane to 1% ethyl acetate 
in hexane, to yield 1.00 g (96%) of 146 as a colorless oil: [a) +3.6° (c 1.75, CHC13); 
IR (neat) 2959, 2930, 2886, 2859, 1474, 1261, 1057, 838 cm-1; 111 NMR (CDC13, 
300MHz) 8 0.04 (611, s), 0.04 (6H, s), 0.88 (3H, d, J = 6.8 Hz), 0.89 (9H, s), 0.91 (9H, 
s), 1.01 (31-I, d, J = 7 Hz), 1.30-1.39 (1H, m), 1.62-1.69 (1H, m), 1.70-1.81 (1H, m), 
2.33-2.41 (1H, m), 3.38-3.42 (1H, m, J = 8, 4 Hz), 3.55-3.71 (2H, m), 4.91-4.99 (2H, 
m), 5.83-5.96 (1H, m); 13C NMR (CDC13, 75MHz) 8 (-5.3, -3.8)(4C), 14.9, 16.5, 18.0, 
18.3, (25.9, 26.1)(6C),  33.6,  37.3, 42.3, 61.6, 79.8, 113.7, 142.2; MS (CI) m/z 386 
(M+), 385 (M±-1), 371, 329, 273, 255, 199, 159, 147, 123; HRMS (CI) m/z 385.2960 
(calcd for C21H4602S1 2- H÷: 385.2960). This compound was contaminated by ca 
30% (2.5:1 by 13C NMR) of a second stereoisomer. 
0 
OTBS 
TBS 
(2S,3S,4R)-3,6-Di-[( tert-butyldimethylsilypoxy]-2,4-(dimethyl)hexan-1-al (147). A 
stream of ozone was passed through a solution of 146 (3.23 g, 8.35 mmol)  in 
dichloromethane (120 mL) and methanol (27 mL) at -78°C for 25 min. The excess 
ozone was purged with argon for 40 min, a catalytic amount of potassium bicarbonate 
and dimethyl sulfide (35 mL) were added, and the mixture was stirred at room 
temperature for 2 d under argon.  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 100% hexane to 166
 
2% ethyl acetate in hexane, to yield 3.21 g (99%) of 147 as a colorless oil:  [4232 
+27.3° (c 2.46, CHC13); IR (neat) 2957, 2932, 2887, 2859, 1730, 1473, 1257, 1102, 838 
cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 0.06 (6H, s), 0.88 (18H, s), 0.90 
(3H, d, J = 7 Hz), 1.07 (3H, d, J = 7 Hz), 1.24-1.35 (1H, m), 1.63-1.75 (1H, m), 1.80­
1.93 (IH, m), 2.49-2.60 (1H, m), 3.55-3.59 (IH, m), 3.60-3.70 (1H, m), 3.76 (1H, t, J = 
4 Hz), 9.76 (1H, d, J = 3 Hz); 13C NMR (CDC13, 75MHz) 8 -5.5, -5.4, -4.6, -4.0, 12.4, 
14.4, 18.1(2C), 25.8(6C), 34.1, 35.9, 49.7, 61.0, 78.3, 205.1; MS (CI) m/z 387 (M+-1), 
373, 331, 315, 273, 257, 235,  199,  159, 125; HRMS (CI) Fez 373.2596 (calcd for 
C20114403Si2 CH3: 373.2595). This compound was contaminated by ca 20% (4.5:1 
by 13C NMR) of a second stereoisomer. 
0  OH 
TBSO 
TBS 
(3R,4S,5R,6S,7S)-1,4-Dit(tert-butyldimethylsilypoxy]-6-hydroxy-3,5,7-trimethyl­
non-8-ene (149). The (E)-crotylboronate 148 was prepared by the same procedure as 
was used for 138 except that (R, R)-diisopropyl tartrate replaced the (S,S) enantiomer. 
A suspension of crude 148 (34.3 mmol) and powdered activated 4A molecular 
sieves (5.00 g) in toluene (100 mL) under argon was stirred for 15 min at room 
temperature and cooled to -78°C. A solution of 147 (3.13 g, 8.05 mmol) in toluene (30 
mL) was added dropwise via cannula, and the slurry was stirred for 2.5 d at -78°C. The 
reaction was quenched by addition of 1 N sodium hydroxide solution (90 mL), and 
stirred for 2 h at room temperature. The mixture was diluted with ether (200 mL), and 
the solution was washed with water (200 mL) and brine (200 mL). The aqueous 
washing were extracted three times with ether (300 mL), and the combined ethereal 167 
extracts were dried (magnesium sulfate). Removal of the solvent was followed by 
radial chromatography (4 mm plate) of the residue on silica gel, with gradient elution 
from 100% hexane to 1% ethyl acetate in hexane, to yield 2.79 g (78%) of 149 as a 
colorless oil:  [42)2 +4.0° (c 4.74, CHC13); IR (neat) 3518 (br), 2957, 2931, 2887, 
2859, 1473, 1390, 1257, 1100, 838 cm-1; 1H NMR (CDC13, 300MHz) 8 0.05 (6H, s), 
0.09 (6H, d, J = 8 Hz), 0.89 (9H, s), 0.89-0.99 (11H, m), 0.91 (9H, s), 1.24-1.31 (1H, 
m), 1.34-1.43 (1H, m), 1.71-1.80 (1H, m), 1.80-1.88 (1H, m), 1.88-1.96 (1H, m), 2.20­
2.29 (1H, m, J = 7 Hz), 3.57-3.65 (2H, m), 3.67-3.75 (2H, m), 5.04-5.12 (2H, m), 5.79­
5.90 (1H, m); 13C NMR (CDC13, 75MHz) 8 (-5.4, -4.0, -3.7)(4C), 11.1, 15.0, 16.5, 
18.2, 18.4, (25.9, 26.2)(6C), 33.7, 36.3, 37.0, 41.8, 61.4, 74.0, 81.0, 114.7, 142.5; 
HRMS (CI) nilz 444.3455 (calcd for C24H52O3Si2: 444.3457); Anal. Ca lcd for 
C24H52O3Si2: C, 64.80; H, 11.78. Found: C, 64.95; H, 11.74. 
TBS 
(3R,4S,5R,6S,7S)-1,4-Di-[( tert-butyldimethylsilyl)oxy]-6-(triethylsily1)oxy-3,5,7-tri­
methylnon-8-ene (150). To a solution of 149 (250 mg, 0.560 mmol) and 4,4­
dimethylaminopyridine (42.0 mg, 0.340 mmol) in pyridine (7 mL) under argon at room 
temperature was added triethylsilyl chloride (0.239 mL, 1.41 mmol). The mixture was 
stirred for 2 d, after which additional triethylsilyl chloride (0.210 mL) was added and 
stirring was continued for 2 d. The mixture was added to water (20 mL) and ether (20 
mL), and was partitioned. The aqueous layer was extracted three times with ether (20 
mL), and the combined ethereal extracts were dried (magnesium sulfate). Removal of 
the solvent was followed by chromatography of the residue on silica gel, with gradient 168
 
elution from 100% hexane to 3% ethyl acetate in hexane, to yield 258 mg (82%) of 150 
as a colorless oil: [at +1.6° (c 2.17, CHC13); lR (neat) 2952, 2928, 2880, 2859, 
1473, 1254, 1100, 838 cm-1; 1H NMR (CDC13, 300MHz) 8 0.02-0.08 (12H, m), 0.64 
(6H, q, J = 8 Hz), 0.85-1.03 (25H, m), 0.98 (9H, t, J = 8 Hz), 1.25 (2H, m), 1.33-1.60 
(2H, m), 1.63-1.84 (2H, m), 2.25-2.31 (1H, m), 3.51-3.70 (4H, m), 4.96-5.19 (2H, m), 
5.83-5.95 (1H, m); 13C NMR (CDC13, 75MHz) 5 -5.4, -5.3, -4.5, -3.7, 5.6(3C), 
7.1(3C), 12.2, 13.9, 18.1, 18.2, (25.8, 25.9, 26.0)(6C), 32.0, 34.4, 39.5, 42.6, 43.0, 61.0, 
75.8, 78.0, 114.5, 140.6; MS (FAB) m/z 558 (Mt), 544, 501, 427, 397, 371, 331, 315, 
273, 239, 199; HRMS (FAB) m/z 543.4083 (calcd for C30H66O3Si3 - CH3: 
543.4087); Anal. Calcd for C30116603Si3: C, 64.44; H, 11.90. Found: C, 64.51; H, 
11.72. 
TBS
 
(2R,3R,4R,5S,6R)-5,8-Di-[( tert-butyldimethylsilypoxy]-3-(triethylsilypoxy-2,4,6­
trimethyloctan-1-al (9). A stream of ozone was passed through a solution of 150 (143 
mg, 0.256 mmol) in dichloromethane (6 mL) and methanol (1 mL) at -78°C for 7 min. 
The excess ozone was purged with argon for 30 min, a catalytic amount of potassium 
bicarbonate and dimethyl sufide (2.6 mL) were added, and the mixture was stirred for 2 
d at room temperature under argon.  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 1% to 3% ethyl 
acetate in hexane, to yield 144 mg (100%) of 9 as a colorless oil:  [a]232 -9.5° (c 3.05, 
CHC13); IR (neat) 2957, 2932, 2880, 2860, 1730, 1473, 1257, 1052, 838 cm-1; 1H 
NMR (CDC13, 300MHz) 8 0.04-0.08 (12H, m), 0.64 (6H, q, J = 8 Hz), 0.86-1.01 (24H, 169 
m), 0.98 (9H, t, J = 8 Hz), 1.10 (3H, d, J = 7 Hz), 1.37-1.47 (1H, m), 1.51-1.62 (1H, 
m), 1.68-1.80 (1H, m), 1.83-1.91 (1H, m, J = 7 Hz), 2.48-2.57 (1H, m), 3.54-3.68 (3H, 
m), 3.90-4.02 (1H, qd, J = 24, 6, 4 Hz), 9.75 (1H, d, J = 3 Hz); 13C NMR (CDC13, 
75MHz) 5 -5.5, -5.4, -4.2, -4.1, 5.6(3C), 7.0(3C), 11.9, 12.3, 13.7, 18.2, 18.3, (25.8, 
25.9, 26.0)(6C), 31.7, 38.5, 43.2, 50.8, 60.9, 76.1, 76.7, 205.1; MS (FAB) m/z 561 
(M++1), 560 (Mt), 559, 504, 487, 463, 447, 390, 371, 331, 315, 273, 239, 199. 
TBS 
OH 
(2R,3R,4S)-1-[ (tert-Butyldimethylsilyl)oxy]-3-hydroxy-2,4-dimethylhex-5-ene 
(152). An oven-dried 250 mL round-bottom three-neck flask equipped with an internal 
thermometer under argon at room temperature was charged with potassium tert­
butoxide (8.00 g, 71.0 mmol) and tetrahydrofuran (50 mL). The solution was cooled to 
-78°C and trans-2-butene (7.40 mL, 80.0 mmol) was added dropwise via cannula while 
n-butyllithium (2.5 M in hexane, 28.4 mL, 71.0 mmol) was added via syringe pump. 
Addition took place over a period of 1.5 h in order that the internal temperature did not 
rise above -60°C. The flask which contained a the clear yellow-orange solution, was 
raised partially out of the cooling bath allowing the internal temperature to rise to 
-50°C, and the mixture was kept at this temperature for 25 min. The mixture was 
recooled to -78°C and tri-n-butylchlorostannane (17.6 mL, 65.0 mmol) was added 
dropwise over a period of 1 h via syringe pump in order that the internal temperature 
did not rise above -60°C. The mixture was stirred for 1.25 h at -78°C, quenched with 1 
N hydrochloric acid solution (120 mL), and was diluted with hexane (200 mL). After 
separation, the aqueous layer was extracted three times with hexane (150 mL), and the 170 
combined organic layers were dried (magnesium sulfate). Removal of the solvent gave 
crude 151 as a mixture of steoreisomers. 
To a solution of crude 133 (9.19 mmol) in dichloromethane (40 mL) under 
argon at -90°C was added trifluoroboron etherate (10.1 mmol). The solution was 
stirred for 5 min and a solution of crude 151 (4.09 g, 10.1 mmol) in dichloromethane 
(15 mL) was added dropwise. The slightly turbid mixture was stirred for 4 h at -90°C 
and removed from the cooling bath.  The reaction was quenched with saturated 
ammonium chloride solution (50 mL), and the mixture was stirred for 15 min. Water 
(20 mL) was added to dissolve precipitated solids, and after separation the aqueous 
layer was extracted three times with ether (20 mL) and the combined organic layers 
were dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 5% to 10% 
ethyl acetate in hexane, to yield (81%) of 152. A second chromatography on silica gel, 
using 7% of ethyl acetate in hexane as eluant, afforded 1.70 g (75% from 41) of 152 as 
a colorless oil:  [a]o -4.9° (c 1.05, CHC13); IR (neat) 3509, 2958, 2932, 2901, 2890, 
2860, 1467, 1255, 1093, 838 cm-1; 1H NMR (CDC13, 300MHz) 8 0.07 (6H, s), 0.90 
(9H, s), 0.95 (3H, d, J = 7 Hz), 1.11 (3H, d, J = 7 Hz), 1.72-1.81 (1H, m), 2.23-2.35 
(1H, m), 3.20 (1H, brd, J = 2 Hz), 3.57 (1H, dt, J = 9, 2 Hz), 3.67 (1H, dd, J = 10, 4 
Hz), 3.39 (1H, dd, J = 10, 2 Hz), 4.97 (111, dd J = 10, 2 Hz), 5.05 (1H, dd, J = 17, 1 
Hz), 5.62 (1H, ddd, J = 17, 10, 9 Hz); 13C NMR (CDC13, 75MHz) 8 -5.8, -5.7, 9.2, 
17.1, 18.1, 25.8(3C), 36.1, 42.1, 69.3, 78.2, 114.4, 141.2; MS (CI) m/z 259 (M++1), 
258 (Mt), 243, 203, 145, 127, 109; HRMS (CI) m/z 259.2093 (calcd for C14H3002Si 
+ H-1-: 259.2093). 171
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(2R,3R,4S)-1,3-Dit(tert-butyldimethylsilyl)oxy]-2,4-dimethylhex-5-ene (153). To a 
solution of 152 (2.06 g, 7.98 mmol) in dichloromethane (45 mL) under argon at 0°C 
was added triethylamine (2.78 mL, 19.9 mmol) and  tert-butyldimethylsilyl triflate 
(2.56 mL, 11.2 mmol). The mixture was stirred for 1.5 h at 0°C and the reaction was 
quenched by addition of saturated sodium bicarbonate solution (60 mL). The mixture 
was diluted with ether (250 mL), and after separation the organic layer was washed 
with water (150 mL) and was dried (magnesium sulfate). Removal of the solvent was 
followed by chromatography of the residue on silica gel, with gradient elution from 
100% hexane to 2% ethyl acetate in hexane, to yield 2.93 g (99%) of 153 as a colorless 
oil: [ar -17.2° (c 1.04, CHC13); IR (neat) 2957, 2931, 2889, 2859, 1488, 1254, 1105, 
1052, 775 cm-1; 1H NMR (CDC13, 300MHz) 8 0.03 (6H, s), 0.06 (6H, s), 0.78 (3H, d, 
J = 7 Hz), 0.89 (9H, s), 0.91 (9H, s), 1.00 (3H, d, J = 7 Hz), 1.71-1.84 (1H, m), 2.29­
2.41 (1H, m), 3.33-3.47 (2H, m), 3.68 (1H, dd, J = 7, 2 Hz), 4.92-5.02 (2H, m), 5.81 
(1H, ddd, J = 18, 10, 8 Hz); 13C NMR (CDC13, 75MHz) 8 -5.4, -5.4, -4.3, -3.8, 10.5, 
16.8, 18.1, 18.4, (25.8, 26.1)(6C), 38.7, 42.7, 65.9, 74.8, 113.2, 142.1; HRMS (CI) m/z 
373.2958 (calcd for C20H45O2Si2: 373.2957); Anal. Calcd for C20H4502Si2: C, 
64.44; H, 11.90. Found: C, 64.55; H, 11.79. 172
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OTBS 
(2R,3R,4S)-3-[(tert-Butyldimethylsilyl)oxy]-1-hydroxy-2,4-dimethylhex-5-ene 
(154). A stirred solution of 153 (279 mg, 0.750 mmol) and ammonium fluoride (278 
mg, 7.50 mmol) in methanol (10 mL) was heated at reflux for 12 h and allowed to cool 
to room temperature. The solvent was removed under reduced pressure, and the 
residue was dissolved in 10% ethyl acetate in hexane (10 mL). Chromatography on 
silica gel, with gradient elution from 10% to 75% ethyl acetate in hexane, yielded 170 
mg (88%) of 154 as a colorless oil:  [a][2:2, -21.3° (c 0.97, CHC13); IR (neat) 3540 (br), 
2959, 2932, 2887, 2859, 1487, 1254, 1100, 838 cm-1; 1H NMR (CDC13, 300MHz) 8 
0.07 (6H, s), 0.08 (3H, s), 0.84 (3H, d, J = 7 Hz), 0.91 (9H, s), 1.03 (3H, d, J = 7 Hz), 
1.88-1.94 (2H, m), 2.37-2.43 (2H, m), 3.43-3.61 (2H, m), 3.65 (1H, dd, J = 7, 2 Hz), 
4.94-5.02 (2H, m), 5.80 (1H, ddd, J = 18, 10, 8 Hz); 13C NMR (CDC13, 75MHz) 8 
-4.2, -3.9, 11.4, 17.1, 18.3, 26.1(3C), 39.5, 42.0, 66.1, 76.5, 113.6, 142.1; HRMS (CI) 
m/z 259.2093 (calcd for C14H3002Si + H+: 259.2093); Anal. Calcd for C14H3002Si: 
C, 65.07; H, 11.71. Found: C, 65.22; H, 11.81. 
0  OTBS 
(4S,5R,6S)-5-[( tert-Butyldimethylsilypoxy]-4,6-dimethyloct-7-en-3-one (157). To a 
solution of oxalyl chloride (1.25 mL, 14.0 mmol) in dichloromethane (60 mL) under 
argon at -78°C was added dimethyl sulfoxide (1.99 mL, 28.0 mmol). The mixture was 
stirred for 35 min and a solution of 154 (725 mg, 2.80 mmol) in dichloromethane (10 173
 
mL) was added dropwise via cannula. Stirring was continued for 1 h and triethylamine 
(7.8 mL, 56 mmol) was added. The mixture was stirred for 40 min at -78°C and 
allowed to warm to room temperature for 1 h. The reaction was quenched by addition 
of water (2 mL), and the mixture was diluted with pentane (30 mL) and was washed 
with brine (30 mL) and water (30 mL). The aqueous wash was extracted with pentane 
(30 mL) and twice with ether (30 mL), and the combined organic layers were dried 
(sodium sulfate). Removal of the solvent gave crude 155 as a yellow oil which was 
used without purification: 1H NMR (CDC13, 300MHz) 5 -0.01 (3H, s), 0.08 (3H, s), 
0.88 (9H, s), 1.03 (3H, d, J = 7 Hz), 1.10 (3H, d, J = 7 Hz), 2.32-2.44 (1H, m, J = 7 
Hz), 2.48-2.56 (1H, dq, J = 7, 3 Hz), 4.04 (1H, dd, J = 7, 3 Hz), 4.99-5.07 (2H, m), 
5.77 (1H, ddd, J = 18, 10, 8 Hz), 9.73 (1H, s). 
To a solution of crude 155 (2.80 mmol) in ether (65 mL) under argon at -78°C 
was added ethylmagnesium bromide (3.0 M in ether, 3.73 mL, 11.2 mmol) dropwise. 
The solution was stirred for 2 h at -78°C and the reaction was quenched with saturated 
ammonium chloride solution (7 mL) followed by 1 N hydrochloric acid solution (7 
mL). The mixture was stirred for 10 min and was diluted with ether (30 mL). The 
mixture was washed with saturated ammonium chloride solution (30 mL). The 
aqueous wash was extracted three times with ether (30 mL), and the combined ethereal 
extracts were dried (sodium sulfate). Removal of the solvent gave crude 156 as a 
yellow oil which was used without purification. A sample of 156 was purified for 
analysis: [at-2 -29.0° (c 1.09, CHC13); IR (neat) 3016, 2961, 2931, 2887, 2859, 1465, 
1254, 1052, 838 cm-1; 1H NMR (CDC13, 400MHz) 5 0.09 (6H, s), 0.89 (3H, d, J = 7 
Hz), 0.91 (9H, s), 0.93 (3H, t, J = 7 Hz), 1.00 (3H, d, J = 7 Hz), 1.43-1.50 (2H, m), 
1.63-1.69 (1H, m), 1.83 (1H, brs), 2.42-2.47 (1H, m), 3.51-3.55 (1H, m), 3.68 (1H, dd, 
J = 5, 3 Hz), 4.97-5.02 (2H, m), 5.94 (1H, ddd, J = 18, 11, 7 Hz); 13C NMR (CDC13, 
100MHz) 8 -4.1, -3.4, 8.4, 10.3, 15.7, 18.3, 26.1, 28.0, 40.1, 42.3, 76.0, 79.1, 113.5, 174
 
141.6; MS (CI) m/z 287 (M++1), 286 (Mt), 285, 269, 257, 231, 201, 199, 173, 159, 
155, 137, 109; HRMS (CI) m/z 287.2405 (calcd for C16H3402Si + H+: 287.2407). 
A solution of crude 156 (2.80 mmol) and Dess-Martin periodinane (3.13 g, 7.40 
mmol) in wet dichloromethane (55 mL) was stirred for 1.5 h at room temperature, and 
ether (50 mL) and 1 N sodium hydroxide solution (50 mL) were added.  After 
separation, the organic layer was washed with water (50 mL). The combined aqueous 
washes were extracted three times with ether (60 mL), and the combined organic layers 
were dried (magnesium sulfate).  Removal of the solvent was followed by 
chromatography of the residue on silica gel, with gradient elution from 2% to 5% ethyl 
acetate in hexane, to yield 651 mg (82% from 154) of pure 157 as a colorless oil: 
[a]o -2.7° (c 2.25, CHC13); IR (neat) 2961, 2936, 2893, 2856, 1716, 1465, 1260, 1057, 
838 cm-1; 1H NMR (CDC13, 400MHz) 8 -0.05 (3H, s), 0.02 (3H, s), 0.85 (9H, s), 0.92 
(3H, d, J = 7 Hz), 0.98 (3H, t, J = 7 Hz), 1.03 (3H, d, J = 7 Hz), 2.17-2.26 (1H, m), 
2.36-2.49 (2H, m), 2.59-2.65 (1H, m), 3.92 (1H, dd, J = 5 Hz), 4.93-4.97 (2H, m), 
5.71-5.80 (1H, m); 13C NMR (CDC13, 100MHz) 8 -4.1(2C), 7.6, 12.3, 15.5, 18.3, 
26.0(3C), 35.0, 43.0, 49.8, 75.9, 114.3, 141.4, 213.5; HRMS (CI) m/z 285.2249 (calcd 
for C16H3202Si + H+: 285.2251). 175
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Ethyl Ketone 158. A stream of ozone was passed through a solution of 157 (30.0 mg, 
0.105 mmol) in dichloromethane (3 mL) and methanol (0.5 mL) at -78°C for 5 min. 
The excess ozone was purged with argon for 15 min. Dimethyl sufide (0.8 mL) was 
added and the mixture was stirred for 2 h at room temperature under argon. Removal 
of the sovent gave 28.0 mg of crude 10 as a pale oil which was used immediately for 
the next step. 
To a solution of diisopropylamine (0.037 mL, 0.026 mmol) in tetrahydrofuran 
(0.2 mL) under argon at 0°C was added n-butyllithium (1.33 M in hexane, 0.020 mL, 
0.027 mmol) dropwise and the mixture was stirred for 15 min at 0°C. The solution was 
cooled to -78°C and a solution of 7 (20 mg, 0.026 mmol) in tetrahydrofuran (0.4 mL) 
was added dropwise. The solution was stirred for 45  min at -78°C and a solution of 
crude 10 (8.1 mg, 0.028 mmol) in tetrahydrofuran (0.2 mL) was added dropwise. The 
solution was stirred for 45 min at -78°C, slowly warmed to 0°C over a period of 15 
min, and stirred for 30 min at 0°C. A saturated ammonium chloride solution (2 mL) 
was added, and the mixture was stirred for 15 min and was diluted with ether (20 mL). 
After separation, the aqueous layer was extracted three times with ether (10 mL), and 
the combined organic layers were washed with 5% hydrochloric acid solution (20 mL), 
water (20 mL) and brine (20 mL), and were dried (magnesium sulfate). Removal of the 176 
solvent followed by chromatography of the residue on silica gel, using 7% ether in 
hexane as eluant, afforded 17 mg (76%) of 158 as a colorless oil:  [0]232 -52.9° (c 1.17, 
CHC13); IR (neat) 2958, 2930, 1716, 1254, 1095, 834 cm- 1; 1H NMR (CDC13, 
300MHz) 8 0.01 (3H, s), 0.05 (9H, s), 0.80-1.00 (25H, m), 1.02-1.05 (6H, m), 1.07 
(3H, d, J = 8 Hz), 1.18 (3H, d, J = 6 Hz), 1.25-1.66 (15H, m), 1.76 (1H, dd, J = 13, 5 
Hz), 1.89-2.09 (3H, m), 2.37-2.51 (3H, m), 2.61 (1H, quint, J = 7 Hz), 3.64-3.74 (2H, 
m), 3.80 (1H, m), 4.03 (1H, t, J = 5 Hz), 5.28 (1H, dt, J = 12, 5 Hz), 5.75 (1H, dd, J = 
16, 1 Hz), 5.94 (1H, d, J = 14 Hz), 6.25 (1H, dd, J = 14, 9 Hz), 6.96 (1H, dd, J = 16, 7 
Hz); 13C NMR (CDC13, 75MHz) 8 (-4.5, -4.3, -4.1)(4C), 4.9, 7.6, 11.0, 11.5, 13.3, 
14.1, 18.1, 18.3, 24.5, (25.9, 26.0)(6C), 26.4, 27.0, 29.6, 29.7, 30.2, 31.0, 35.1, 35.3, 
35.7, 41.5, 43.2, 48.7, 49.9, 67.2, 69.5, 70.3, 70.6, 74.2, 75.3, 97.5, 121.2, 150.4, 151.5, 
165.6, 213.5; MS (FAB) m/z 904 (M-E), 890, 876, 847, 820, 759, 703, 637, 577, 519, 
445, 403, 373, 345, 325, 267, 229, 193, 159; HRMS (FAB) m/z 577.2572 [calcd for 
C441181107Si 2 OC(0)R (C17H3104Si) : 577.2572]. 
Hydroxy Ketone 159. To a solution of 158 (110 mg, 0.121 mmol) in dichloromethane 
(0.8 mL) under argon at -78°C was added dropwise a solution of titanium(IV) chloride 
(1.0 M in dichloromethane, 0.326 mL, 0.326 mmol) followed by diisopropylethylamine 177 
(0.058 mL, 0.419 mmol). The deep red solution was stirred for 2 h at -78°C, after 
which a precooled (-78°C) solution of 9 (144 mg, 0.256 mmol) in dichloromethane (1.2 
mL) was added via cannula. The resulting pale red solution was stirred for 1 h at 
-78°C, allowed to slowly warm, and was stirred at -45°C for 7 h. The reaction was 
quenched by addition of pH 7 phosphate buffer solution (2 mL) and was diluted with 
ether (20 mL). The solution was washed with saturated sodium bicarbonate solution 
(20 mL) and brine (20 mL), and the aqueous wash was extracted three times with ether 
(20 mL). The combined ethereal extracts were dried (magnesium sulfate) and the 
solvent was removed. Chromatography of the residue on silica gel, with gradient 
elution from 2% to 20% ethyl acetate in hexane yielded 79.0 mg (72%) of 158, and 
75.0 mg of a mixture of 159 and 9. A purified sample of 159 was obtained by 
repeating the chromatographic separation described above:  [a]p2 -35.5° (c 0.77, 
CHC13); IR. (neat) 3487 (br), 2956, 2930, 2884, 2857, 1724, 1713, 1481, 1464, 1254, 
1095, 834 cm-1; 1H NMR (CDC13, 300MHz) 8 0.01-0.17 (24H, m), 0.59-0.71 (6H, q, 
J = 5 Hz), 0.81 (6H, d, J = 8 Hz), 0.86-1.03 (19H, m), 0.87-0.88 (36H, m), 0.98 (9H, t, 
J = 8 Hz), 1.11-1.33 (20H, m), 1.38-1.53 (8H, m), 1.57-1.64 (5H, m), 1.70-1.80 (1H, 
m), 1.84-1.97 (1H, m), 1.98-2.10 (2H, m), 2.30-2.43 (1H, m), 2.60-2.64 (1H, m), 2.78­
2.90 (1H, m), 3.52-3.74 (6H, m), 3.75-3.86 (1H, m), 3.92 (1H, d, J = 11 Hz), 4.08-4.19 
(2H, m), 5.20-5.30 (1H, td, J = 11, 5 Hz), 5.75 (1H, d, J = 16 Hz), 5.94 (1H, d, J = 14 
Hz), 6.22-6.30 (1H, dd, J = 14, 9 Hz), 6.94-7.00 (1H, dd, J = 16, 7 Hz);  13C NMR 
(CDC13, 75MHz) 8 (-5.5, -5.3, -4.5, -4.4, -4.3, -4.0, -3.8)(8C), (4.9, 5.4)(3C), 7.0(3C), 
10.9,  11.5, 12.1, 12.7, 13.0, 13.4, 14.0, 15.2, 15.8, (18.0, 18.1,  18.3)(4C), 22.6, 24.4, 
25.7, (25.80, 25.83, 25.9, 25.97, 26.00)(12C), 26.3, 27.0, 29.4, 29.6, 30.1, 31.0, 31.5, 
35.0, 35.6, 39.0, 41.4, 43.1, 48.7, 50.3, 55.5, 60.6, 67.1, 69.4, 70.2, 70.4, 73.5, 74.1, 
75.8,  77.1, 78.9, 97.4, 120.9, 150.3, 151.7, 165.5, 214.9; MS (FAB) m/z 1487 178
 
(M++Na), 1465 (M++1), 1407, 1316, 1276, 1183, 1155, 1087, 989, 875, 819; HRMS 
(FAB) m/z 1407.8050 (calcd for C731-11451011Si5-C4H9: 1407.7978). 
TBS
 
Hexasilyl Ether 160. To a solution of 159 (74 mg) in dichloromethane (0.7 mL) under 
argon at 0°C was added 2,6-lutidine (0.048 mL, 0.40 mmol) and the mixture was stirred 
for 5 min at 0°C. tert-Butyldimethylsilyl triflate (0.048 mL, 0.20 mmol) was added 
dropwise and the mixture was stirred for 2.5 h at 0°C, after which an additional 
quantity of 2,6-lutidine (0.048 mL, 0.40 mmol) and tert-butyldimethylsilyl triflate 
(0.048 mL, 0.20 mmol) was added.  Stirring was continued for 17 h at 0°C, and the 
reaction was quenched by addition of saturated sodium bicarbonate solution (2 mL). 
The mixture was diluted with ether (20 mL) and was washed with saturated sodium 
bicarbonate solution (20 mL) and water (20 mL). The aqueous wash was extracted 
three times with ether (20 mL), and the combined ethereal extracts were dried 
(magnesium sulfate). Removal of the solvent was followed by chromatography of the 
residue on silica gel, with gradient elution from 2% to 5% ethyl acetate in hexane, to 
yield 41 mg of recovered impure 159 and 30 mg (84% based on recovered 159, 30% 
from 158 based on recovered 158) of 160 as a colorless oil:  [a]p -27.0° (c 1.40, 
CHC13); IR (neat) 2956, 2930, 2884, 2859, 1724, 1713, 1480, 1464, 1254, 1095, 834 179
 
cm-1; 1H NMR (CDC13, 300MHz) 8 -0.05-0.13 (30H, m), 0.57-0.70 (6H, m, J = 5 
Hz), 0.81 (6H, d, J = 7 Hz), 0.83-1.00 (6H, m), 0.87-0.88 (45H, m), 0.96 (9H, t, J = 8 
Hz), 1.00-1.05 (5H, m), 1.09 (3H, d, J = 7 Hz), 1.18-1.34 (12H, m), 1.38-1.64 (12H, 
m), 1.67-1.82 (4H, m), 1.84-1.97 (1H, m), 1.98-2.10 (2H, m), 2.20-2.30 (1H, m), 2.64­
2.73 (1H, d, J = 7 Hz), 2.92 (1H, t, J = 7 Hz), 3.41-3.51 (1H, m), 3.53-3.65 (4H, m), 
3.71-3.75 (1H, m), 3.78-3.84 (2H, m), 4.06-4.09 (1H, dd, J = 7, 2 Hz), 4.15 (1H, d, J = 
8 Hz), 5.24-5.31 (1H, td, J= 12, 5 Hz), 5.71-5.76 (1H, dd, J= 16, 2 Hz), 5.94 (1H, d, J 
= 14 Hz), 6.22-6.30 (1H, dd, J = 14, 9 Hz), 6.91-6.98 (1H, dd, J = 16, 6 Hz); 13C NMR 
(CDC13, 75MHz) 8 -5.5, -5.4, -4.5, -4.3, -4.2, -4.1, -4.0, -3.9, -3.7, -3.4, (4.8, 5.6)(3C), 
(7.1, 7.2)(3C), 10.7, 11.3, 11.8, 13.9, 14.5, 15.4, 18.0, 18.1, 18.31, 18.35, 18.5, 24.4, 
25.6, (25.83, 25.87, 25.90, 26.0, 26.19, 26.23, 26.32)(15C), 27.0, 29.5, 29.6, 30.1, 31.0, 
31.6, 35.0, 35.6, 39.4, 40.7, 42.2, 43.1, 43.5, 47.7, 48.7, 51.2, 60.8, 61.4, 67.1, 69.4, 
70.2, 70.3, 71.2, 74.1, 75.2, 75.5, 76.1, 77.1, 78.2, 97.4, 121.0, 150.3, 152.4, 165.4, 
213.8; MS (FAB) m/z 1579 (M++1), 1578 (Mt), 1577 (Mt-1), 1521, 1448,  1390, 
1316, 1276, 1183, 1155, 1087, 989, 875, 819; HRMS (FAB) m/z 1521.8788 (calcd for 
C79H159IO11Si 6 C4H9: 1521.8838). 180
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